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ABSTRACT
Advisor: Paul L. Sorgen, Ph.D.

Gap junctions are intercellular channels that permit the free passage of ions, small metabolites,
and signaling molecules between neighboring cells. In the diseased human heart, altered
ventricular gap junction organization and connexin expression (i.e., remodeling) are key
contributors to rhythm disturbances and contractile dysfunction. Connexin43 (Cx43) is the
dominant gap junction protein isoform in the ventricle which is under tight regulation by
serine/tyrosine phosphorylation. Phosphorylation and dephosphorylation regulate many aspects of
Cx43 function including trafficking, assembly and disassembly, electrical and metabolic coupling
at the plaque, as well as to modulate the interaction with other proteins.
Serine phosphorylation has long been reported to regulate Cx43, however, the understanding
of tyrosine kinases/phosphatases in the modulation of gap junction intercellular communication
and subsequent down-stream effects on cellular processes is limited to Src. Using a combination
of biophysical and cellular biology techniques, we identified and characterized a novel tyrosine
phosphatase T-Cell Protein Tyrosine Phosphatase (TC-PTP) and a tyrosine kinase Tyrosine Kinase
2 (Tyk2) that directly interact with the Cx43 carboxyl terminal domain (CT). Cx43CT residues
Y247 and Y265, which are phosphorylated by c-Src and v-Src, are also directly targeted by both
TC-PTP and Tyk2. Additionally, activation of both TC-PTP and Tyk2 also indirectly affect serine
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phosphorylation of Cx43. Specifically, TC-PTP leads to dephosphorylation of Cx43 S368 by
inactivating PKCα and PKCδ, while Tyk2 increases phosphorylation of S368 and S279/282
through activation of PKC and MAPK, respectively. These effects are independent of Src.
In the cardiovascular system, an increased level of angiotensin II (Ang II) is associated with
increased risk of ventricular arrhythmia, hypertrophy, and sudden death. Ang II reduces TC-PTP
expression while increasing Tyk2 activity. Our data show that TC-PTP dephosphorylation
maintains Cx43 gap junctions at the plaque as well as partially reverses channel closure caused by
v-Src phosphorylation. Conversely, Tyk2 inhibits gap junction communication and increases
turnover rate by phosphorylating Cx43. These findings suggest that a decrease of TC-PTP and an
increase of Tyk2 may mediate Cx43 gap junction remodeling by altering phosphorylation in Ang
II induced cardiovascular pathology.
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CHAPTER 1
Introduction
CHAPTER 1 Introduction
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1.

Gap Junction Overview
Many mechanisms enable cells to influence the behavior of one another in order to

maintain proper tissue and organ function. Cells secrete signal molecules that can
influence itself (autocrine signaling), neighboring cells (paracrine signaling), or cells
from large distances (endocrine signaling). In addition, cells can directly communicate
with adjacent cells by exchanging ions and low molecular weight metabolites (<1 kDa)
through gap junction channels.
Gap junctions are integral membrane proteins that provide an intercellular pathway
for the propagation and/or amplification of signal transduction cascades triggered by
cytokines, growth factors, and other cell signaling molecules involved in growth
regulation and development. Gap junctions are formed by the apposition of connexons
from adjacent cells, where six connexin proteins make each connexon. Connexins are
proteins with four transmembrane domains (TM1-TM4), two extracellular loops (E1
and E2), and intracellular N-terminal (NT), cytoplasmic loop (CL), and C-terminal (CT)
domains (Figure 1.1). In mammals, there are 21 human and 20 mouse isoforms, of
which 19 can be paired orthologously (Sohl and Willecke, 2004). In invertebrates, gap
junctions are assembled from another class of tetra transmembrane proteins named
innexins (Phelan et al., 1998). The most frequently used nomenclature of connexin is
based on their molecular weight differences. For example, the 43 kDa connexin is
named Cx43. Also, connexin genes can be categorized into 3 subgroups (α, β, or γ)
based on their overall gene homology and structure motifs (Eiberger et al., 2001), as
well as named according to the order of discovery in the subgroup (e.g. Cx43 gene is
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also named Gja1).
Connexins are differentially expressed in almost all tissues within the human body,
with exceptions in skeletal muscle and mobile cell types such as sperm and erythrocytes
(Rackauskas et al., 2010). Commonly, a cell can express several connexin isoforms.
The same isoform of connexins oligomerize to form a homomeric connexon, different
isoforms oligomerize to form a heteromeric connexon. To date, all heteromeric
connexons are composed of two isoforms from the same subgroup (Falk et al., 1997).
In addition, a gap junction channel can be formed from two identical connexons
(homotypic) or different connexons (heterotypic) (Figure 1.1). Since different types of
gap junction channels have different channel properties, including pore size,
conductance, and ion selectivity, alterations in both the amount and distribution of
connexins in cells are associated with a number of pathological situation such as
arrhythmia , atherosclerosis (Morel et al., 2009), deafness (Martinez et al., 2009), and
cancers (Naus and Laird, 2010). For example, Cx40, Cx43, and Cx45 expression in a
cardiomyocyte can form either homomeric pattern or heterogeneous pattern with each
other. The unitary conductance, which reflects single channel current-voltage
relationship, is Cx40 (150 ps)>Cx43 (115 ps)>Cx45 (32 ps) (Bukauskas et al., 2002;
Rackauskas et al., 2007). Cx40 and Cx45 channels exhibit smaller permeability to
anions than cations, whereas Cx43 channels are nonselective to charge (Rackauskas et
al., 2007). In failing human hearts, decreased expression of Cx43 correlates with an
increase of Cx45. These gap junctions exhibit a decreased conductance which increase
the risk of ventricular arrhythmias (Teunissen et al., 2004).
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Figure 1.1 Structure and molecular organization of gap junctions. (A) Gap junction
channels are composed of hemichannels (connexons) from adjacent cells docking with
each

other. Three

different

types

of

gap

junctions

have

been

shown:

homomeric/homotypic (1,4), heterotypic (2), and heteromeric (3). (B) A connexon is an
assembly of six connexins. A connexin has four transmembrane domains (TM1-TM4),
two extracellular loops (E1 and E2), and one cytoplasmic loop (CL), cytoplasmic
carboxyl termini (CT) and amino termini (NT).
.

Figure 1.1 Structure and molecular organization of gap
junctions
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Gap junction intercellular communication is essential in many physiological
processes, including cell growth and sorting, differentiation and synchronization,
metabolic coordination, as well as in the immune response. Loss-of-function mutations
of connexin genes are often associated with hereditary diseases. Mutations in Cx26
gene are responsible for a large proportion of autosomal recessive hearing impairment
in human (Rabionet et al., 2002). Mice with homozygous ablation of Cx26 in the
epithelial network of the inner ear leads to deafness and cell death in cochlear epithelial
network and sensory hair cells shortly after birth (Cohen-Salmon et al., 2002). More
than 240 mutations in Cx32 have been found to be related to Charcot-Marie-Tooth
disease (CMTX), one of the most common inherited neurological disorders in the
United States (Bergoffen et al., 1993). Cx32 knockout mice also developed CMTX-like
phenotype, including a progressive, demyelinating peripheral neuropathy (Rabionet et
al., 2002). Both Cx46 and Cx50 are required for lens development in human and mouse
eyes (White, 2002). Tissue specific deletion of Cx46 or Cx50 in a mouse model resulted
in cataract formation (White, 2002). Knockout of some connexin isoforms are lethal to
animals. For example, Cx45-deficient mice died before birth and Cx43-knockout mice
died shortly after birth (Kruger et al., 2000; Reaume et al., 1995). These results suggest
the importance in development of these isoforms and their function cannot be
substituted by other isoforms (Sohl and Willecke, 2004). Mutations in Cx43 lead to
oculodentodigital dysplasia (ODDD) in humans, which is characterized by multiple,
variable craniofacial, limb, ocular and dental abnormalities. A mouse model harboring
the same mutation shows a similar phenotype (Churko et al., 2011).
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2.

Gap Junction Regulation
As an important channel that enables communication between adjacent cells, gap

junctions are under tight regulation. First, different tissues and cell types express
different connexin isoforms and their expression levels vary over time even in the same
cell. Multiple mechanisms are involved in tissue and time specific control of connexins
at the mRNA level, protein synthesis, trafficking, assembly, and degradation.
Additionally, the function of gap junction channels at the plaque is regulated by various
factors such as phosphorylation, voltage, Ca2+, pH, and binding partners. In this section,
we will discuss the regulation of connexins in details.

2.1

Transcriptional Regulation of Connexins
The gene structure of connexins usually contains two or more exons. Classically,

the last exon has the coding region that is preceded by uncoding exons containing a 5′
untranslated region (5′-UTR). These uncoding exons allow alternative splicing to
generate different transcripts (Oyamada et al., 2005). This is important for connexin
tissue-specific expression. One example is Cx32, which has two transcripts. The first
promoter P1 is activated by hepatocyte nuclear factor-1 that leads to the synthesis of
one transcript in liver epithelial cells (Koffler et al., 2002). The second promoter P2 is
activated by Sox-10 that results in another transcript in Schwann cells (Bondurand et
al., 2001). Transcription factors play important role in connexin expression by
regulating alternative splicing. For example, nine Cx43 mRNA species have been
identified due to three promoter regions in Cx43 and alternative splicing mechanisms
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(Pfeifer et al., 2004). These alternatively spliced 5′-UTRs regulate Cx43 at the posttranscriptional level. Since transcription factor profiles are diverse from different cell
lines or tissues, the splicing mechanisms of Cx43 vary which generate different Cx43
transcripts, leading to different expression level of Cx43 (Pfeifer et al., 2004). Like
most genes, transcription of connexins is regulated by a cooperation of tissue specific
and universal transcription factors. For example, universal transcription factor Sp-1
binding sites have been found in connexin genes such as Cx32, Cx40, and Cx43 which
regulates the basal transcription of the mentioned connexin isoforms (Echetebu et al.,
1999; Linhares et al., 2004; Piechocki et al., 2000). Also, Cx40 can be regulated by
cardiac specific transcription factor Nkx2-5, GATA4, and Tbx5 (Linhares et al., 2004).
Cx40 is expressed in ventricles up to 14 days postcoitum, and disappears on day 19
(Delorme et al., 1995). This change within a very short period can be explained by
transcriptional factor HRT2 repressing the transcription of Tbx5 and GATA4 (Kathiriya
et al., 2004). The ubiquitous transcription factors can also be regulated by different
physiological conditions, leading to the different expression of connexins at different
periods. For example, progesterone inhibits Cx43 transcription by downregulating the
universal transcription factor AP-1 which results in the low expression level of Cx43
during pregnancy (Mitchell and Lye, 2002; Ou et al., 1997). At the time of labor, due
to the stretch of the myometrium and increase of estrogen, AP-1 expression is
upregulated which activates Cx43 transcription (Petrocelli and Lye, 1993; Presley et al.,
2005).
Epigenetic regulation also plays an important role in regulating connexin mRNA
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levels. This epigenetic regulation includes histone acetylation, DNA methylation, and
micro-RNAs. Histone acetylation, which usually associates with loss of chromatin
structure and activation of transcription, is mediated by histone acetryltransferases
(HATs). The deacetylation is mediated by histone deacytylases (HDAC). In some
studies, inhibition of HDAC is associated with increase of connexin expression in some
tissues, but this is not always the case (Ogawa et al., 2005) (Hernandez et al., 2006)
(Xu et al., 2013). Using a HDAC inhibitor to treat nonmalignant human peritoneal
mesothelial cells led to a rise of Cx43 mRNA and protein level in a dose-dependent
manner (Ogawa et al., 2005). A similar result was found in prostate cancer cell lines
(Hernandez et al., 2006). However, in primary cultured neonatal mouse ventricular
myocytes, HDAC inhibitors TSA and vorinostat dose-dependently decreased Cx43
mRNA and protein expression levels as well as the area of Cx43 gap junction plaques
(Xu et al., 2013). Interestingly, in primary cultures of adult rat hepatocytes, TSA
increased Cx32 protein levels while decreasing Cx26 protein levels (Vinken et al.,
2006). These differential regulatory mechanism by histone acetylation on connexins
expression may correlate to particular patterns of histone modification and different
transcriptional factors that are involved in connexin tissue-specific expression
(Hernandez et al., 2006; Vinken et al., 2006).
Methylation of cytosines regulates connexin expression in both normal
physiological and pathological situations, especially in cancer cells. In the normal
situation, DNA methylation contributes to the differential expression of different
isoforms. For example, in liver epithelium which expresses Cx43, the Cx32 promotor
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is methylated; whereas in hepatocytes which expresses Cx32, the Cx43 promotor is
methylated (Piechocki et al., 1999). In most cancer cells, connexin expression is
generally lower than in normal tissue or completely lost which is associated with the
uncontrolled growth. A high frequency of connexin promoter methylation is often
observed in connexin-silenced patients or cells (Yamasaki et al., 1999). For example,
methylation of Cx43 promotor decreasing the level of Cx43 has been found in nonsmall cell lung cancer (Chen et al., 2003) and nasopharyngeal carcinoma cells (Yi et al.,
2007). Cx26 methylation at the promotor region are associated with gene silencing in
lung cancer (Shimizu et al., 2006), breast cancer (Tan et al., 2002), and hepatocellular
carcinoma (Tsujiuchi et al., 2007). In colorectal carcinomas, hypermethylation was
found in Cx37, Cx30, Cx36, and Cx45 at various frequencies, however, only Cx45
methylation status was correlated with gene expression (Sirnes et al., 2011). Treatment
with the demethylating drug 5-aza-2'deoxycytidine restored Cx45 expression in cell
lines (HCT15, HT29, RKO and SW48) (Sirnes et al., 2011). Demethylation also reexpressed Cx43 and decreased cell growth in HeLa cells (King et al., 2000).
MicroRNA can also regulate connexin mRNA stability and translation. Cx43 is a
target for miR1. In coronary artery disease and ischemia, increased miR1 associates
with a reduction of Cx43 (Abdellatif, 2012). During skeletal muscle development, the
expression of Cx43 is lost in myoblasts, which is associated with the upregulated miR1
and miR-206 (Anderson et al., 2006). In the sciatic nerve of a chronic constriction injury
rat model, the downregulation of miR1 corresponds to the increase of Cx43 (Neumann
et al., 2015). This high expression of Cx43 contributes to the induction and/or
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maintenance of pain (Neumann et al., 2015). Furthermore, a recent study reported that
Cx43 is a functional target of miR-1298 in arteriosclerosis obliterans (Hu et al., 2015).
To date, Cx43 is the only isoform that has clear linked to the physiological relevance
mediated by microRNA. However, on Cx36 and Cx45 genes, multiple binding sites of
microRNA have been identifed (Rash et al., 2005).
In most cancers, such as breast cancer (reviewed in (McLachlan et al., 2007)),
colorectal cancer (reviewed in (Sirnes et al., 2015)), liver cancer (reviewed in (Vinken
et al., 2012)), and ovarian cancer ((Umhauer et al., 2000)), connexin protein expression
level decreases or connexins relocalize from the plasma membrane to intracellular
compartments. However, mRNA levels do not always correspond to these protein
levels. Caltabiano et al. (2010) found 90% of high histological grade astrocyte tumors
showed an intracytoplasmic positivity for Cx43 mRNA, although 80% of the high grade
astrocyte tumors had a significant reduction or negativity for Cx43 protein (Caltabiano
et al., 2010). Likewise, in malignant grade IV glioma samples with minimal Cx43
protein levels, 27.3% of the dataset exhibited a 2-fold decrease of Cx43 mRNA, while
20.3% showed a 2-fold increase of Cx43 mRNA (Gielen et al., 2013). Not only in brain
cancers, in lung cancer cell lines, traceable level of Cx43 mRNA and variable level of
Cx45 mRNA were detected by RT-PCR, but neither Cx43 nor Cx45 protein could be
detected by Western blot (Zhang et al., 2004). These findings suggest that the lack of
Cx43 protein in some cancer samples or cell lines are not due to a reduction of
transcription. Post-transcriptional and post-translational mechanisms could also play
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important roles in the regulation of Cx43’s life cycle, such as protein synthesis,
trafficking, gap junction assembly, internalization, and degradation.

2.2

Connexin Life Cycle

2.2.1

Synthesis of Connexin

Most connexins co-translationally insert into the ER membrane and fold into a
mature form with assistance from chaperones and disulphide-isomerases (John and
Revel, 1991) (Figure 1.2). A small portion of Cx26 and Cx43 can also be posttranslationally incorporated into ER microsomes (Ahmad et al., 1999; Zhang et al.,
1996). These misfolded or superfluous connexins will be removed through ERassociated degradation mechanism (ERAD) which will be discussed later (VanSlyke
and Musil, 2002).
Once translated, most connexins have a very short life span. The half-life of
connexins usually ranges from 1 to 5 h in both tissue and cultured cells (Beardslee et
al., 1998; Fallon and Goodenough, 1981; Laird, 2006). Connexins’ very short half-lives
contribute to the up- or down-regulation of gap junction coupling in order to meet the
quickly changed physiological requirement such as gap junction clear-up after laboring
(Laird, 2006). Similar to most proteins that form channels, oligomerization of
connexins occurs before delivery to the plasma membrane. Depending on the connexin
subtype, oligomerization can occur either in the ER–Golgi intermediate compartment
(Cx32) or trans-Golgi network (Cx43) (Koval, 2006).
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Figure 1.2 Life cycle of connexins.
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Figure 1.2 Life cycle of connexins. Connexins typically co-translationally insert into
the ER. Misfolded connexins are targeted for ERAD. Mature connexins can
oligomerize in either trans-Golgi network (TGN, such as Cx43) or in ER-Golgi
intermediate compartment (ERGIC, such as Cx32). Connexons are subsequently
transported to the plasma membrane, which is facilitated by microtubules. Connexons
may be functional as hemichannels or dock with another connexon from neighboring
cells to form a gap junction channel. Gap-junction channels assemble into plaques,
opening and exchanging secondary messengers. Old channels are found in the center
of plaques and new channels are at the boundaries. Gap-junction plaques internalize
into one of two adjacent cells as a double-membrane structure named annular junction
(connexosome). Also, connexons may internalize via endocytic pathways. Gap junction
degradation occurs in lysosomes or proteasome. This figure is adopted from (Laird,
2010).
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2.2.2

Connexin Trafficking and Gap Junction Assembly

Trafficking of connexins from Golgi to the cell membrane occurs by successive
vesicles budding and fusion from the ER through the Golgi stacks, and then the vesicles
are transported to the cell membrane. Some isoforms (e.g. Cx43) require microtubules
transport to reach the membrane while some others (e.g. Cx32 and Cx30) trafficking
independently from the microtubules (Qu et al., 2009; Thomas et al., 2005). Once
inserted into the plasma membranes, connexons diffuse freely within the lipid bilayer
(Thomas et al., 2005). A pulse–chase experiment demonstrated that new connexons
incorporate at the outer margins of old gap junction plaques (Gaietta et al., 2002). In
the Cx43 gap junction plaque, old and new channels can be distinctly separated (Lauf
et al., 2002; Thomas et al., 2005), whereas Cx26 plaque has substantially larger mobility
(Thomas et al., 2005). Older channels in the middle of a plaque internalize into vesicles
with various sizes (Gaietta et al., 2002). Interestingly, the traditional model of how new
synthesized Cx43 gap junction incorporate into the plaque was challenged by Shaw et
al. (Shaw et al., 2007). They found that Cx43 hemichannels were directly guided to gap
junction plaque dependent on EB1 (microtubule plus-end-tracking protein) which
tethers microtubules to the adhesion junctions (Shaw et al., 2007). Their model
emphasizes the importance of adhesion junction in the gap junction assembly, which
could be essential in the gap junction organization.

2.2.3

Gap Junction Internalization and Degradation

The internalization of large double-membrane gap junction vesicles termed
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“annular junctions” (also called connexosomes) were identified by electron microscopy
(Bjorkman, 1962; Ginzberg and Gilula, 1979). Accumulated evidence confirm that
annular junctions exist in cell lines and tissues (Kojima et al., 1996; Mazet et al., 1985;
Murray et al., 1997; Naus et al., 1993). When gap junction channels internalize, one
cell plays the role of acceptor and the other performs as a donor, as the doublemembrane vesicle internalizes into one of two opposing cells (Jordan et al., 2001). The
internalization of annular gap junction is clathrin-dependent (Larsen et al., 1979; Piehl
et al., 2007), while adaptor proteins such as Dab2, AP-2, and dynamin assist the process
(Gumpert et al., 2008). Besides annular junctions, gap junctions also internalize through
other mechanisms. In regenerating hepatocytes, the Cx32 gap junction plaque
disassembles into smaller aggregates, possibly for internalization (Fujimoto et al.,
1997). Caveolin also has been shown to co-immunoprecipitate and colocalize with
Cx43 and Cx26, indicating that connexins can be guided to lipid rafts and internalized
in a caveolae-dependent mechanism (Schubert et al., 2002).
Connexin degradation depends on both the proteasome and lysosome pathways.
The participation of the proteasome has been found for Cx43 and Cx32 degradation in
the ER (VanSlyke and Musil, 2002). Although most of the connexin proteins degraded
by the proteasome via ERAD are incorrectly folded, VanSlyke et al. (2002) estimated
that over 40% of Cx43 and Cx32 undergo ERAD under normal conditions. Inhibition
of ERAD increases gap junction channel formation and function (VanSlyke and Musil,
2002). One possible reason is that ERAD may regulate gap junction stability by
regulating Cx43’s binding partner, like ZO-1 (Girao et al., 2009). Ubiquitination is an
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important step for lysosomal degradation. Eps-15 interacts with unbiquitinated Cx43
that leads to degradation of Cx43 via endocytic pathway (Girao et al., 2009). Lysosomal
degradation is also important to gap junction. Annular gap junctions were detected in
lysosomes by electron microscopy (Ginzberg and Gilula, 1979; Qin et al., 2003).
Inhibition of lysosomal function increases the protein level of connexins (Laing et al.,
1997; Qin et al., 2003). Blocking lysosomal degradation associates with an increase of
Cx43 protein half-life but not preservation of gap junction plaques, while inhibition of
proteasomal degradation also increases the level of Cx43 as well as stabilizes Cx43 in
gap junction plaques in most cell types (Solan and Lampe, 2016).
Gap junctions are also degraded via autophagy. Cx43 and Cx50 annular gap
junctions were detected being enclosed by the autophagy-related protein LC3 via
electron microscopy (Lichtenstein et al., 2011). Knockdown of autophagy-related
protein Atg5 blocks the starvation induced connexin degradation (Lichtenstein et al.,
2011). In the liver, an increased enrichment of Cx26, Cx32, and Cx43 in
autophagosomes and lysosomes was identified in starved mice compared with fed wildtype mice (Bejarano et al., 2012).

2.3

Gap Junction Channel Gating
Gap junction channel gating is characterized by conductance. Gap junction

conductance Gj is described as Gj=N × Po × γ, where N is the amount of active channels
in the plasma membrane, Po is the open probability, and γ is the conductance of a single
channel. N is determined by gap junction expression, trafficking, assembly, and
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degradation, which was discussed in the last section. γ is dependent on the property of
different connexin isoforms. Po is controlled by the voltage, Ca2+ pH, phosphorylation,
and protein partner interaction which will be discussed in this section (Imanaga et al.,
2004).

2.3.1

Voltage Gating

Most gap junction channels are influenced by voltage. Gap junction channel detect
voltage changes by a “voltage sensor”, which includes charged amino acids. Then, the
voltage sensor transfers the electrical energy into mechanical energy, leading to the
conformational changes that affect channel gating (Gonzalez et al., 2007).
All vertebrate junctional conductance can be regulated by the transjunctional
voltage (Vj) and some gap junctions are sensitive to both Vj and Vm (transmembrane
voltage) (Gonzalez et al., 2007). Mutational analyses on Cx32 and Cx26 indicate that
charged amino acids on the NT-domain are essential to the Vj dependence (Oh et al.,
1999; Purnick et al., 2000; Verselis et al., 1994). The CT-domain is also an important
component of fast Vj-gating. Truncation of the CT-domain at Cx32220stop and Cx43257stop
lead to the loss of fast conductance and induce novel gating properties mostly dependent
on the slow gating (Revilla et al., 1999). A “ball-and-chain” model has helped to
describe the mechanism of fast Vj-gating in Cx channels. In this model, the movement
of the CT-domain toward the channel pore would cause the physical blockage of the
pore (Gonzalez et al., 2007). A similar model (so called “particle-receptor” model) was
used in the chemical gating of gap junction channels, such as acidification and
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phosphorylation that drive the channels into the closed state (will be discussed later)

Figure 1.3 “Receptor-and-particle” model (also “ball and chain” model) of
connexin regulation. (A) Under normal conditions, the particle (CT) is apart from the
pore. Under the particular stimulus (such as pH, Ca2+, phosphorylation), the particle
swings toward the channel, interacts with a receptor (CL) and blocks the channel. (B)
the bottom view of receptor and particle model.
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(Figure 1.3) (Homma et al., 1998; Liu et al., 1993; Zhou et al., 1999).
In some connexin channels, such as the rat Cx43 and the mouse Cx45, junctional
conductance is also sensitive to membrane potential, Vm (Barrio et al., 1997).
Interestingly, Vm sensitivity of Cx43 was observed in Xenopus oocytes but not in HeLa
cells (Bukauskas et al., 2001; Revilla et al., 2000). The uncoupling by membrane
depolarization may be a protection mechanism to keep neighboring cells from
electrotonic effect (passive spread of charge) of damaged cells.

2.3.2

pH-dependent Channel Gating

In the pathological situation, acidification closes most gap junction channels
(Bevans and Harris, 1999; Eckert, 2002; Liu et al., 1993; Werner et al., 1991), which
may be a mechanism for minimizing injury to normal cells via the bystander effect
(Spray et al., 2013). Gap junctions composed of different connexin isoforms have
different opening rates at physiological pH. For example, Cx43 channels are mainly
open at pH 7.2 (Ek-Vitorin et al., 1996), whereas only 1% of mouse Cx57 channels
open at this pH (Palacios-Prado et al., 2009). Under various pH conditions, some
connexin CT domains have different secondary structures. For example, circular
dichroism (CD) data identified that the soluble Cx43CT domain at pH 5.8 contains 7%
α-helical whereas little-to-no α-helical content was observed at pH 7.5 (Bouvier et al.,
2009). Besides Cx43, the Cx32 and Cx45 soluble CT domains gain α-helical structure
outside the membrane interface under acidic pH conditions (pH 5.8) (Spagnol et al.,
2016). Trexler et al. (1999) observed rapid closure with low pH application in Cx46
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hemichannels which demonstrates direct action of H+ on connexins (Trexler et al.,
1999). The pH sensor (H+ binding site) is located on the cytoplasmic side, probably
near the entrance of the pore (Trexler et al., 1999). As mentioned previously, pH
induced channel gating can also be explained by “particle-receptor” model (Morley et
al., 1996). Several studies in Xenopus oocytes have suggested the participation of
residues located in the CL and the CT in the pH gating (Ek-Vitorin et al., 1996; Ek et
al., 1994) (Peracchia and Wang, 1997; Wang and Peracchia, 1996). Truncation of
Cx43CT led to pH-insensitivity of the channel (Morley et al., 1996). pH sensitivity was
restored when co-expression of Cx43CT domain and the truncated pH-insensitive Cx43
(Morley et al., 1996). Additionally, co-expressing the Cx43CT with Cx32 (a less pHsensitive connexin isoform) increased the pH sensitivity (Morley et al., 1996). The
potential pharmaceutical applications of pH-dependent channel gating include a
cyclized heptapeptide, CyRP-71, which binds to Cx43CT and partially inhibits channel
closure by acidification (Verma et al., 2009).

2.3.3

Ca2+-dependent Channel Gating

Gap junctional communication can be inhibited by elevated intracellular Ca2+
concentration. Ca2+ effect on gating is mediated by calmodulin (CaM) via Ca2+dependent interactions with connexin cytoplasmic domains (Blodow et al., 2003;
Peracchia et al., 1983; Sotkis et al., 2001). Channel gating regulated by CaM has been
found for Cx32 (Peracchia et al., 2000), Cx36 (Burr et al., 2005), Cx43 (Lurtz and Louis,
2007), Cx44 (Zhou et al., 2009), Cx45 (Peracchia et al., 2003) and Cx50 (Chen et al.,
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2011). The interaction of CaM with connexins usually induces a conformational change
on the connexin proteins. Zhou et al. (2007) used multiple biophysic methods to identify
that CaM directly bound to the Cx43CL (aa 136-158) in a Ca2+ dependent manner (Zhou
et al., 2007). Upon CaM binding, the α-helical content in this Cx43CL increased (Zhou
et al., 2007). Cx32 has two CaM binding sites on the NT and the CT domains
respectively (Torok et al., 1997). Cx32CT, which is an intrinsically disordered protein,
exhibits an increased α-helical content upon binding CaM (Stauch et al., 2012).
Likewise, the induced α-helix by CaM was also found in the other connexin isoforms,
such as Cx44 and Cx50 (Chen et al., 2011; Zhou et al., 2009). This induced
conformational change in the cytosolic domains may block the pore of the gap junction
channel to limit passage of ions (Dodd et al., 2008; Peracchia et al., 2000). Addition of
connexin-derived peptides or CaM inhibitor to counteract the Ca2+/CaM-connexin
interaction can alter channel gating from the closed to open state (reviewed in (Zou et
al., 2014)).

2.4

Importance of the CT Domain for Regulation on Connexins

2.4.1

Intrinsically Disordered Proteins

Many proteins need to adopt a unique and well-ordered structure to be functional.
The precise conformation of functional groups is crucial for protein binding or catalysis
of a chemical reaction. However, over the last several decades, there has been a growing
recognition of functional proteins that do not adopt a defined three-dimensional
structure (nearly 40% in eukaryotic proteome). These proteins, which are defined as
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having over 30 continuous residues forming unstructured regions or domains, are
classified as intrinsically disordered proteins (IDPs). Indeed, the intrinsically
disordered portions in a protein are crucial. First, the unstructured regions may provide
a large interaction surface area for protein binding. Second, the conformational
flexibility of IDPs allows binding motifs to overlap, thus they can interact with
numerous other proteins. Third, various post-translational modification may induce a
conformation change in order to regulate the function of the protein (Babu et al., 2011).

2.4.2

Connexin Cytoplasmic Domains

The connexin cytoplasmic domains (NT, CL, and CT) play roles in gap junction
channel gating and modulating channel formation and function. They contain sites for
post-translational modifications and are able to interact with multiple protein partners
(Goodenough and Paul, 2009). NT is relatively conserved in length, whereas CL and
CT are various among different isoforms. Chimeric and point mutants are used to study
different features of cytoplasmic domains; CD, AUC and NMR have allowed for the
structural study of these domains. The following sections will provide detailed
information regarding the important features and structural aspects of connexin
cytoplasmic domains.
The connexin NT domains are composed of 22 (α-group connexins) or 23 (β-group
connexins) amino acids except Cx36 (24 residues) and Cx47 (25 residues) (Kyle et al.,
2008). NT domain is necessary for proper incorporation into the membrane as several
positively charged residues which act as anchors for the insertion are essential (Thomas
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et al., 2008). Mutation of a positively charged residue on the NT to a negatively charged
amino acid on Cx50 lead to the completely failure of plaque formation (Thomas et al.,
2008). Many mutations in the NT domain have been found to associate with different
diseases including CMTX (Cx32) (Bergoffen et al., 1993), deafness (Cx30) (Common
et al., 2002) and ODDD (Cx43) (Shibayama et al., 2005); most of these mutations cause
cytoplasmic retention or non-functional channels. The NT domain also participates in
regulating voltage gating and plays a fundamental role in ion permeation since it is
close to the channel where it can act as a voltage sensor (Purnick et al., 2000). The 3.5 Å
X-ray structure of Cx26 channel showed that the NT domains of six connexins compose
the funnel in the pore and could form the plug to close the pore while sensing the Vj
change (Maeda et al., 2009). A few post-translational modifications were found in the
NT domain of different connexins by MS. These include phosphorylation (Cx26 and
Cx32), hydroxylation (Cx26), deamidation (Cx46), and acetylation Cx26 (Locke et al.,
2006; Wang and Schey, 2009). However, functional study of these modifications are
lacking. Although the length of the NT domain is conserved among different connexin
isoforms, the structures are different. Solution NMR was used to determine the NT
domain structure from two β-group connexins: while Cx26NT contains a α-helix,
Cx32NT is completely disordered (Kalmatsky et al., 2009; Piechocki et al., 2000).
The length of the CL domains varies among the different connexin isoforms. Based
on length, they can be divided into three categories: short (30-35 aa), medium (50-55
aa), and large (80-105 aa) (Sohl and Willecke, 2004). The CL is also involved in
connexin trafficking and gap junction plaque formation. Studies show that deletion of
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the Cx43CL (aa 130-134) forms gap junction plaques but not deletion of aa 130-137,
suggesting the amino acids 135-137 could be critical for gap junction assembly
(Oyamada et al., 2002; Seki et al., 2004); notably, none of these mutants form functional
gap junctions. Similarly, deletion of Cx32CL (aa 111-116) shows less efficiency in the
dye transfer assay compare with wild-type (Martin et al., 2000). CL domain is also
important for protein interactions, which are involved in channel function. For example,
CaM binding sites have been identified in the second half of the CL domain of Cx43,
Cx44, and Cx50 (Chen et al., 2011; Zhou et al., 2009; Zhou et al., 2007). As previously
mentioned, CaM binding is important for the Ca2+-dependent closure of gap junctions.
Cx43CL also has been implicated to interact with the CT domain in a pH-dependent
manner; in the “particle-receptor” model, the Cx43CL domain plays the role as receptor
(Duffy et al., 2002). Post-translational modification on residues of CL domain includes
phosphorylation (Cx49, Cx50, and Cx56) and carboxylation (Cx26 and Cx32) (Locke
et al., 2006; Wang and Schey, 2009) (Berthoud et al., 1997). Phosphorylation on
Cx56CL S118 leads to down-regulation of intercellular communication and increased
degradation (Berthoud et al., 1997). The CL domain is largely unstructured but contains
α-helical propensity. The NMR structure of the Cx43CL peptide (D119-K144) shows
two α-helices (N122-Q129, K136-G143) in the second half of the loop (Duffy et al.,
2002). Cx32 and Cx36 also contain α-helical propensity in the second half of the loop
(Fort and Spray, 2009). Acidification or binding with calmodulin induce helical
structure in the Cx43CL, which increases the affinity for the Cx43CT (Duffy et al.,
2002; Zhou et al., 2007).
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In the connexin primary sequence, the most variable domain among connexin
isoforms is the CT domain. Different connexin CT domains are diverse in size, which
range from 10 amino acids in Cx26 to more than 310 amino acids in Cx62. CD analysis
of the soluble CT domain of Cx26, Cx32, Cx37, Cx40, Cx43, Cx45, and Cx50 shows
that they are all primarily disordered (Spagnol et al., 2016). However, some of the CT
domains have propensity to become α-helical upon post-translational modification or
protein-protein interaction (Bouvier et al., 2009). The structure of the Cx43CT domain
determined by solution NMR shows that the Cx43CT has two α-helical regions (A315T326 and D340-A348) (Sorgen et al., 2004). These two helical regions are involved in
the Cx43CT dimerization and the pH-dependent interaction with the CL domain,
indicating their roles in channel gating and pH sensitivity (Duffy et al., 2002; Sorgen et
al., 2004). In the Cx43CT structure when attached to the 4th transmembrane domain
(TM4-Cx43CT) reported by our laboratory, seven α-helical regions (H1-7) have been
predicted in the CT portion (Grosely et al., 2013). H4 (K303-A322) and H5 (D340L353), which contain the two helical regions identified in the soluble Cx43CT, span a
greater area (Grosely et al., 2013). The disordered regions outside of these helices are
responsible for binding with protein partners, and can undergo structural transitions
upon binding (Kieken et al., 2009; Saidi Brikci-Nigassa et al., 2012). Cx32CT and
Cx36CT also contain two distinctive regions with helical propensity (Fort and Spray,
2009). These α-helical domains may allow the formation of more ordered structure
during chemical gating or facilitate the cross-talk between different binding partners
(Sorgen et al., 2004). To date, among connexin isoforms, Cx45CT contains the largest
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α-helix (33.6%) that is involved in dimer formation (Kopanic and Sorgen, 2013).
Many post-translational modifications occur on the connexin CT domain; these
include phosphorylation, ubiquitination, hydroxylation, acetylation, nitrosylation,
oxidation, and palmitoylation ( reviewed in (Axelsen et al., 2013)). Gap junctions are
known to be highly regulated by phosphorylation and ubiquitination (except Cx26,
which is the only connexin has not been shown to be phosphorylated to date) (Traub et
al., 1989). The frequency of phosphorylation on connexin CT domain is extremely high,
because phosphorylation predominantly occurs in the disordered region of a protein
(Iakoucheva et al., 2004). Indeed, the disordered structure is crucial for establishing
hydrogen bonds between the substrates and its kinase partners, which is less likely if
the site is in ordered region (Iakoucheva et al., 2004). Phosphorylation can result in
changes of charge (each phosphorylation creates 2 negative charges at pH 7),
hydrophobicity, and structural transition (e.g. disorder-to-order) which mediates many
of the major functions in channel gating and life cycle (Davis, 2011; Fuxreiter et al.,
2004; Nishi et al., 2011). Phosphorylation can also regulate protein-protein interactions
by altering the thermodynamic favorability of binding (Boehr et al., 2009). Indeed,
many of the phosphorylation sites on the connexin CT domains are included within
protein binding regions (Kopanic and Sorgen, 2013; Solan and Lampe, 2005). Details
about how phosphorylation regulates gap junction communication will be discussed
later.
Many binding partners of the connexin CT domain have been identified, including
Zonula Occludens 1 (ZO-1), tubulin, mitogen-activated protein kinase (MAPK), v- and
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c-Src, casein kinase 1 (CK1), Drebrin, cAMP-dependent protein kinase, and CaM
(Ambrosi et al., 2016; Cooper and Lampe, 2002; Giepmans, 2004; Giepmans et al.,
2001; Li et al., 2004; Saez et al., 1990; Zou et al., 2014). A disordered connexin CT
domain is an ideal substrate for the regulation of intercellular signaling by facilitating
both high specificity and low affinity interaction with many different binding partners
to allow the rapid feedback to cytoplasmic signals (Dunker and Obradovic, 2001;
Sorgen et al., 2004).
The connexin CT alone has been observed in both of cytoplasm and nucleus to
regulate cell growth (de Feijter et al., 1996; Maqbool et al., 2015; Mennecier et al.,
2008; Moorby and Patel, 2001). Transfection of the Cx43CT domain in cardiomyocytes
and HeLa cells indicate that nuclear localization of the Cx43CT inhibits cell growth
(Dang et al., 2003). The 20 kDa fragment which was higher than the expected size of
Cx43CT (15 kDa) suggests the presence of post-translational modifications (Dang et
al., 2003). Further research discovered that in the Cx43CT down-regulated primary
human breast cancer samples, the decrease of Cx43CT is associated with the decrease
of p53, suggesting the regulatory role of nuclear localized CT domain on particular
genes (Maqbool et al., 2015). Since no DNA-binding motif has been found on the CT
domain, it may interact with transcription factors or complexes to regulate cell cycle
related gene expression.

3. Phosphorylation of Connexins
3.1 General Introduction of Connexin Phosphorylation
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Since connexins were first uncovered as phosphoproteins in the 1980s (Lowenstein,
1985; Saez et al., 1986), numerous phosphorylation sites have been identified (Table 1).
Phosphorylation regulates connexin proteins (except Cx26) in all stages of the connexin
life cycle (i.e. trafficking, assembly/disassembly, degradation, and channel gating
(Solan and Lampe, 2007)), electrical gating, and metabolic coupling (Lampe and Lau,
2004; Solan and Lampe, 2005, 2007; Thevenin et al., 2013). To date, Cx26 is the only
connexin not identified to be phosphorylated (Traub et al., 1989). Since Cx26 can form
functional channel, together with the fact that truncated Cx43 mutants that lack most of
the CT domain (the dominate phosphorylation domain of Cx43) can also form
functional channels, phosphorylation is not required for channel formation (Lampe and
Lau, 2004).
Most of the phosphorylation events that occur on connexins are serine/threonine
residues. Serine/threonine kinases that phosphorylate connexins include PKC, MAPK,
p34(cdc2)/cyclin B kinase, PKA, CK1, p34cdc2, PKG, CaMKII, and Akt (Lampe and
Lau, 2004; Palatinus et al., 2012). Several connexin isoforms are also phosphorylated
on tyrosine residues. To date, tyrosine kinases that have been identified to directly
phosphorylate connexin isoforms include Src (Loo et al., 1995), Fps (Kurata and Lau,
1994) and EGFR (Diez et al., 1998). In this section, we will discuss the methods for
studying phosphorylation on connexins, serine/threonine phosphorylation, and more
emphasis will be on tyrosine phosphorylation. Since Src is the most well studied
tyrosine kinase that directly phosphorylates Cx43 on tyrosine residues of the CT
domain and Cx43 phosphorylation by Src is fundamental to my dissertation, I will
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Table 1.1 Reported phosphorylation sites of connexins, responsible kinases and the
effect on gap junctions.
Kinases
Connexins
Phosphorylated residues Reported effects on GJs
Cx32
S233
increase GJIC
reduce GJIC
Cx35/36
S110, S276
Increase GJIC
PKA
Cx40
n/a
increase GJIC
rapid GJ assembly,
Cx43
S364, 365, 368, 369, 373
increase GJIC
Cx50
S395
increase GJIC
Cx43
S373
increase GJ size and GJIC
Cx50
n/a
increase GJIC
decrease GJ assembly,
decrease GJIC, reduce
Cx43
S365, 368, 369, 372, 373
half-life of Cx43, decrease
coupling
PKC
Cx32
S233
n/a
Cx56 chicken
homologue of
S118
decrease GJIC
Cx46
PKG
Cx35/36
S110, S276, S289
decrease GJIC
S244, 255, 257, 296, 297,
de-phosphorylation of
Cx43
306, 314, 325, 328, 330,
S306 during ischemia
364, 365, 369, 372, 373
reduces GJIC
Cx32
n/a
n/a
CaMKII
Cx36
n/a
increase GJIC
S326, T337, S381, 382,
Cx45
n/a
384, 385, 387, 393
Cx43
S 325, 328, 330
increase GJ assembly
CK1
Cx45
S 326, 382, 384, 387, 393
n/a
prevents membrane
targeting, promotes
Cdk5
Cx43
S279, S282
proteasome dependent
degradation
P34cdc2
Cx43
S255, S262
GJ internalization
GJ internalization,
Cx43
S 255, 262, 279, 282
decrease GJIC
MAPK
Cx50
n/a
n/a
Src
Cx43
T247, 265
reduce GJIC
EGFR
Cx32
Y243
n/a
This table is modulated from (Pogoda et al., 2016).
Table 1.1 Reported phosphorylation sites of connexins, responsible kinases and the effect on gap junctions.
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discuss the mechanism and the biological effects of Src phosphorylation on Cx43 in
detail.

3.2 Methods of Studying Phosphorylation on Connexins
Traditionally, direct incorporation of
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P was the primary choice to study the

phosphorylation on connexins. In this method, tagged-Cx transfected cells were
metabolically labelled with [32P] orthophosphate, immunoprecipitated and ran on 2D
SDS-PAGE. Serine, tyrosine, and threonine phosphorylation can be separated and
analyzed by autoradiography. Although this method does not identify the
phosphorylation site(s), it does provide information regarding the type of
phosphorylation. To study the function of phosphorylation on connexins, however,
identification of the phosphorylation sites is crucial. Before the wide use of MS for this
purpose, Edman degradation and site-directed mutagenesis were the main methods
employed to identify the specific phosphorylation sites. Cx43 S368 phosphorylated by
PKC (Lampe et al., 2000) and S255/279/282 phosphorylated by MAPK (Warn-Cramer
et al., 1996) were identified by these methods. In many connexin isoforms,
phosphorylation results in slower migration on SDS-PAGE gels, such as Cx40 (Chen
et al., 2004), Cx50 (Pelletier et al., 2015), and Cx43 (Solan and Lampe, 2009).
Differentially phosphorylated Cx43 results in multiple electrophoretic isoforms: a fast
migrating isoform (P0) and multiple slower migrating isoforms (P1 and P2) (Crow et
al., 1990; Matesic et al., 1994; Solan and Lampe, 2005). Solan et al. (2009) summarized
some of P0, P1, and P2 components in (Solan and Lampe, 2009). Phosphorylation-

30

dependent shifts may be caused by two reasons: first, phosphorylated residues adjacent
to proline could induce structural perturbations of the protein, which change the
electrophoretic mobility in SDS-PAGE (Smith et al., 1989). Second, the negative
charges on the phosphate group could disturb the charge-to-mass ratio by affecting the
protein-SDS interaction (Grosely et al., 2013b).
Within the past decade, a number of Cx43 phospho-specific antibodies were
developed and played important roles in study of phosphorylation sites in cyto or in
vivo. For example, by using phospho-specific antibody, Lampe et al. (2006) found
phosphorylation of S325/328/330 is involved in the P2 level (Lampe et al., 2006).
However, due to the complicated cell-signaling network, phosphorylation by a single
kinase on Cx43 is less likely. Thus, using phospho-specific antibody is hard to define
the components of the different migration levels of Cx43. For example, Solan et al.
(2008) showed pY247 and pY265 exist in all three migration levels in v-Src activated
LA-25 cells, suggesting the contribution of other phosphorylation sites (Solan and
Lampe, 2008). Therefore, to define the contribution of a single kinase to the migration
levels of Cx43, Grosely et al. (2013) used phospho-mimetic of Cx43CT (S/Y-D
mutation) and discovered that the nonphosphorylated Cx43CT, Src, PKC, and cdc2
phospho-mimetic isoforms migrate at P0, MAPK at P1, and CK1 at P2 (Grosely et al.,
2013b).
Phosphorylation can regulate the conformation of proteins, affecting their
subcellular localization. Thus, structure-specific antibodies can help to study the
relevance between phosphorylation and connexin localization. Lampe’s group in Fred
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Hutchinson Cancer Research Center developed two monoclonal antibodies, CT1 and
IF1, using the same peptide representing Cx43 360-382. However, two antibodies
selectively labelled different subcellular fractions of Cx43. Epitope of Cx43 IF1
developed by mapping to 375PRPDD379 requires P375 and P377 for binding (Sosinsky et
al., 2007). This antibody stains only gap junction plaques and recognizes the P0, P1,
and P2 forms, suggesting that the tertiary structure of P375–A379 is essential in targeting
Cx43 at the gap junction plaque (Sosinsky et al., 2007). Whereas, Cx43 CT1 labels
mainly perinuclear Golgi-like structures detecting a conformation that is nonphosphorylated on S364 and/or S365, suggesting that conformation of pS364/S365 may be
essential for membrane localization (Sosinsky et al., 2007).
Since the mid-1990s, MS has been consistently used for site-specific
phosphorylation analysis due to the development of several technologies. Matrixassociated laser desorption ionization (MALDI)-time-of-flight (TOF)-MS, collisioninduced dissociation (CID)-MS/MS, and electron-capture dissociation (ECD)-MS/MS
have been successfully used in analyzing phosphorylation sites on connexin isoforms
both in vitro and in vivo (Cooper et al., 2000; Huang et al., 2011; Locke et al., 2006).
Compare with traditional methods, MS is highly sensitive which can detect femtomole
of phosphopeptides, sensitive enough to detect most of phospho-proteins (Ficarro et al.,
2002). Also, it does not require phosphopeptides to be radioactively labeled. Moreover,
MS can detect phosphorylation more rapidly and efficiently with relatively low cost.
Although MS is the most widely used technique to identify phosphorylation sites, the
accuracy can be affected by the following reasons. First, a given phospho-protein is
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heterogeneous. Commonly, in sample treated with a kinase, the phosphorylated form of
the target protein represents only a small portion of the total protein. Second, due to the
limitation of fractionation methods and primary sequence of the given protein, the full
coverage of the protein is difficult. Third, when two phosphorylation sites are close to
each other, especially next to another, the identification of the exact phosphorylated
residue is difficult. Besides, the detection of phosphorylation sites from cell lysate is
also affected by the low abundance of phosphorylated proteins and dephosphorylation
caused by phosphatases in cells. Thus, although phosphorylation events were studied
in most of the known connexin family members, it is possible that more
phosphorylation sites will be identified in the future. Some databases based on MS data
provide good sources for studying connexin phosphorylation residue, such as
http://www.phosphosite.org.
Identification of new kinases that phosphorylate connexins would also be very
important for characterizing the function of connexins. One method is combining the
computer algorithm with the in vitro kinase-screening assay. Many of the online
programs can be used to predict connexin’s kinase binding partners based on the
consensus motifs, such as GPS 3.0 (Xue et al., 2008) and NetPhos 2.0 Server (Blom et
al., 1999). Once a list of kinase candidates is identified, purified connexin substrates
can be used to conduct in vitro kinase screening. More details of this methodology will
be discussed in the method section of Chapters 2 and 3.

3.3 Serine Phosphorylation
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To date, Cx43 is the most well understood isoform in terms of serine
phosphorylation. Since my dissertation focuses on Cx43, a detailed review of serine
phosphorylation on this isoform will be emphasized in this section. The Cx43CT is
differentially phosphorylated on at least 21 residues including 19 serine and significant
progress has been achieved in characterizing these phosphorylation sites (Figure 1.4)
(Axelsen et al., 2013; Lampe and Lau, 2004; Solan and Lampe, 2005, 2014).
Phosphorylation on some sites increase gap junctional intercellular communication
whereas others decrease gap junctional intercellular communication (Table 1.1).
Generally, MAPKs, PKC, and Src associate with channel closure, inhibition of
intercellular communication, and enhancement of gap junction internalization (Cottrell
et al., 2003; Li et al., 2014; Pogoda et al., 2016; Warn-Cramer et al., 1996). This
phenotype has been observed in many different cell models and tissues (Cottrell et al.,
2003; Li et al., 2014; Naitoh et al., 2009; Warn-Cramer et al., 1996). To the contrary,
phosphorylation of Cx43 by CK1 and PKA promotes gap junction trafficking, assembly,
and increase intercellular communication (Cooper and Lampe, 2002; Shah et al., 2002;
Solan and Lampe, 2016).
Phosphorylation on Cx43 is spatio-temporally regulated in a “kinase program”.
Falk et al. (2016) provide a model of consecutive serine phosphorylation events to
regulate gap junction assembly and turnover: (1) phosphorylation on S373 (Akt) and
S365 (PKA) promote forward trafficking of connexons to the membrane. (2)
dephosphorylation on S373 (Akt) allows the binding with ZO-1 which facilitates
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Figure 1.4 Connexin43 phosphorylation sites

Figure 1.4 Connexin43 phosphorylation sites. 21 residues have been observed to be
phosphorylated on the Cx43CT domain.Y247 and Y265 are Src phosphorylation sites,
the other 19 residues are serine. Residues phosphorylated by Src (Y247 and Y265),
MAPK (S255,262,279,282), CK1 (S325,328,330), PKA (S364,365,369,323), PKC
(S368 and S372), Akt (S373 and S369) are firmly confirmed in cells (Cooper and
Lampe, 2002; Lampe et al., 2000; Nimlamool et al., 2015; Park et al., 2007; Shah et al.,
2002; Solan and Lampe, 2007, 2008; Yogo et al., 2002). Residues phosphorylated by
CaMKII are only identified by MS but lack of further evidence in cells (Huang et al.,
2011). This figure is reprinted with permission (Pogoda et al., 2016).
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connexon docking and channel formation. (3) during the transition from functional to
closed gap junction channels, phosphorylation on S365 (PKA) decreases which allows
phosphorylation on S368 (PKC). (4) during the prime for internalization, S279/S282
(MAPK) phosphorylation increases. (5) phosphorylation on S279/282 and S368 are
linked to clathrin recruitment and endocytosis of annular gap junction (Falk et al., 2016)
(Figure 1.5). Early events which include S373 and S365 phosphorylation or dephosphorylation occur on the far C-terminal portion of the Cx43CT domain, while later
events (S279/282 phosphorylation) occur upstream of the around AP-2/clathrin binding
sites (Falk et al., 2016). Notably, in their model, S325/328/330 phosphorylated by CK1
which promote gap junction assembly is not mentioned (Cooper and Lampe, 2002;
Lampe et al., 2006). Solan and Lampe (2016) proposed a similar model of
phosphorylation on Cx43 in response to growth factor (EGF), wounding, or other
stimuli (TPA). They measured the time points of these phosphorylation events.
According to their study, the involved kinases that phosphorylate Cx43 are Akt at 5–30
min, PKC and MAPK at 15–60 min, and Src at 30 min–24 h (Solan and Lampe, 2016).
There are slight differences between these two models. First, in the response to the
stimuli, Akt phosphorylation is strong enough to exhaust incoming Cx43 pool to form
large gap junction plaques which prepare for annular gap junction formation. This is
not the case in normal situation. Second, Src phosphorylation participates in facilitating
gap junction internalization in Solan and Lampe’s model. The overall effect is the
decrease of Cx43 level and gap junction communication, which is necessary for wound
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healing because of its role in upregulation of proliferation and migration, or
downregulation of the inflammatory response (Solan and Lampe, 2016).
Cx43 phosphorylation does not often occur only at a single site but rather a number
of sites that work in concert to coordinate other phosphorylation events and protein
partner interactions. For instance, phosphorylation at S365 by PKA serves as a
gatekeeper via blocking S368 phosphorylation-induced channel closure by PKC (Solan
et al., 2007). Some kinases share common phosphorylation sites. Both PKA and Akt
phosphorylate S373. Since they both facilitate Cx43 trafficking to the plasma
membrane (Paulson et al., 2000; Solan et al., 2007), their phosphorylation events may
be cell-cycle or cell-type dependent.
In some situations, phosphorylation is directly involved in the interaction between
Cx43 and other binding partners (Saidi Brikci-Nigassa et al., 2012; Spagnol et al., 2016).
Phosphorylation can alter both local structure and long-range structure. At region near
the phosphorylation sites, phosphorylation can induce steric or electrostatic effects
which impact the secondary structure (Lim et al., 2014). On Cx43CT, serine
phosphorylation is usually associated with an increase of α-helical content whereas
tyrosine phosphorylation leads to a loss of α-helical structure (Grosely et al., 2013b).
Studies from our laboratory compared the secondary structure of Asp-substituted TM4Cx43CT isoforms (phosphorylation mimetics) with TM4-Cx43CT wild type (Grosely
et al., 2013b). CK1, MAPK, PKA and PKC isoforms are more helical than wild type at
both pH 7.5 and pH 5.8, while Src isoform is less helical than wild type at acidification
situation (Grosely et al., 2013b).
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Figure 1.5 Schematic of the post-translational modifications that regulate
gap junction assembly and internalization
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Figure 1.5 Schematic of the post-translational modifications that regulate gap
junction assembly and internalization. Steps [1 – 5] promote and coordinate the process
from functional (green) to close, internalization-prone gap junction channels (yellow,
orange) that then are primed to interact with clathrin components which mediate their
internalization (red). This figure is reprinted with permission (Falk et al., 2016).

39

Phosphorylation on some serine residues promote Cx43CT interacting with its binding
partners. S373 phosphorylated by Akt is required for 14-3-3 binding, which facilitates
Cx43 trafficking to the plasma membrane and incorporation into gap junction plaques
(Park et al., 2007). MAPK phosphorylation on serine residues (pS282 and pS279) increases
the binding affinity by two-fold for the Nedd4 WW domains which explains why MAPK
phosphorylation is involved in Cx43 degradation (Spagnol et al., 2016).
Although many studies have provided a wealth of information on Cx43 serine
phosphorylation, there are still a number of questions to be addressed. For example, S365
phosphorylated by PKA and S368 phosphorylated by PKC are in close proximity and both
induce an increase in α-helical content compare to the WT TM4-Cx43CT at pH 7.5
(Grosely et al., 2013b), however, their effect on gap junctional intercellular communication
is opposite. What mechanism mediates the differential response in gap junctional
intercellular communication to S365 and S368 phosphorylation? Another example is that
both phosphorylation and dephosphorylation on S368 have been reported in ischemia
(Axelsen et al., 2006; Solan et al., 2007). The controversial results suggest a complexity of
phosphorylation events arise from a large number of phosphorylation sites, differential
phosphorylation level or different time frame. What are the particular cellular conditions
that result in differential phosphorylation to regulate gap junction communication?

3.4

Tyrosine Phosphorylation
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3.4.1

Mechanism of Src Interaction with Cx43

In the 1980s, pp60v-src was shown to decrease gap junctional communication in
NIH3T3 cells (Azarnia et al., 1988; Lowenstein, 1985). However, understanding about
tyrosine kinases directly phosphorylating Cx43CT is still limited to v-Src and v-Fps. Since
v-Fps induces phosphorylation of Cx43 in a similar manner to v-Src and is far less studied,
here we will only focus on the mechanism of Src interaction with Cx43.
The Src kinase is composed of a conserved membrane-associated region on its NT that
is myristoylated, followed with SH3, SH2, and kinase domains (Boggon and Eck, 2004).
Phosphorylation on the Y416 in the kinase domain is required for Src activation and the
autoinhibitory phosphorylation site is Y527 at the CT domain (Boggon and Eck, 2004). vSrc, the oncogene which lacks the Y527, is therefore constitutively active as opposed to
normal Src (c-Src) (Smart et al., 1981). Two identified tyrosine sites on Cx43, Y265 and
Y247, are sequentially phosphorylated by v-Src. The interaction of v-Src and Cx43 is
dependent on the SH3 and SH2 domains of v-Src (Kanemitsu et al., 1997). The prolinerich sequence of Cx43 P274–P284 (contains a PXXP motif) is required for the interaction
with the v-Src SH3 domain which adopts a left-handed type II helix upon binding (Kieken
et al., 2009); this interaction leads to the phosphorylation of Cx43 Y265 site occurring first,
which creates a docking site for the v-Src SH2 domain (Lin et al., 2001). Consequently,
the Cx43 Y247 is phosphorylated (Lin et al., 2001). Additionally, in Cx43 Y265F and vSrc co-transfected HEK293 cells, co-immunoprecipitation between Cx43 Y265F and v-Src
was lost, and phosphorylation on Cx43 was significantly decreased. These data indicate
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that Y265 is the prime site of phosphorylation (Kanemitsu et al., 1997). This potential
mechanism would explain why pY265 appears in this and other studies to label a larger
population of plaques than pY247 (Solan and Lampe, 2008).
Early study indicates that v-Src phosphorylated Cx43 on tyrosine residues and
expression of v-Src completely blocked the communication induced by Cx43 in paired
Xenopus oocytes (Swenson et al., 1990). Later, investigations showed that Src also
increasesd phosphorylation level of MAPK (S279/282 and S262) and PKC (S368) sites,
and decreased PKA phosphorylation at S364/365 (Li et al., 2014; Solan and Lampe, 2008).
Results of biological effects caused by Src on gap junctional communication are
controversial from different groups. In Cx43 knock-out mouse cell line, expression of
Y247F, Y265F, or Y247F/Y265F Cx43 mutants was resistant to disruption of gap
junctional intercellular communication by v-Src (Lin et al., 2001). However, in another
study using Xenopus oocyte system, junctional conductance established by Y247F, Y265F,
or Y247F/Y265F mutants were disrupted by v-Src (3-6 hrs after v-Src injection), which
suggested that phosphorylation sites other than the two tyrosines are involved in the
disruption of gap junctional intercellular communication induced by the v-Src (Zhou et al.,
1999). Why are results different between using stable cell lines and Xenopus oocyte? First,
the different cell system could have different activation of signaling pathways by Src, thus,
the effects caused by Src may be different. Considering half-life of Cx43 in Xenopus
oocyte is around 22 hours (Lin et al., 2006), Solan and Lampe (2014) hypothesized that
tyrosine phosphorylation by v-Src is necessary for decreasing gap junction communication
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chronically but not acutely; Src induced phosphorylation by MAPK and PKC are
responsible for the rapid gap junction closure (Solan and Lampe, 2014).
Src kinase can also directly affect the interaction between the Cx43CT and other
molecular partners by inducing favorable/unfavorable conformations or blocking the
binding site. ZO-1 is a PDZ domain containing scaffolding protein and the interaction
between Cx43 and ZO-1 is essential in regulating gap junction size, stability, localization,
and turnover in cardiomyocyte (Hunter et al., 2005; Toyofuku et al., 1998). The binding of
ZO-1 to Cx43 can be disrupted by Src (Toyofuku et al., 2001). NMR results indicate that
the interaction between SH3 and Cx43CT induces indirect long range changes in the
Cx43CT structure, which disrupts binding of the PDZ-2 domain of ZO-1 to the last residues
of Cx43CT (S372-I382) (Kieken et al., 2009; Sorgen et al., 2004).

3.4.2

Regulation of Receptor Tyrosine Kinases on Cx43 Phosphorylation

Tyrosine kinases increasing the level of Cx43 serine phosphorylation indirectly is
commonly observed since tyrosine kinases activate serine kinases in cell signaling
networks. Activation of EGFR, PDGFR, and VEGFR are associated with a decrease in gap
junctional intercellular communication (reviewed in (Warn-Cramer and Lau, 2004)). These
receptor tyrosine kinases do not directly phosphorylate Cx43, but indirectly induce Cx43
serine phosphorylation via downstream activation of MAPK and/or c-Src (Warn-Cramer
and Lau, 2004). The activation of insulin receptor tyrosine kinase also increases serine
phosphorylation of Cx43 via activation of PKCγ, and induces a decrease of gap junctional
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intercellular communication in rabbit lens epithelial cells (Lin et al., 2003). Tropomyosin
receptor kinase A (TrkA) activated by nerve growth factor also rapidly increases Cx43
serine phosphorylation in bovine thecal (Mayerhofer et al., 1996).
Some tyrosine kinases can regulate Cx43 expression at the transcription level. Longterm activation of basic fibroblast growth factor receptor (bFGR) (>6 h) up-regulates Cx43
mRNA and protein levels in cardiac fibroblasts (Doble and Kardami, 1995). Since
fibroblast growth factor is important in wound healing, this would be consequential in
injured myocardium.

3.4.3

The Significance of Tyrosine Residues on Cx43CT in Binding Motifs
The Cx43CT domain has 6 tyrosine residues (Y247, Y265, Y267, Y286, Y301, Y313).

Some of them are involved in binding motifs of Cx43 protein partners, thus,
phosphorylation or de-phosphorylation on these residues could affect the protein-protein
interaction. An NMR study using a nonphosphorylated and phosphorylated Cx43CT
peptide (K234–D259) found that phosphorylated Y247 negatively regulated the interaction
between Cx43 peptide and tubulin by destabilizing the hydrophobic face necessary for the
interaction (Saidi Brikci-Nigassa et al., 2012). The disorder nonphosphorylated-peptide
adopts an α-helix upon interaction with tubulin where Y247 is on the hydrophobic face
(Saidi Brikci-Nigassa et al., 2012). Because microtubules play important roles in rapid
connexin delivery to gap junction plaques (Shaw et al., 2007), phosphorylation on Y247
would be detrimental to Cx43 trafficking and intercellular communication.
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Y265 is located in the domain essential for many binding partners that regulate gap
junction endocytosis. As mentioned above, phosphorylation on Y265 establishes a docking
site for the SH2 domain of Src, increasing binding affinity (Lin et al., 2001). Moreover,
Ambrosi et al. (2016) reported that the point mutation Y265D (phosphorylation mimetic)
abolished the interaction with drebrin, an F-actin-binding protein that is required for
stabilizing gap junctions at the plasma membrane (Ambrosi et al., 2016; Butkevich et al.,
2004) (del Valle et al., 2012). Another function of Y265 is to form part of a tyrosine-based
sorting motif (YXXΦ, where Y is tyrosine, X is any amino acid, and Φ is a bulky
hydrophobic amino acid) which enables an interaction with the μ subunit of the
heterotetrameric adaptor protein complex AP-2 to mediate clathrin-dependent
internalization of Cx43 (Fong et al., 2013) (Gumpert et al., 2008; Piehl et al., 2007).
However, the ability of this tyrosine residue to bind AP-2 is negatively influenced by
tyrosine phosphorylation. For example, phosphorylation of GluN2B residue Y1472 within
the YEKL tyrosine-based sorting signal motif by Fyn inhibits AP2 binding and
internalization of GluN2B-containing NMDA-type glutamate receptors (Nakazawa et al.,
2001). Similarly, phosphorylation of GluN2A by Src inhibits endocytosis of GluN2Acontaining NMDA-type glutamate receptors (Hayashi et al., 2009; Yang et al., 2012).
These results suggest that Y265 phosphorylation may not be directly involved in clathrindependent internalization, but indirectly increase internalization by destabilizing gap
junctions at the plaque. To date, there is no published data regarding phosphorylation of
Y267. However, we can not exclude it as a potential target of phosphorylation. Since Y267
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is very close to Y265 and it is also involved in the AP-2 binding motif, the phosphorylation
of Y267 could interfere with the phosphorylation of both Y265 and Y247, as well as
decrease AP-2 binding capability.
Y286 is located in the other YXXΦ AP-2-binding motif (286YKLV289); additionally,
this residue is involved in the binding site PPXY motif (283PPGY286) of a ubiquitin ligase,
NEDD4 (Leykauf et al., 2006; Spagnol et al., 2016). All three WW domains of NEDD4
interact with the 283PPGY286 motif (Spagnol et al., 2016). Of note, the WW domains, named
after the presence of two conserved tryptophan residues, regulate substrate selection. Our
NMR study shows that any modification of Y286 (mutation, Y286A; phosphorylation,
pY286) significantly decreased the binding affinity with all three WW domains, suggesting
that Y286 is crucial for the NEDD4 binding (Spagnol et al., 2016). Also, Y286 is required
for targeting Cx43-eYFP to the basolateral membrane domain of MDCK cells since
mutagenesis of Y286 to A or substitution of 284PGYKLV289 by a sequence containing the
transferrin receptor internalization signal disrupted basolateral targeting (Chtchetinin et al.,
2009). Although phosphorylation on Y286 and the kinase that phosphorylates Y286 site
are unknown, the potential important role of phosphorylation on Y286 in Cx43 degradation
and cell polarity is expected.
Y313 phosphorylation was observed in FGF-2 stimulated human embryonic stem cells
(phosphoproteomics data) (Li et al., 2016; Lundby et al., 2013). Located in one of the
helical regions identified in the TM4-Cx43CT (K303-A322) (Grosely et al., 2013), Y313
phosphorylation may induce a conformational change since the negative charge of
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phosphate would disrupt or form electrostatic interactions. FGF has been reported to
increase serine phosphorylation (Sakurai et al., 2013; Srisakuldee et al., 2009). However,
no study show which tyrosine kinase directly targets to Y313. In Chapter 3 and Chapter 4,
we will discuss our study which identify that Src and Pyk2 that phosphorylate Y313.

3.4.4

Cx43 Tyrosine Phosphorylation and Diseases

A.

Cx43 Tyrosine Phosphorylation in Cancer
As a proto-oncogene, c-Src is found to be over-expressed and/or highly activated in a

wide variety of human cancers (Irby and Yeatman, 2000). Phosphorylation on Cx43 by Src
affects cancer initiation, development, and treatments. One of the problem in cancer
chemotherapy is the resistance of cancer cells to chemotherapeutic drugs like cisplatin.
Previous research suggested that the cytotoxic signal triggered by cisplatin could transmit
to a neighboring cell via gap junctional intercellular communication to cause cell death
(Jensen and Glazer, 2004). Active Src phosphorylating Cx43 could increase cell survival
of the neighboring cells in response to cisplatin while using Src inhibitor Dasatinib (sprycel)
could be a strategy to enhance the efficacy of cisplatin (Peterson-Roth et al., 2009). In
radiotherapy, irradiated cells can pass signals through the gap junctional intercellular
communication to neighboring non-irradiated cells or release signals through connexin
hemichannels causing bystander effect (Edwards et al., 2004; Ohshima et al., 2012).
Closure of Cx43 gap junctions which is associated with hyperphosphorylation of Cx43 is
proportional to the dose of ultrasoft X-rays received (Edwards et al., 2004). Thus, radiation
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type and dose need to be carefully considered in order to get best anti-tumor effect by
allowing the spread of cytotoxic metabolites (Edwards et al., 2004).

B.

Cx43 Tyrosine Phosphorylation in Cardiovascular Diseases
Gap junctions are essential for normal electrical propagation in heart. Many cardiac

diseases are associated with remodeling of gap junction organization and connexin
expression, including ischemic cardiomyopathy, heart failure, and sudden cardiac death
(Severs et al., 2006). In the normal situation, gap junctions preferentially locate at
intercalated discs, which is the region between two adjacent cardiomyocytes in longitude
(Severs, 1985). In this way, gap junctions mediate myocyte-to-myocyte electrical coupling
and communication. In the pathological situation, Cx43 redistributes and localizes at the
cardiomyocyte lateral membranes, which would result in a reduction of ventricular
conduction velocity (Severs, 2001). Evidence show that Src is crucial for Cx43 expression
and distribution in some cardiac pathologies. In epicardial border zone myocytes after
myocardial infarction, active c-Src is significantly increased and colocalized with Cx43 at
the intercalated disk 1 hr after postcoronary occlusion while the colocalization of ZO-1 and
Cx43 decreases (Kieken et al., 2009). These alternations are associated with the loss of
Cx43 from the intercalated disk (Kieken et al., 2009). Another group used the similar
myocardial infarction mice model (12-week-old mice by coronary artery occlusion) and
found that inhibition of Src by PP1 treatment increased Cx43 level in both scar border
(69%) and distal ventricle (73%) (Rutledge et al., 2014). Chronically, c-Src activation is
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associated with the decrease of Cx43 level in different animal models. In an angiotensin II
(Ang II) over-activation mice model (ACE8/8), c-Src was increased and Cx43 was
decreased in ventricular myocytes (Sovari et al., 2011). Further study indicated that the
decreased Cx43 level and impaired Cx43 gap junction is caused by caveolin-1 (Cav-1)
dissociation from c-Src which resulted in the c-Src activation (Yang et al., 2014). Although
the tyrosine phosphorylation level of Cx43 in these animal model was not studied, c-Src
and ZO-1 competitively interact with Cx43 which results in the destabilization of Cx43 at
the gap junction plaque. In hereditary cardiomyopathic model Syrian BIO 14.6 hamsters,
c-Src activation in the late stage of congestive heart failure is associated with increased
Cx43 tyrosine phosphorylation level (Toyofuku et al., 1999). These are directly evidence
that tyrosine phosphorylation by Src plays a role in cardiac pathology.

C.

Cx43 Tyrosine Phosphorylation in Other Diseases
A variety of extracellular pathological and inflammatory stimuli regulating changes in

gap junction communication includes lipopolysaccharide (LPS) and tumor necrosis factor
α (TNFα). LPS not only induces Cx43 tyrosine phosphorylation and decreases gap junction
coupling in cultured rat microvascular endothelial cells (Lidington et al., 2002), but also
leads to the degradation of Cx43 in rat astrocytes (Liao et al., 2013). Airway epithelial cells
initiate immune signaling caused by inhaled bacteria, which play a surveillance role in the
respiratory tract. TNFα rapidly closes Cx43 gap junction channels in the airway epithelial
cells (Huang et al., 2003; Huang et al., 2003). TNFα induces the activation of c-Src in
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airway epithelial cell but not in cystic fibrosis airway epithelial cells (Huang et al., 2003).
Expression of a dominant negative version of c-Src or transfection of Cx43 mutants on
Y247 and Y265 prevented the effect of TNFα on gap junction closure, which suggests that
c-Src mediates the closure of gap junction channel caused by TNFα (Huang et al., 2003).
In diabetes, c-Src participates in down-regulation of Cx43 protein level. In high glucose
stimulated glomerular mesangial cells, Cx43 downregulation by NF-κB activates c-Src
which in turn activates NF-κB, resulting in renal inflammation (Xie et al., 2013). In this
situation, activated NF-κB regulates the further decrease of Cx43 in kidneys of diabetic
animals (Xie et al., 2013).

3.4.5

Tyrosine Phosphorylation on Isoforms Other Than Cx43

Despite Cx43 phosphorylation being well studied, our understanding of the complex
symphony of tyrosine phosphorylation events and their outcomes is lacking. Furthermore,
tyrosine phosphorylation of other Cx family members has not been studied as extensively
as Cx43 and thus poorly characterized. Diez et al. (1998) found that the only two tyrosine
residues on Cx32, Y243 on the CT and/or Y7 on the NT, were phosphorylated directly by
the EGFR in vitro (Diez et al., 1998). However, they did not test if the phosphorylation
occurs in cells. Locke et al. (2006) used MALDI–TOF-MS to detect post-translational
modification in Cx32 transfected HeLa cells and found tyrosine phosphorylation on the
Cx32 NT domain (Locke et al., 2006). Traub et al. (1998) studied the different types of
phosphorylation in the mouse Cx37 transfected HeLa cells by autoradiography and found
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phosphorylation mainly on serine, less on tyrosine and little on threonine residues (Traub
et al., 1998). Hertlein et al. (1998) used autoradiography and found that in the mouse Cx45
stable transfected HeLa cells, serine, tyrosine, threonine phosphorylation are detectable
(Hertlein et al., 1998). Of note, most of the phosphorylated residues are found on the CT
domain (Hertlein et al., 1998). Using a tyrosine phosphatase inhibitor pervanadate
increases phosphorylated form of Cx45 suggesting the exist of tyrosine phosphorylation
on Cx45 (van Veen et al., 2000). Although there is no direct evidence that Cx40 has
tyrosine phosphorylation, Bolon et al. (2007) found that lipopolysaccharide treatment
decreased the electrical coupling in cultured mouse microvascular endothelial cells by
targeting Cx40 via tyrosine-, ERK1/2-, PKA-, and PKC-dependent signaling (Bolon et al.,
2007). Evidence has been found that tyrosine phosphorylation can occur on connexin
isoforms other than Cx43, nevertheless, new phosphorylation sites and additional kinases
that target connexins need to be identified and characterized.

4.

Regulation of Connexins by Phosphatases
Phosphorylation is a highly regulated dynamic interplay between protein kinases and

phosphatases. Phosphatase counterbalance the effects of kinases, thus plays important roles
in regulating connexins life cycle, channel gating as well as interaction with other cellular
proteins (Herve and Sarrouilhe, 2002). Although kinases play established roles in the life
cycle of connexin, less information exists about the involvement of phosphatases. In this
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section, regulation of connexins by phosphoserine/phosphothreonine protein phosphatases
(PS/PTPP) and protein-tyrosine phosphatases (PTP) will be discussed.

4.1

PS/PTPP and Connexins
PS/PTPP are divided by function into two classes, protein phosphatase 1 (PP1) and

protein phosphatase 2 (PP2). The latter includes PP2A, PP2B, and PP2C (Ingebritsen and
Cohen, 1983). In ventricular myocytes of newborn rats, inhibition of PP1 and PP2A, but
not PP2B and PP2C, preserved the channel activity (Duthe et al., 2001). In MDCK, WBF344 and cultured astrocytes, PP1/PP2A inhibitors also increased Cx43 phosphorylation
(Berthoud et al., 1992; Guan et al., 1996; Li and Nagy, 2000). In another study, serine
phosphatases PP1, PP2A, PP2B, and PP2C were used to test the dephosphorylation of
immunoprecipitated Cx43, and PP2A was the most efficient (Cruciani et al., 1999).
However, the same study also found PP2B participated in the maintenance of intercellular
communication in TPA-treated V79 fibroblasts, although did not dephosphorylate
immunoprecipitated Cx43 (Cruciani et al., 1999). This could associate with
dephosphorylation of Cx43 binding partners by PP2B, since PP2B has been shown to
regulate PKC(Lum et al., 2001). In arrhythmogenic rabbit model of non-ischemic heart
failure and heart failure patients, Cx43 colocalized and coimmunoprecipitated with both
PP1 and PP2A (Ai and Pogwizd, 2005). An increased colocalization of PP2A and Cx43
(but not PP1 and Cx43), which is responsible for a decrease of phosphorylated Cx43,
contributed to uncoupling (Ai and Pogwizd, 2005). In TNF-α acutly treated FS TtT/GF cell
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line, there was a transient dephosphorylation of S368 caused by recruitment of PP2A at the
plasma membrane; this led to a transient cell uncoupling (Meilleur et al., 2007). Although
phosphorylation of S368 is accepted as a factor of cell uncoupling, the author emphasized
that the length of the treatment is the key point (Meilleur et al., 2007). Specifically, PMA
treated cells exhibit transient (within 5min and only last for 5 min) increase of gap junction
coupling, and followed up with fast decrease of gap junction coupling (Meilleur et al.,
2007). Similarly, during the acquirment of the epidermal barrier function in embryonic
development, there is a transient interaction between Cx43 and ZO-1. PP2A is necessary
both for the initial interaction between ZO-1 and Cx43 and the consequential
dephosphorylation of Cx43 on S368 (Gerner et al., 2013).

4.2 PTPs and Connexins
Traditionally, PTPs have been categorized into two types, the receptor-like and the
intracellular PTPs (Zhang, 1998). The receptor-like PTP generally contains an extracellular
domain, a single transmembrane region, and a cytoplasmic PTP domains (Zhang, 1998).
The intracellular PTP is composed of a single catalytic domain and various amino or
carboxyl terminal domains usually determining substrate binding or regulating
phosphatase functions (Zhang, 1998). The importance of PTP on gap junction regulation
was initially evidenced from studies using pervanadate, a PTP inhibitor, which was found
to decrease gap junctional intercellular communication and enhance Cx43 tyrosine
phosphorylation in syrian hamster embryo cells, and in V79 Chinese hamster lung
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fibroblasts (Husoy et al., 1993). In Cx45 transfected HeLa cells, pervanadate reduced the
junctional conductance and relatively increased the 48 kD signal, suggesting PTP is
involved in the regulation of Cx45 phosphorylation (van Veen et al., 2000).
In 2003, two potential Cx43 tyrosine phosphatases were identified – vascular protein
tyrosine phosphatase 1 (identified by mass spectroscopy) and receptor protein tyrosine
phosphatase μ (RPTPµ) (identified by immunoprecipitation) (Giepmans et al., 2003; Singh
and Lampe, 2003); however, direct interactions were not verified, and direct roles in cellto-cell communication were not established. Lezcano et al. (2014) showed that Cx43 and
RPTPµ colocalized throughout the entire ROS 17/2.8 cells, although RPTPµ is a
transmembrane protein and the interaction was expected to occur at the plasma membrane
(Lezcano et al., 2014).

5. Objective
Phosphorylation is one of the most important post-translational modifications of
connexins. Although significant strides have been made in understanding connexin
regulation by serine phosphorylation, few tyrosine kinases and phosphatases that interact
with connexins have been identified.
The objective of this dissertation is to identify novel tyrosine phosphatase and kinases
that directly interact with Cx43 to affect the function and to characterize the biological
function of the interactions, in vitro and in cyto. Chapter 2 includes the mechanistic study
of Cx43 dephosphorylation by a novel protein-tyrosine phosphatase, TC-PTP. In Chapter
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3, we will discuss a novel kinase, Tyk2, that phosphorylates Cx43 in a manner similar to
Src but independent from Src activation. Chapter 4 contains additional studies on connexin
phosphorylation and dephosphorylation extending from my dissertation. In Chapter 5, I
will summarize my projects and propose future directions.
The important roles of gap junction in growth control, electronic coupling, cell
differentiation, cell sorting and immune response indicate the possibility of using gap
junction as therapeutic target in particular diseases. Understanding phosphorylation and
dephosphorylation might lead to methods that modulate the regulation of gap junction
channels, with potential benefits for human health.
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CHAPTER 2

Tyrosine Phosphatase TC-PTP Directly Interacts with Connexin43 to
Regulate Gap Junction Intercellular Communication

Material in this chapter has been published in the following article:
Li H, Spagnol G, Naslavsky N, Caplan S, Sorgen PL. Journal of cell science, 2014, 127
(15), 3269-3279, doi: 10.1242/jcs.145193
Manuscript is linked to http://jcs.biologists.org/content/127/15/3269.long

CHAPTER 2 Tyrosine Phosphatase TC-PTP Directly Interacts with
Connexin43 to Regulate Gap Junction Intercellular Communication
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6. Introduction
In Chapter 1, we discussed that kinases have well-established roles in the regulation
of a connexin’s function. However, phosphorylation are highly regulated and dynamic due
to the action of phosphatase, and to date, very little is known about the regulation of Cx43
by phosphatase. In this Chapter, we will discuss our findings that a tyrosine phosphatase,
TC-PTP (also known as PTPN2), is a novel bind partner for Cx43.
TC-PTP was cloned from a peripheral human T-cell cDNA library and despite its name,
is ubiquitously expressed in all tissues and at all stages of mammalian development (Cool
et al., 1989). Alternative splicing in the C-terminus gives rise to a 48-kDa form ( PTP1B,
minor) localized to the ER and a 45-kDa form (TC-PTP, major) that is targeted to the
nucleus (Cool et al., 1989). Mice lacking the TC-PTP gene die within five weeks of birth
from defects in hematopoiesis and immune function (You-Ten et al., 1997). Heterozygous
TC-PTP+/- mice implicated TC-PTP as an important regulator of inflammatory cytokine
signaling and in the pathophysiology associated with inflammatory bowel disease (Hassan
et al., 2010). Several substrates, such as the insulin receptor and EGFR (Galic et al., 2003;
Tiganis et al., 1998), as well as cytoplasmic JAK and STAT proteins (Lu et al., 2007;
Simoncic et al., 2002; ten Hoeve et al., 2002), have implicated broad roles of TC-PTP in
regulation of celling pathways. Additionally, a high level of Ang II (10-7 M) decreases TCPTP in vascular smooth muscle cells, suggesting that TC-PTP is improtant in pathogenesis
of Ang II induced cardiovascular diseases (Tsiropoulou S, 2014). We provide evidence of
a relationship between Cx43 tyrosine phosphorylation by v-Src and de-phosphorylation by
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TC-PTP. TC-PTP increased gap junction stability at the plasma membrane and partially
reversed closure of Cx43 gap junction channels caused by v-Src phosphorylation.

7. Materials and Methods
7.1 Expression and Purification of Recombinant GST-tagged Proteins
Rat Cx43CT236-382 was expressed and purified as described previously (Duffy et al.,
2002). TC-PTP1-314 was cloned into the pGEX-6p-2 vector and overexpressed in the BL21
(DE3)-derived Rosetta strain (Novagen). A 20 ml overnight culture was diluted 1:50 and
grown at 37°C to A600 = 0.6, then induced with 0.5 mM isopropyl β-D-thiogalactoside for
20 h at 19°C. 1 L of cultured cells was lysed by an EmulsiFlex-C3 in 25 ml of the following
buffer: 25 mM Tris-HCl (pH 7.5), 5 mM DTT, 0.1% Brij 35, and one protease inhibitor
cocktail tablet (Roche). The cell lysate was incubated with glutathione-Sepharose beads
(Genescript) for 2 h at 4°C, then the beads were incubate with Tris-HCl buffer (50 mM
Tris-HCl, 2 mM ATP, 10 mM MgSO4) for 10 min at 37°C to remove a contaminating
chaperone protein. The beads were washed in Tris-HCl buffers containing high salt (300
mM NaCl) or detergent (1% Brij 35) and then washed 4x with 25 mM Tris-HCl (pH 7.5)
and 5 mM DTT. Turbo 3C protease (Accelagen) was used to cleave TC-PTP1-314 from
glutathione S-transferase tag at 4°C for two days.

7.2 NMR
All NMR data were acquired using a 600 MHz Varian INOVA NMR Spectrometer
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outfitted with a cryo-probe at the NMR Facility of the University of Nebraska Medical
Center. Gradient-enhanced two-dimensional

15

N-HSQC experiments were acquired to

detect backbone amide bond resonances from the 15N-Cx43CT (30 μM) in the absence and
presence of different concentration of unlabeled TC-PTP1-314. NMR spectra were processed
using NMRPipe (Delaglio et al., 1995) and analyzed with NMRView (Johnson and Blevins,
1994). Binding affinity from the

15

N-HSQC titration experiments were calculated by

Graphpad Prism 5 (GraphPad Software, Inc.).

7.3 Cell Culture and transfection
NRK and LA-25 cells (NRK cells containing temperature sensitive v-Src) were
generous gifts from Dr. Paul Lampe (Fred Hutchinson Cancer Research Center). Both cell
lines were grown in Dulbecco's modiﬁed Eagle's medium (DMEM) (Hyclone, Thermo
Fisher Scientific Inc.) supplemented with 10% fetal bovine serum (FBS) (Hyclone, Thermo
Fisher Scientific Inc.) and antibiotics in an atmosphere of humidified 5% CO2. NRK cells
were serum staved for 4 hrs in DMEM with 0.1% FBS before EGF treatment. TC-PTP 1314

was cloned in pcDNA 3.1 vector and transfected in to NRK or LA-25 cells following

lipofectmine 2000 protocol (Thermo Fisher Scientific).

7.4 Antibodies and Immunostaining
The following antibodies were used in this study: Cx43 monoclonal antibodies against
amino acids 360-382 (Cx43CT1 and Cx43IF1, described in (Cooper and Lampe, 2002;
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Lampe et al., 2006)), rabbit anti-phosphorylated Y247, rabbit anti-phosphorylated Y265,
and rabbit anti-phosphorylated S279/282 (described in (Solan and Lampe, 2008)) (all
generous gifts from Dr. Paul Lampe, Fred Hutchinson Cancer Research Center); Cx43
monoclonal antibody against residues 1-20 (Cx43NT1, Fred Hutchinson Cancer Research
Center Hybridoma Development Facility); rabbit anti-phosphorylated S368 (Millipore);
TC-PTP antibodies against the N-terminus and C-terminus (SAB4200495 and
SAB4200249, Sigma-Aldrich); non-specific phospho-tyrosine antibody (Abcam); and
antibodies against total and active Src (phosphorylated Y416, Millipore).
Cells were immunostained as described previously (Mehta et al., 1991). Briefly, cells
grown on cover slips to ~60% confluence were fixed with 2% para-formaldehyde for 15
min. Cells were blocked for 30 min at room temperature (RT) by MPS buffer (1x PBS, 1%
Goat Serum) containing 0.2% TX100 for permeabilization. Then, cells were
immunostained with appropriate primary antibodies at RT for 1 h, followed by several
PBS-0.5% Tween washes. Secondary antibodies (Alexa 594-conjugated goat anti-rabbit
antibody and/or Alexa 488-conjugated goat anti-mouse antibody) were applied for 1 h at
RT. Images of immunostained cells were acquired with a Zeiss 510 Meta Confocal Laser
Scanning Microscope using a 63×1.4 numerical aperture objective with appropriate filters.
Colocalization was quantified using the Manders method in Image J plugin JACoP, by
which the Cx43 signal (green) coincident with a signal in the red channel over the total
intensity of Cx43 was measured (Bolte and Cordelieres, 2006).
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7.5 Co-IP and Western blot
NRK cells were lysed in complete lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM
NaCl, 0.5% Na-deoxycholate, 1% TX 100, 5 mM NaF, and one-half tablet of complete
protease inhibitor [Roche] in 20 ml buffer), maintained on ice for 30 min, precleared with
protein G beads for 30 min at 4°C, and then spun at 12,000 rpm for 15 min. Total protein
was assessed using the BCA protein assay kit (Pierce). 2 mg lysate was incubated with 2
μg of anti-TC-PTP-NT or anti-TC-PTP-CT or rabbit IgG (4 h at 4°C) and then incubated
with 100 μl of protein G sepharose (GE Healthcare) (overnight at 4°C). The sepharose was
washed 4x with cold lysis buffer and the co-IP was analyzed by SDS-PAGE and Western
blot. Anti-Cx43 antibody Cx43NT1 was used to detect Cx43 co-IP with TC-PTP.
Protein levels were detected by SDS-PAGE and Western blot. One exception for
detecting tyrosine phosphorylation was that 5 mM Na3VO4 was added in the blocking
buffer and primer antibody buffer in order to minimize the loss of phosphorylation. Western
blot data were scanned and quantified using Image J as described in (Schneider et al., 2012).

7.6 GST Pull Downs
The GST pull down assay was modified from (Leykauf et al., 2006). Briefly, purified
GST-fusion TC-PTP1-314 and GST control protein were bound to glutathione-Sepharose
beads in buffer 1 containing 25 mM Tris-HCl (pH=7.4),150 mM NaCl, 0.1% TX100, 1
mM DTT, 0.1 mM EDTA and one-half tablet of complete protease inhibitor in 20 ml buffer.
5 mg of purified Cx43CT were incubated with GST-fusion TC-PTP1-314 or the GST control
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overnight at 4°C on a rotating wheel. Beads were washed for 5 times with buffer 1 and
bound protein were eluted with SDS-PAGE sample buffer and were used for SDS-PAGE.
Western blot was used to analyze GST pull down results.

7.7 In vitro Phosphatase Assay
Cx43 phospho-peptides pY247 (KGKSDPpYHATSGA) and pY265 (GSQKpYAYFNG)
were used in the malachite green assay (Millipore) to detect if they are substrates of TCPTP in vitro. Positive and negative controls were DADEpYL (described in (Peters et al.,
2000)) and ARKRIpYPP (described in (Ren et al., 2011)), respectively. Peptides and
enzyme were dissolved and diluted in reaction buffer (60 mM Hepes [pH 7.2], 150 mM
NaCl, 1 mM EDTA, 0.17 mM DTT, 0.83% glycerol, 0.017% BSA, and 0.002% Brij-35)
and temperature-equilibrated for 15 min at 25°C. 500 μM of each peptide was added into
a 96-well plate, and then TC-PTP1-314 was added to each peptide at different time points.
The final concentration of TC-PTP1-314 was 0.6 nM. All reactions were terminated by
adding 100 μl malachite green solution and incubated for 15 min at RT to allow color
development. Absorbance at 650 nm was read using a SpectraMax 190 spectrometer
(Molecular devices).
The Malachite green assay was also used to measure the kinetic parameters of dephosphorylation (Peters et al., 2000). The reaction was performed in 96-well plates with a
final volume of 25 μl. A standard curve of KH2PO4, used for calculating the release of
inorganic phosphate, was determined on the same plate as the reaction samples. Different
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concentrations of peptides [substrate] were combined with 1.2 nM TC-PTP1-314. Time
points of the reaction were sampled from 0-15 min to calculate the initial velocity (v) versus
[substrate]. Lineweaver-Burk double-reciprocal plot (rearranged from the MichaelisMenten equation) was created based on 1/v and 1/[substrate]. The kinetic parameters were
determined by the linear equation from the lineweaver-Burk double-reciprocal plot. All the
reactions were conducted at pH 7.5, 25°C. The reported results were calculated from three
independent experiments.
The in vitro phosphatase screening assay was conducted by SignalChem (Richmond,
Canada). The CDC25A, CDC25B, CDC25C, PP1A, PP1B, PP2Aalpha, PP2Calpha and
PP2Cgamma phosphatase activity to pS279/282 phospho-peptide (Cx43CT 276-289) was
determined by performing assays at 37°C for 15 min in a final volume of 25μl according to
the following assay reaction recipe:
Component 1

5 μl of diluted active protein phosphatase
10 μl of substrate assay solution OMFP for CDC25 family, Thr-

Component 2
phosphopeptide T69-58 for PP1 and PP2 family
Component 3

5 μl Phosphatase assay Buffer

Component 4

5 μl of compound (50 μM) or assay buffer.

The assay was started by incubating the reaction mixture at 37°C for 15 minutes. After
the 15 minutes incubation period, the assay was terminated by the addition of 100 μl of
Malachite Green reagent. The absorbance of the reaction solution was measured in a
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spectrophotometer at 650 nm. Blank control was set up that included all the assay components
except the addition of the substrate (replace with equal volume of phosphatase assay buffer).
The corrected activity for CDC25A, CDC25B, CDC25C, PP1A, PP1B, PP2Aalpha,
PP2Calpha and PP2Cgamma targets was determined by removing the blank control value.

7.8 Scrape-loading Assay
Cells were scrape-loaded as described in (Stauch et al., 2012). Briefly, LA-25 cells
seeded on cover slips were transfected with TC-PTP1-314 or pcDNA3.1 vector (mock group)
for 24 h at 37°C and then incubated at 40°C for 1 hr before addition of the MAPK inhibitor
(U0126, 50 μM) or PKC inhibitor (BIM, 0.1 μM) at 40°C for another 30 min. Then, cells
were incubated at 35°C for 12 hrs. The medium with the inhibitor was changed every 3 hrs
to ensure a consistent effect during the treatment. The confluence of cells was 100% on the
cover slips. Cell culture medium from 100% confluent cells was removed and replaced
with 1 ml of PBS containing 0.25% Lucifer Yellow and Texas Red-conjugated fluorescent
dextran (10 kDa, 1.5 mg/ml: fixable). Cells were scrape-loaded with a sterile scalpel by
two longitudinal scratches and then incubate at RT for 1 min. Cells were washed quickly
3x with warm PBS (contain MgCl2 and CaCl2) or cell culture medium followed by
incubating at 37°C for 5 min. After incubation, cells were washed 2x with warm PBS, and
fixed with 3.7% buffered paraformaldehyde for 15 min. 0.1 M glycine was used to quench
autofluorescence for 15 min. Cover slips were mounted on glass slides in a droplet of
SlowFade (invitrogen). The result was confirmed by repeating the experiment 3x and for
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each trial, capturing 4 side-by-side images. The method to quantify dye transfer was
described previously (Stauch et al., 2012). Briefly, cells with Lucifer yellow were counted
while the cells with dextran which indicated the initially loaded cells were excluded.

7.9 TX 100 (TX100) Solubility
The TX100 solubility assay was modified from the method described in (Mitra et al.,
2006). LA-25 cells grown in 10 cm petri dishes were rinsed 3x with PBS and scraped into
1 ml lysis buffer (50 mM Tris-HCl [pH 7.4], 1 mM EGTA, 1 mM EDTA, 1 mM PMSF,
100 mM NaCl, one-half tablet of complete protease inhibitor for 25 ml of buffer [Roche],
5 mM NaF, 5 mM Na3VO4). Then, cells were sonicated for 10 s on ice. Protein estimation
was determined using the BCA method. 450 μl cell lysate samples were added to 50 μl of
10% SDS, which was saved as total protein, or to 10% TX100 (final concentration of 1%)
and incubated at 4°C for 30 min. Lysates were then separated into cytosolic (supernatant,
soluble) and membrane (pellet, insoluble) fractions by centrifugation at 100,000 g for 1 h
at 4°C. The pellets were dissolved in 500 μl dissolving buffer (70 mM Tris-HCl [pH 6.8],
8 M urea, 2.5% SDS, 0.1 M DTT, 5 mM NaF, 5 mM Na3VO4, and one-half tablet of
complete protease inhibitor for 25 ml of buffer). Equal volume of total lysate, TX100
soluble and insoluble portions, were loaded on a 12% SDS-PAGE and immunoblotted with
the Cx43NT1 antibody.
For the detergent extraction in situ, LA-25 cells on cover slips were extracted in situ
with 1% TX100 buffer (1% TX100, PBS pH 7.4, 1mM CaCl2, 1 mM MgCl2, and protease
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inhibitor cocktail) for 30 min at 4°C, gently shacked every 10 min. The control cells were
treated in the same way without 1% TX100. The cover slips were fixed and immunostained
as described in (Johnson et al., 2013).

7.10 TC-PTP siRNA Treatment
Oligonucleotides siRNA1 (5’AACAGATACAGAGATGTAAGC3’) and siRNA 2m
(5’AAGATTGACAGACACCTAAAT3’ ) used to knockdown TC-PTP in LA-25 cells
according to (Galic et al., 2005). Oligonucleotide from the non-target pool (Dharmacon,
Lafayette, CO) was used as negative control. Lipofectmine RNAi MAX (Invitrogen) was
used to carry the oligonucleotide according to manufacture protocol. Cells were incublated
at 35°C for another 12 hrs after 36 hrs of siRNA treatment. Protein levels were detected by
Western blot.

7.11 Subcellular Fractionation
Analysis of subcellular colocalization of the PKC isoforms was performed according
to (Saxon et al., 1994; Zang et al., 1995). Briefly, cells with different treatments from 60mm petri dishes were washed with ice-cold PBS and then suspended in 0.4 ml digitonin
buffer (0.5 mg/ml digitonin in 20 mM Tris-HCl pH 7.5, 140 mM NaCl, 25 mM KCl, 5 mM
MgCl2, 2 mM EDTA, 2 mM EGTA, 1/4 protease inhibitor tablet, and 1 phosphatase
inhibitor tablet for 10 ml buffer). Cells were dispersed by pipetted up and down, incubated
on ice for 5 min, and the cell lysate was centrifuged at 100,000g for 1 h. The supernatant
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was collected as cytosolic fraction. The pellet was re-suspended in the same volume of
triton buffer (1% TX100 to substitute for the digitonin in the digitonin buffer) and
incubated on a rotating wheel for 30 min at 4°C. The suspension was centrifuged as
described above and the supernatant was collected as the membrane fraction.

7.12 Statistical Analysis
All data were analyzed by GraphPad Prism 5.0 and presented as the standard error of
the mean (±S.E.M). Paired t-test was used to compare differences between the
experimental group and control or the two parallel experimental groups. P<0.05 was
considered to be statistically significant.

8. Results
8.1 TC-PTP Directly Interacts and Dephosphorylates the Cx43CT Domain
Identification of proteins that interact with connexins has been invaluable towards
understanding the regulation of gap junctional communication. Based upon the wellcharacterized role of Src phosphorylation to inhibit gap junctional communication, we
sought to identify if a tyrosine phosphatase could reverse this effect. Interestingly, a
correlation exists between the activation of Src by stress conditions (e.g. oxidation stress)
(Zhuang and Schnellmann, 2004) or mitogens (e.g. insulin and EGF) (Goi et al., 2000; Li
et al., 2010; Rosenzweig et al., 2004) and redistribution of the tyrosine phosphatase TCPTP (diffusion from the nucleus and/or prevented from (re)entry into the nucleus) to the
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plasma membrane (Fukushima et al., 2010; Lam et al., 2001; Tiganis et al., 1998). To
identify if a direct interaction exists between TC-PTP and the Cx43 carboxyl terminal (CT)
domain, nuclear magnetic resonance (NMR) titration experiments were performed with
purified TC-PTP catalytic domain (TC-PTP1-314) and Cx43CT. NMR is an ideal method to
detect protein-protein interactions because chemical shifts are sensitive to the environment
and even small changes in structure and/or dynamics can influence the chemical shift of an
amino acid. Different concentrations of unlabeled TC-PTP1-314 were titrated into

15

N-

labeled Cx43CT (residues 236-382) and 15N-HSQC spectra were acquired. The 15N-HSQC
is a 2D experiment in which each residue (expect proline) gives one chemical shift that
corresponds to the amide group. Therefore, the Cx43CT resonance assignment is necessary
to determine which residues are affected by the interaction. Our lab has published the
Cx43CT

15

N-HSQC assignment (Grosely et al., 2013c), however the spectrum was

collected in Phosphate Buffered Saline (PBS), a buffer that caused TC-PTP1-314 to
precipitate at elevated concentrations, unlike Tris-NaCl buffer. To assign the Cx43CT
domain in Tris-NaCl buffer at pH 7.5, Cx43CT in PBS was initially titrated from pH 5.8 to
pH 7.5 and then PBS was titrated to Tris-NaCl buffer at pH 7.5. The optimal buffer to
visualize the peaks and maintain solubility of TC-PTP1-314 was 25% PBS/75% Tris-NaCl
buffer at pH 7.5 (a sampling of the reassignments is shown in Figure 2.1A). Titration of
TC-PTP1-314 caused a subset of Cx43CT residues to broaden beyond detection. These are
highlighted on the Cx43CT sequence (Figure 2.1B). Strongly affected Cx43CT residues
G261-T275 include Y265 and Y267. Also affected were areas which include Y247, Y286,
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Y301, and Y313. The decrease in signal intensity caused by increasing TC-PTP1-314
concentrations was fit according to the nonlinear least square method. The binding affinity
(KD) was determined to be 350±80 μM. A glutathione S-transferase (GST) pull down
experiment was performed to validate the NMR results. Purified GST or GST-TC-PTP1-314
bound to glutathione agarose were incubated with purified Cx43CT and immunoblotting
using an anti-Cx43CT antibody identified that GST-TC-PTP1-314, but not GST, directly
interacted with the Cx43CT (Figure 2.1C).
Of the 6 Cx43CT tyrosine residues affected by TC-PTP1-314, Y265 and Y247 are known
sites phosphorylated by c- and v-Src, leading to closure of Cx43 gap junction channels
(Kanemitsu et al., 1997; Lin et al., 2001). To identify if TC-PTP dephosphorylates these
residues, an in vitro phosphatase assay was conducted using peptides containing phosphoY247 (pY247) or phospho-Y265 (pY265) incubated with TC-PTP1-314. Following the
protocol for the Malachite green assay (Millipore), we observed an increase in the amount
of inorganic phosphate production indicating TC-PTP dephosphorylates Cx43 on pY247
and pY265 (Figure. 2.2). The rate of de-phosphorylation was different between the two
sites, with pY265 being a more efficient substrate for TC-PTP than pY247. This
observation is consistent with the kinetic rate constant data (Km and kcat) which indicate
that TC-PTP is more efficient in dephosphorylating pY265 than pY247 (Table 1.1).
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Figure 2.1 Cx43CT residues affected by the direct interaction with TC-PTP. (A)
Overlaid 15N-HSQC spectra of the 15N-Cx43CT (residues 236-382; 30 μM) in the presence
of different concentrations (60 μM - 540 μM) of unlabeled TC-PTP1-314. The cross-peak
color changes according to the concentration ratio. A sample of the affected peaks is labeled.
Figure 2.1 Cx43CT residues affected by the

(B) Amino acid sequence of Cx43CT. Residues strongly affected by addition of TC-PTP1direct interaction with TC-PTP

314 are

highlighted in green (residues broadened beyond detection at 1:12 molar ratio) and

those less affected in yellow (residues broadened beyond detection at 1:18 molar ratio). In
red are the Cx43 residues Y247 and Y265 phosphorylated by Src. The remaining four
tyrosine residues have been underlined. (C) Purified GST or GST-TC-PTP1-314 on
glutathione agarose beads were incubated with (+) and without (-) purified Cx43CT236-382.
After washes, the anti-GST antibody (top) detected both GST alone (26 kDa) and GSTTC-PTP1-314 (58 kDa), however the anti-Cx43CT antibody (bottom) only detected Cx43CT
when incubated with GST-TC-PTP1-314.
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Figure 2.2 TC-PTP dephosphorylated Cx43 residues pY247 and pY265 in vitro. Plot
of the Malachite green assay showed the time course of Cx43 phospho-peptides (600 nM)
containing pY247 or pY265 dephosphorylated by the TC-PTP catalytic domain (0.6 nM).
Statistic data were recorded based on readings at OD650. Each experiment was repeated
three times.

Figure 2.2 TC-PTP dephosphorylated Cx43
residues pY247 and pY265 in vitro
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Table 2.1. Kinetic constants for de-phosphorylation of pY265 and pY247 by TC-PTP 1-314
Km

kcat

kcat/Km•10-6

(mM)

(s-1)

(M-1s-1)

Positive control*#

0.022±0.001

52.820±10.622

2.418±0.473

pY265*

0.075±0.003

56.588±3.320

0.751±0.197

pY247*

0.224±0.035

14.164±1.295

0.064±0.012

*All data were collected at pH 7.5, 25°C
#

Notably, the kinetic constants determined for the positive control (DADEpYL) by TC-

PTP1-314 are consistent with a previous report of the same peptide with the PTP1B catalytic
domain, whose sequence is very similar with TC-PTP1-314 (Peters et al., 2000).
Table 2.1 Kinetic constants for de-phosphorylation of pY265 and pY247 by TC-PTP 1-314
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8.2 TC-PTP Dephosphorylates Cx43 in Normal Rat Kidney (NRK) Epithelial Cells
To determine if de-phosphorylation of pY265 and pY247 by TC-PTP occurs in cells,
we initially tested whether endogenous Cx43 and TC-PTP colocalize in NRK cells.
Immunostaining in the absence of EGF shows TC-PTP in the nucleus and Cx43 at the
plasma membrane (Figure. 2.3A, -EGF). Within one hour after EGF treatment, TC-PTP is
recruited to the plasma membrane and partially colocalizes with Cx43 (Figure. 2.3A,
+EGF). Co-immunoprecipitation (IP) using an anti-TC-PTP antibody that interacts with
the CT domain (anti-TC-CT) followed by Western blot analysis demonstrated TC-PTP and
Cx43 are in the same complex (Figure. 2.3B). Numerous studies have shown that
differentially phosphorylated Cx43 results in multiple electrophoretic isoforms: a fast
migrating isoform (P0), and multiple slower migrating isoforms (P1 and P2) (Crow et al.,
1990; Matesic et al., 1994; Solan and Lampe, 2005). TC-PTP has a preference for the P2
isoform in NRK cells.
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Figure 2.3 EGF induced TC-PTP to colocalize
Figure 2.3 EGF induced TC-PTP to colocalize
with Cx43 in NRK cells. (A) Cellular
with Cx43 in NRK cells.

localization of endogenous Cx43 and TC-PTP in NRK cells with or without human
recombinant EGF (50 ng/ml; 1 hr, Peprotech, Rocky Hill, NJ) using immunofluorescence
(green, Cx43; blue, DAPI; red, TC-PTP). Colocalization of Cx43 and TC-PTP (yellow) is
highlighted by white arrows. Scale bar is 20 μm. Colocalization of Cx43 and TC-PTP was
analyzed based on 10 images from 3 independent experiments. Manders method was used
to measure green signal (Cx43) coincident with red signal (TC-PTP) over the total intensity
of green signal. Error bars indicate S.E.M. (B) Lysates of NRK cells were IP with anti-TCNT, anti-TC-CT, or IgG and then blotted for Cx43 and TC-PTP. Input was lysates of NRK
cells. The Cx43 mobility shift P0, P1, and P2 have been labeled.
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TC-PTP can interact with protein partners through both the N-terminal (NT) catalytic
domain and the CT inhibitory and nuclear targeting domain (Iversen et al., 2002). Dephosphorylation of Cx43 would therefore depend on the interaction with the TC-PTP
catalytic domain. Co-IP using an anti-TC-PTP-CT antibody pulled down Cx43 (Figure.
2.3B). However, an anti-TC-PTP-NT antibody was unable to pull down Cx43, suggesting
that the epitope was blocked due to the interaction of the catalytic domain with Cx43;
results consistent with the in vitro binding experiments. Based on these observations, the
catalytic domain alone (TC-PTP1-314; missing nuclear localization domain and localized in
the cytoplasm) was transfected into NRK cells to test for TC-PTP de-phosphorylation of
Cx43. Immunostaining demonstrates that TC-PTP1-314 colocalizes with Cx43 on the plasma
membrane with or without EGF treatment (Figure. 2.4A). Next, Cx43 phospho-specific
antibodies were used to test if TC-PTP can decrease Cx43 tyrosine phosphorylation levels
in cells (Figure. 2.4B). The amount of pY265 and pY247 was decreased in the TC-PTP1314 transfected

group compared with the pcDNA 3.1 vector transfection group. Of note, the

basal level of Cx43 tyrosine phosphorylation observed in the NRK cells (Figure. 2.4B, TC-PTP1-314) is significantly greater than what has been observed in other cell lines
(Kanemitsu et al., 1997; Lampe et al., 1998; Lau et al., 1992; Lidington et al., 2002). While
to the best of our knowledge the basel level of tyrosine phosphorylation in NRK cells has
not been previously reported, a basel level of tyrosine phosphorylation has been observed
in a derivative of the NRK cell line (called LA-25 (Solan and Lampe, 2014), discussed
further below). The differences may be the result of higher sensitivity by the specific
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Figure 2.4 TC-PTP causes Cx43 de-phosphorylation in NRK cells. (A)
Immunofluorescence of NRK cells transfected with the catalytically active, cytoplasmic
TC-PTP domain (TC-PTP1-314) with or without EGF (50 ng/ml; 1 hr). Colocalization of
Cx43 and TC-PTP (yellow)
highlighted
by white
Scale bar is 20 μm.
Figureis 2.4
TC-PTP causes
Cx43 arrows.
dephosphorylation in NRK cells

Colocalization of Cx43 and TC-PTP was analyzed based on 8 images from three
independent experiments. (B) Western blot using Cx43 Y247 and Y265 phospho-specific,
as well as Cx43 and TC-PTP antibodies in NRK cells. Relative protein levels were
quantified by analyzing scanned blots by Image J software. The data are representative of
three independent experiments.
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tyrosine antibodies (used in this study and in (Solan and Lampe, 2014)) and/or TC-PTP
might be somewhat less active in NRK (and LA-25) cells under the given conditions.
Altogether, these studies indicate that TC-PTP and Cx43 exist in the same complex in cells
and that TC-PTP can cause a decrease in the levels of Cx43 tyrosine phosphorylation.

8.3 TC-PTP Dephosphorylates Cx43 Residues pY247 and pY265 in LA-25 cells
NRK cells containing a temperature sensitive v-Src, called LA-25, are commonly used
in the gap junction field to characterize Cx43 regulation by v-Src (Solan and Lampe, 2008;
Zhou et al., 1999). v-Src is active in this cell line at the permissive temperature (35°C) and
not at the non-permissive temperature (40°C). Worth mentioning, temperature alone does
not affect gap junction communication in NRK cells (Atkinson et al., 1981). Here, the LA25 cells were used to characterize the interplay between TC-PTP and v-Src on Cx43
tyrosine phosphorylation levels. To begin with, immunostaining data indicate that active vSrc at 35°C resulted in v-Src colocalization with Cx43 at the plasma membrane (Figure.
2.5A). Immunostaining data then confirmed that after activation of v-Src, endogenous TCPTP colocalizes with Cx43 at the plasma membrane (Figure. 2.5B). These data suggest TCPTP could mitigate the effect caused by v-Src in order to maintain cell-to-cell
communication.
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Figure 2.5 v-Src induces TC-PTP to colocalize with Cx43 in LA-25 cells.
Immunostaining studies show (A) active Src (Src pY416, red) and (B) TC-PTP (red) colocalized with Cx43 at the permissive temperature (35°C) in LA-25 cells. For each panel,
green and blue represent Cx43
respectively.
Colocalization of Cx43 and active
Figureand
2.5 DAPI,
v-Src induces
TC-PTP to colocalize
with Cx43 in LA-25 cells

v-Src or TC-PTP (yellow) is highlighted by white arrows. Scale bar is 50 μm for (A) and
20 μm for (B). Colocalization of Cx43 and active v-Src or TC-PTP was analyzed based on
12 images from three independent experiments.
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To test this possibility, tyrosine phosphorylation levels were evaluated in the LA-25
cells using the Cx43 pY265 and pY247 phospho-specific antibodies (Figure. 2.6). Active
v-Src at 35°C increased both Y265 and Y247 phosphorylation levels as compared to 40°C.
However, if transfected with TC-PTP1-314 prior to v-Src activation, Y265 and Y247
phosphorylation levels decreased significantly. Additionally, at 35°C, TC-PTP1-314 did not
dephosphorylate v-Src (Src pY416), which supports that the decrease of pY247 and pY265
in the TC-PTP1-314 transfected group is caused by TC-PTP and not by decreased kinase
activity of v-Src. Since MAPK and PKC were reported to phosphorylate Cx43 to down
regulate Cx43 gap junction intercellular communication in response to active v-Src in the
LA-25 cells (as well as other cell lines (Mitra et al., 2012; Solan and Lampe, 2008)), we
investigated if TC-PTP indirectly affected serine phosphorylation. Cx43 serine
phosphorylation levels were evaluated using phospho-serine specific antibodies to
pS279/282 (MAPK target) and pS368 (PKC target). pS279/282 and pS368 levels were upregulated at 35°C as expected; interestingly, expression of TC-PTP1-314 indirectly led to
decreased pS368 levels but not pS279/282 at 35°C. S368 is a known phosphorylation site
by different PKC isoforms (α, δ, and ) (Cone et al., 2014; Mitra et al., 2012) as well as
PKCα and PKCδ, in particular, can be up-regulated by v-Src expression (Zang et al., 1995).
To address if TC-PTP is affecting activation of PKC, we initially identified that LA-25 cells
express PKCα and PKCδ (Figure. 2.6B) but not PKCε (data not shown). Next, a wellestablished method of measuring membrane-associated PKC isoforms was used since PKC
isoforms translocate from cytosolic to membrane distribution when activated. (Borner et
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al., 1992; Ha and Exton, 1993; Saxon et al., 1994). The level of activated PKCα and PKCδ
increased at 35°C compared to 40°C (16.3±2% to 25.7±3% for PKCα; 13.0±2% to
36.7±0.3% for PKCδ). Transfection of TC-PTP1-314 caused a decrease in the level of both
membrane-associated PKCα (14.3±4%) and PKCδ (16.7±5% ) indicating that TC-PTP can
inhibit the activation of PKCα and PKCδ by v-Src (Figure. 2.6B).
To determine the specificity of TC-PTP to decrease the level of Cx43 tyrosine
phosphorylation, TC-PTP siRNA was used to knockdown endogenous TC-PTP in the LA25 cells. Colocalization between TC-PTP and Cx43 was investigated at 35°C, where
endogenous TC-PTP colocalizes with Cx43 at cell membrane (Figure 2.5B). In the TCPTP siRNA group, both pY265 and pY247 increased approximately 2-fold in the TC-PTP
siRNA group (even with a decrease in the total levels of Cx43), compared to the scramble
siRNA group. The decrease of Cx43 correlates with the decrease observed for pS279/282,
indicating that down-regulation of TC-PTP does not affect MAPK phosphorylation. On the
other hand, the relative decrease of Cx43 was greater than that of pS368, indicating upregulation of PKC activity in the absence of TC-PTP. This result is consistent with the
down-regulation of PKCα and PKCδ with the transfection of TC-PTP 1-314 (Figure 2.6B).
Next, we addressed the functional significance of Cx43 de-phosphorylation by TC-PTP.
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Figure 2.6 TC-PTP dephosphorylated Cx43
residues pY247 and pY265 in LA-25 cells.
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Figure 2.6 TC-PTP dephosphorylated Cx43 residues pY247 and pY265 in LA-25
cells. (A) Western blot of TC-PTP (wild type-WT and transfected TC-PTP1-314-NT),
active v-Src (Src pY416), total v-Src, pY265, pY247, pS279/282, pS368, and total
Cx43 (blot with Cx43NT1) levels from LA-25 cells at 40°C and 35°C (12 hr) with or
without TC-PTP1-314 transfection. Relative protein levels were quantified by analyzing
scanned blots by Image J software with normalization of protein expression to the - TCPTP1-314 lane at 35°C lane (value = 1). The data is representative of three independent
experiments. (B) Activation of PKC isoforms α and δ in LA-25 cells at 40°C and 35°C
with or without TC-PTP1-314 transfection. PKC isoforms α and δ in cytosolic (C) and
membrane (M) fractions were analyzed by Western blot. Na+/K+ ATPase was blotted as
membrane fraction marker, GAPDH was blotted as cytosolic fraction marker. Relative
protein levels were quantified by analyzing scanned blots from 3 independent
experiment by Image J software. (C) Scramble RNA or TC-PTP siRNA treated LA-25
cells were incubated at 35°C for 12 hrs. Cx43 phosphorylation level were analyzed by
Western blot.
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8.4 TC-PTP Increases Gap Junction Intercellular Communication and Stability
of the Gap Junction Plaque
To determine if TC-PTP de-phosphorylation of Cx43 affects cell-to-cell
communication, the junctional transfer of the fluorescent tracer Lucifer yellow (MW
443) was measured in a scrape-loading using the LA-25 cells (Figure 2.7A). Gap
junctions were functional at 40°C and the number of fluorescent cells was significantly
reduced at 35°C from 115.2±5 to 8.6±3 (Figure 2.7B). Conversely, transfection of TCPTP1-314 increased the number of fluorescent cells at 35°C, albeit not to levels observed
without active v-Src (from 8.6±3 to 56.4±3 vs. 115.2±5). These findings indicate that
the inhibition of Cx43 gap junction intercellular communication caused by v-Src can
be partially rescued by TC-PTP. A plausible explanation for the “partial” rescue of gap
junction intercellular communication is that Cx43 MAPK phosphorylation levels were
unaffected (Figure 2.6). Using the MAPK specific inhibitor U0126, the number of
fluorescent (non-TC-PTP1-314 transfected) cells at 35°C increased greater than what was
observed with TC-PTP1-314 transfection alone (88±5), but still reduced from 40°C.
Finally, we used the PKC specific inhibitor BIM to test the contribution of PKC
phosphorylation on channel closure. BIM treatment also resulted in increased
fluorescent cells (43±5) from control (DMSO), but not to the levels of TC-PTP1-314
transfection or the presence of the MAPK specific inhibitor U0126.
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Figure 2.7 Scrape loading assay shows TC-PTP
increased

gap

junction

intercellular

communication in LA-25 cells.
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Figure 2.7 Scrape loading assay shows TC-PTP increased gap junction
intercellular communication in LA-25 cells. (A) Cells grown on glass cover slips
were scrape-loaded with Lucifer Yellow (LY, green) and Texas Red-conjugated dextran
(red). Cell nucleus was stained by DAPI to show the confluence of cells. Scale bar is
100 μm. (B) Quantification of fluorescent cells shows the effect of TC-PTP1-314 and
serine kinase inhibitors on gap junctional permeability. Number of fluorescent cells at
40°C is significantly more than at 35°C (p<0.0001). At 35°C, transfection of TC-PTP1314 or

addition of the MAPK inhibitor U0126 (50 μM) or PKC inhibitor BIM (0.1 μM)

significantly increased the number of fluorescent cells compared with control (DMSO)
at 35°C (p<0.0001). Each experiment was repeated for three times.
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Both MAPK and PKC phosphorylation contribute to gap junction channel closure.
TC-PTP can prevent the phosphorylation and channel closure caused by PKC but not
MAPK. S279/282 phosphorylated by MAPK could increase binding with Nadd 4, that
is associated with Cx43 internalization (Spagnol et al., 2016). Thus, the
dephosphorylation on Cx43 MAPK sites is important for indirectly increasing gap
junction intercellular communication. Previous studies showed that PP2A
dephosphorylated TPA-treated immunoprecipitated Cx43, however they did not test
phosphorylation sites that PP2A affects (Cruciani et al., 1999). To further study which
phosphatase targets MAPK sites, the MAPK phospho-peptide was used as the substrate
in in vitro phosphatase screening assay, several phosphatases were used in the assay
(Table 2.2). The results show that the PP2A was the most specific phosphatase to
dephosphorylate S279/282 compare to the other tested phosphatases, with 39% of
control activity. PP2A could also dephosphorylate the PKC site (pS368) with high
efficiency, which is 122% activity of control (Figure 2.8).
Cx43 gap junction channels are localized in detergent-insoluble junctional plaques
(Musil and Goodenough, 1991; Sirnes et al., 2008). To test the possibility that rescue
of gap junctional coupling by TC-PTP was caused by an increase in the amount of Cx43
at junctional plaques, we assessed levels of TX100 detergent solubility. The detergent
extraction in situ fluorescence and Western blot data show that active v-Src in LA-25
cells at 35°C decreased the detergent-insoluble fraction of Cx43 (Figure. 2.9A, B).
Quantification of the data revealed that the insoluble to insoluble+soluble ratio (I/(S+I))
was 79.6±8% at 40°C (Figure. 2.9C). However, the number of assembled gap junctions
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Table 2.2 PP2Aalpha dephosphorylated pS279/282 peptide
phosphatase

% Activity

PP1A

6

PP1B

3

PP2A alpha

39

PP2C alpha

-1

PP2C gamma

0

CDC25A

5

CDC25B

6

CDC25C

18

In vitro phosphatase screening assay using pS279/282 peptide as substrate. The
profiling data for the peptide substrate pS279/282 against various protein phosphatase
targets using the melachite green assay method showed weak to moderate dephosphorylation of the peptide substrate pS279/282 by 2 phosphatase targets PP2A
alpha and CDC25C. The protein phosphatase target PP2A alpha showed the highest
activity against the peptide substrate pS279/282. The rest of the phosphatase targets did
not show any significant activity against the peptide substrate pS279/282 (values of >10%
to be significant).
Table 2.2 PP2Aalpha dephosphorylated pS279/282 peptide
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Figure 2.8 in vitro phosphatase assay using Cx43CT pS279/282 or Cx43CT pS368 phospho-peptides as substrate
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Figure 2.8 In vitro phosphatase assay using Cx43CT pS279/282 or Cx43CT pS368
phospho-peptides as substrates. (A) Using PP2B to dephosphorylate the Cx43CT
pS279/282 peptide. (B) Using PP2A to dephosphorylate the Cx43CT pS279/282
peptide. (C) Using PP2B to dephosphorylate the Cx43CT pS368 peptide. (D) Using
PP2A to dephosphorylate the Cx43CT pS368 peptide. Lanes 1, 2, and 3 are different
negative controls. Lane 4 is a positive control. In Lane 5, Cx43CT phospho-peptides
were used as substrates.
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significantly decreased at 35°C to 45.1±10%. The effect of v-Src was substantially
blocked by transfection of TC-PTP1-314. TC-PTP1-314 increased the Cx43 resistant to
TX100 (I/(S+I) = 72.9±8%) at 35°C, suggesting that TC-PTP contributed to the stability
of Cx43 at the junctional plaque.
9. Discussion
Here we identified that TC-PTP is the first tyrosine phosphatase, to the best of our
knowledge, which directly interacts with Cx43 to modulate gap junction intercellular
communication. TC-PTP-mediated de-phosphorylation of Cx43 tyrosine residues
Y265 and Y247, as well as indirect serine de-phosphorylation at S368, increased gap
junction intercellular communication, and stability of gap junction channels at the
plaque. Our studies are consistent with prior observations that TC-PTP is a negative
regulator of cytokine signaling as EGF stimulation of NRK cells caused TC-PTP to colocalize with Cx43 at the plasma membrane. In addition, v-Src expression alone was
able to mimic the effects of cytokine stimulation. How cytokines and/or v-Src induce
TC-PTP redistribution is not clear. TC-PTP has been reported to exit from the nucleus
via passive diffusion after cellular stress, while another possibility is that cytoplasmic
accumulation occurs by inhibiting nuclear import (Lam et al., 2001).
Closure of Cx43 gap junction channels by v-Src was first observed over 30 years
ago (Atkinson et al., 1981); however, the specific sites of Cx43 phosphorylation
required for this process are still a matter of debate. Several studies implicate the
activation of v-Src in both the direct phosphorylation of Cx43 tyrosines (Y247 and
Y265) and the indirect phosphorylation of serines by MAPK (S279/S282) and PKC
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Figure 2.9 TX100 solubility assay shows TC-PTP stabilized Cx43 at the gap
junction plaque in LA-25 cells. (A) Cx43 was extracted in situ with 1% TX100 and
immunostained for Cx43 (green). Scale bar is 10 μm. (B) Equal amounts of total protein
fraction (T), TX100 soluble fraction (S), and insoluble fraction (I) were run on SDSPAGE and blotted with anti-Cx43 antibody. (C) Protein levels were quantified to
determine the insoluble to insoluble+soluble ratio I/(I+S). I/(I+S) at 40°C is
significantly higher than at 35°C (p<0.001). At 35°C, I/(I+S) in the TC-PTP1-314
transfected group is significantly different from the empty vector transfected control
(p<0.01).
Figure 2.9 TX100 solubility assay shows TCPTP stabilized Cx43 at the gap junction plaque
in LA-25 cells
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(S368) (Mitra et al.,2012; Solan and Lampe, 2008). We also show that v-Src increased
the level of Y265, Y247, S279/282 and S368 phosphorylation. Conversely, TC-PTP
decreased the phosphorylation level of Y265 (direct), Y247 (direct), and S368 (indirect),
but not S279/282. The indirect decrease of pS368 was caused by inactivation of PKCα
PKCδ. No change in pS279/282 levels is consistent with a previous study in which TCPTP had no effect on MAPK signaling after EGF-induced activation (van Vliet et al.,
2005). Of note, one mechanism by which EGF up regulates MAPK signaling is through
c-Src activation (Faivre and Lange, 2007; Zhang et al., 2012). The use of kinase
inhibitors identified that v-Src, MAPK, and PKC are all involved in gap junction
closure, although they decreased the level of communication differently. MAPK
phosphorylation had the greatest effect on channel closure and the observation that TCPTP did not affect the phosphorylation level of S279/282 explains why TC-PTP only
partially reversed gap junction closure caused by v-Src.
To detect the phosphatase(s) that dephosphorylate Cx43CT residues S279/282, we
performed in vitro phosphatase screening assays. We found that only PP2A could
dephosphorylate the pS279/282 sites, however, only 39% of control. Future studies to
validate this finding would include cell studies. Western blot using Cx43 phosphospecific antibodies could be applied on PP2A transfected cells with TPA stimulation. In
fact, some of MAPK substrates can be dephosphorylated by PP2A, such as Caspase 3
(Alvarado-Kristensson and Andersson, 2005) and pro-apoptotic protein Bad (Grethe
and Porn-Ares, 2006). These evidence suggest the possibility of dephosphorylation on
Cx43 S279/282 by PP2A. Other strategies targeting MAPK phosphorylation sites, such
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as peptide or small molecule drugs to block S279/282 on Cx43, could be applied to
maintain functional gap junction.
Several hypotheses, which are not mutually exclusive, could describe the
mechanism(s) by which phosphorylation regulates gap junction intercellular
communication. First, the negative charge of the phosphate could affect the
permeability of ions through the pore via electrostatic attraction or repulsion. In this
study, the negatively charged Lucifer yellow was used as probe for gap junction
intercellular communication. The placement of at least 60 negative charges (5
phosphorylation sites: 2 Src, 2 MAPK, and 1 PKC; phosphate charge of -2) within a
connexon (6 connexins) caused by v-Src could contribute to the reduction of Lucifer
yellow transport. Second, phosphorylation can directly (and possibly indirectly, see
(Grosely et al., 2013c)) alter the binding affinities of proteins involved in Cx43
regulation. As mentioned in the introduction section, Y247 is directly involved in
microtubule binding and pY247 would be detrimental to Cx43 intercellular
communication.(Saidi Brikci-Nigassa et al., 2012). This is consistent with our results
that dephosphorylation of pY247 by TC-PTP correlates with an increase in the number
of Cx43 gap junctions at the plaque. Phosphorylation on Y265 also facilitates gap
junction endocytosis by disrupting the interaction with drebrin, an F-actin-binding
protein that is required for stabilizing gap junctions at the plasma membrane (Ambrosi
et al., 2016; Butkevich et al., 2004) (del Valle et al., 2012). These results are in
agreement with our finding that TC-PTP dephosphorylation of Y265 also correlates
with an increase in Cx43 gap junction channels at the plaque. Finally, Cx43CT
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phosphorylation could alter the structure of the transmembrane α-helices to influence
pore size and/or drive gating by a “ball and chain” mechanism, similar to what had been
shown for pH gating of Cx43 (ek-vitorin 1996 and Morley 1996).
Phosphorylation is a primary means of mediating signal transduction events that
control cellular processes via a highly regulated dynamic interplay between protein
kinases and phosphatases. Many kinases are known to phosphorylate Cx43 with the
predominant effect being a decrease in gap junction intercellular communication. While
kinases have established roles in the life cycle of a connexin, unfortunately, a
significantly less amount of information is known about the involvement of
phosphatases. Identification of a new tyrosine phosphatase TC-PTP, which
dephosphorylates Src-mediated phosphorylation of Cx43, presents an opportunity to
contribute beyond what other studies have focused upon, which is channel closure, by
characterizing the timeline of gap junction channel opening. Understanding both
phosphorylation and de-phosphorylation will help build a better foundation to target
gap junction channels to benefit human health. For example, inhibitor treatment of cSrc in a myocardial infarction mouse model significantly increased Cx43 expression in
scar border and distal ventricle, leading to improved conduction velocity and lower
arrhythmic inducibility (Rutledge et al., 2014). Our data demonstrating that TC-PTP
dephosphorylates Cx43 and increases the level of Cx43 level on the cell membrane
supports their conclusion, from a cellular perspective. Future research using an animal
model to study the relevance of Cx43 de-phosphorylation by TC-PTP may provide new
avenues for disease therapy.
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CHAPTER 3

Regulation of Connexin43 Function and Expression by Tyrosine Kinase 2

Material in this chapter has been published in the following article:
Li H, Spagnol G, Zheng L, Stauch KL, Sorgen PL. (2016) J Biol Chem. 2016 May 27.
pii: jbc.M116.727008. [Epub ahead of print] doi: 10.1074/jbc.M116.727008.
Manuscript is linked to http://www.jbc.org/content/291/30/15867.long

CHAPTER 3 Regulation of Connexin43 Function and Expression by
Tyrosine Kinase 2
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10. Introduction
The Cx43CT is differentially phosphorylated on at least 20 residues and significant
progress has been achieved in characterizing the kinases involved (Axelsen et al., 2013;
Lampe and Lau, 2004; Solan and Lampe, 2005, 2014). Unfortunately, an understanding
of the mechanism(s) by which Cx43 phosphorylation alters channel function is lacking.
Several problems contributing to this difficulty include the transient nature of a
particular CT phosphorylation state, the ability of many kinases to phosphorylate more
than one CT residue, the ability of various kinases to phosphorylate the CT at the same
time, and the inability to precisely control which residue(s) are phosphorylated.
Strategies employed to overcome these difficulties include the use of phospho-specific
CT antibodies (Sosinsky et al., 2007) and short CT phosphopeptides (Chen et al., 2008;
Saidi Brikci-Nigassa et al., 2012). Also well appreciated is the use of Asp (or Glu)
substitutions as a mimetic for phosphorylation (Grosely et al., 2013b; Solan et al., 2007).
Numerous serine protein kinases have been identified to directly phosphorylate Cx43
(for review see (Axelsen et al., 2013)), however tyrosine protein kinases have been
limited to the well-studied cases involving c- and v-Src-induced phosphorylation
(Azarnia et al., 1988; Filson et al., 1990; Kanemitsu et al., 1997; Kurata and Lau, 1994;
Loo et al., 1995). In this study, we identified Cx43 as a novel substrate of Tyrosine
kinase 2 (Tyk2).
Tyk2, a JAK family member, is a ubiquitously expressed non-receptor tyrosine
kinase. Tyk2 associates with the intracellular domains from a wide range of cytokine
and growth factor receptors via its N-terminal FERM and SH2-like (Firmbach-Kraft et
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al., 1990; Strobl et al., 2011; Wallweber et al., 2014). This leads to recruitment and
phosphorylation of STATs (Ghoreschi et al., 2009), which translocate to the nucleus
where they induce transcription of genes involved in diverse biological processes (e.g.
cellular proliferation and differentiation, inflammation, and defense against infection
(Leonard, 2001; Stark and Darnell, 2012)). Patients with non-functional Tyk2 display a
number of immunodeficiency conditions and increased susceptibility to infections
caused by defects in IFNα/β, IL-6, IL-10, IL-12 and IL-23 signaling (Minegishi et al.,
2006). Tyk2 deficient mice display reduced responses to IFNα/β and IL-12 and a
deficiency in STAT3 activation (Karaghiosoff et al., 2000). The Tyk2/STAT3 axis has
also been implicated in the induction of neuronal death in Alzheimer disease (Wan et
al., 2010), as a biomarker for Crohn’s disease (Sato et al., 2009), and in controlling
allergic asthma (Ubel et al., 2014). Marrero et al. (Marrero et al., 1995) first showed
that Ang II induces Tyk2 activation in rat aortic smooth muscle cells; a finding verified
in other studies (Kodama et al., 1998; Pan et al., 1997; Pan et al., 1999; Yoon et al.,
2013). The renin-angiotensin system (RAS) is a key signaling pathway associated with
the pathogenesis of cardiovascular disease (Lonn et al., 1994; Pagliaro and Penna,
2005). Increased Ang II levels are linked with an increased risk of ventricular
arrhythmia, and treatment with angiotensin-converting enzyme (ACE) inhibitors has
demonstrated survival benefits in congestive heart failure and myocardial infarction
(1991; Akar et al., 2004; Pfeffer et al., 1992). A transgenic mouse model of RAS
activation by overexpression of ACE restricted to the heart (ACE8/8) has normal
ventricular structure; however, it exhibits cardiac oxidative stress, a high incidence of
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ventricular tachycardia and subsequent sudden cardiac death. With no significant
change in Na+ current, these observations were associated with downregulation of Cx43
gap junction intercellular communication (Kasi et al., 2007). Altered cardiac Cx43
protein level and change in cellular localization were also observed in other models of
RAS activation (hypertension, hypertrophy, mechanical stress; (Emdad et al., 2001;
Hussain et al., 2010; Tan et al., 2013; Wang et al., 2014)). We provide evidence of a
relationship between Tyk2 activation by Ang II and Tyk2 phosphorylation of Cx43.
Tyk2 decreased gap junction stability at the plasma membrane, and through STAT3
activation increased the intracellular protein level of Cx43.

11. Materials and Methods
11.1 Cell Culture
Normal rat kidney (NRK) and LA-25 cells (NRK cells containing temperature
sensitive v-Src) were generous gifts from Dr. Paul Lampe (Fred Hutchinson Cancer
Research Center). The MDA-MB-231 cell line was from Dr. Melissa Teoh-Fitzgerald
(University of Nebraska Medical Center). All cells were grown in Dulbecco's modiﬁed
Eagle's medium (DMEM) (Hyclone, Thermo Fisher Scientific Inc.) supplemented with
10% fetal bovine serum (FBS) (Hyclone, Thermo Fisher Scientific Inc.) and antibiotics
in an atmosphere of humidified 5% CO2.

11.2 Antibody and Immunostaining
The following antibodies were used in this study: Cx43 monoclonal antibodies
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against amino acids 360-382 (Cx43CT1 and Cx43IF1, described in (Cooper and Lampe,
2002; Lampe et al., 2006)); Cx43 polyclonal antibody (C6219, Sigma-aldrich); rabbit
anti-Cx43 phosphorylated Y247, rabbit anti-phosphorylated Y265, and rabbit antiphosphorylated S279/282 (described in (Solan and Lampe, 2008)) (all generous gifts
from Dr. Paul Lampe, Fred Hutchinson Cancer Research Center); rabbit anti-Cx43
phosphorylated S368 (Millipore); non-specific phospho-tyrosine antibody (P-Tyr-100,
Cell Signaling); anti-Tyk2 (Santa Cruz), anti-active Tyk2 (phosphorylated 1054/1055);
anti-tubulin β (Sigma); and antibodies against total and active Src (phosphorylated
Y416, Millipore), STAT antibodies sampler kit (9939, Cell Signalling).
Cells were immunostained as described previously (Mehta et al., 1991). Briefly,
cells grown on cover slips to ~60% confluence were fixed with 3.7 % paraformaldehyde for 10 min. Cells were blocked for 30 min at room temperature (RT) by
MPS buffer (1x Phosphate-buffered saline (PBS), 1% Goat Serum) containing 0.2%
TX-100 for permeabilization. Then, cells were immunostained with appropriate
primary antibodies at RT for 1 h, followed by several PBS-0.5% Tween washes.
Secondary antibodies (Alexa 594-conjugated goat anti-rabbit antibody and/or Alexa
488-conjugated goat anti-mouse antibody) were applied for 1 hr at RT. Images of
immunostained cells were acquired with a Zeiss 510 Meta Confocal Laser Scanning
Microscope using a 63×1.4 numerical aperture objective with appropriate filters.
Colocalization was quantified using the Manders method in Image J (Bolte and
Cordelieres, 2006).
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11.3 In vitro Kinase Assay
Rat Cx43CT236-382 was expressed and purified as described previously (Duffy et al.,
2002). An in vitro kinase screen was performed by Eurofins Scientific using the purified
protein. The catalytic domain of JAK1 (866-1154), JAK2 (808-1132), and Tyk2 (8751187) were used to phosphorylate the Cx43CT. A positive control was used for each
kinase

(JAK1,

GEEPLYWSFPAKKK;

KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC;

JAK2,
Tyk2,

GGMEDIYFEFMGGKKK). Controls and Cx43CT were incubated with the tyrosine
kinase and ATP [γ-33P] for 40 min at 30°C and then transferred to P30 Filtermat for
substrate capture. Assays were performed in duplicate and acid blanks were used as a
negative control. The level of phosphorylation for each sample was determined
according to Merck Millipore’s radiometric assay.
11.4 Mass Spectrometry
Purified rat Cx43CT236-382 (12.5 nmol) was incubated with 1.5 µg Tyk2 (amino
acids 833-1187, ThermoFisher Scientific) and 500 µM ATP at 30°C for 15 hrs. In the
control group, the volume of Tyk2 was substituted by reaction buffer (25 mM HEPES
[pH 7.5], 10 mM MgCl2, 0.5 mM EGTA, and 0.005% Brij-35). The reaction was
stopped on ice, and 1 nmol of protein was ran on a SDS-PAGE gel and Western blotted
using a phospho-tyrosine antibody. 10 nmol of protein was run on a SDS-PAGE gel and
stained with Coomassie. The Cx43CT band was cut and sent to the Beth Israel
Deaconess Medical Center Mass Spectrometry Facility for analysis (Breitkopf and
Asara, 2012).

102

11.5 Glutathione S-transferase (GST) Pull-down Assay
The GST pull-down assay was modified from (Leykauf et al., 2006). Briefly,
purified GST-fusion Cx43CT and GST control proteins were bound to glutathioneSepharose beads in buffer containing 25 mM Tris-HCl [pH=7.4], 150 mM NaCl, 1 mM
DTT, 0.5% TX-100 and Complete protease inhibitor (Roche). 4 mg of MDA-MB-231
or LA-25 cell lysate protein (in cell lysis buffer containing 25 mM Tris-HCl (pH 7.4),
150 mM NaCl, 0.5% TX-100, 0.5% sodium deoxycholate, 2 mM EDTA, PhosSTOP
(Roche), and Complete protease inhibitor) were incubated with GST-fusion Cx43CT or
the GST control for 6 hrs at 4°C on a rotating wheel. Beads were washed 5x with cell
lysis buffer and bound proteins were eluted with SDS-PAGE sample buffer, and
analyzed by Western blot.

11.6 Co-immunoprecipitation (IP)
NRK or LA-25 cells were lysed in complete lysis buffer (50 mM Tris-HCl [pH 7.4],
150 mM NaCl, 0.5% Na-deoxycholate, 0.5 % TX 100, 5 mM NaF, and Complete
protease inhibitor), maintained on ice for 30 min, precleared with protein G beads for
30 min at 4°C, and then spun at 12,000 rpm for 15 min. Total protein was assessed using
the bicinchoninic acid (BCA) protein assay kit (Pierce). 2 mg lysate was incubated with
2 μg of Cx43 polyclonal or rabbit IgG (4 h at 4°C) and then incubated with 100 μl of
protein G sepharose (GE Healthcare) (overnight at 4°C). The sepharose was washed 4x
with cold lysis buffer and the co-IP product was analyzed by SDS-PAGE and Western
blot.
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When detecting tyrosine phosphorylation levels, 5 mM Na3VO4 was added in the
blocking and primary antibody buffer in order to minimize the loss of phosphorylation.
Western blot data were scanned and quantified using ImageJ software as described in
(Schneider et al., 2012).

11.7 Tyk2 siRNA Treatment
Tyk2 siRNA (Invitrogen) was used to knockdown Tyk2 expression in LA-25 cells.
Oligonucleotide from the non-target pool (Dharmacon) was used as negative control.
Lipofectmine RNAi MAX (Invitrogen) was used to carry the oligonucleotide according
to manufacturer’s protocol. Cells were treated with Tyk2 siRNA for 36 hrs and then
incubated at 35°C for another 12 hrs. Protein levels were detected by Western blot.

11.8 Cycloheximide Treatment and Cx43 Degradation
Cells equally seeded on 60-mm dishes were grown for 24 hrs to 70-80% confluency
before transfection. 24 hrs post-tranfection, cells were treated with 100 μg/ml
cycloheximide (Cell Signaling) for 1, 1.5, 2, 2.5, 3, 4 hrs to inhibit protein synthesis.
Cells were then scraped off and lysed for Cx43 immunoblotting. β-actin was also
blotted for quantification.

11.9 TX 100 Solubility
The T100 solubility assay was modified from the method described in (Mitra et al.,
2006). NRK cells grown in 10-cm dishes were rinsed 3x with PBS and scraped into 1
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ml lysis buffer (50 mM Tris-HCl [pH 7.4], 1 mM EGTA, 1 mM EDTA, 1 mM PMSF,
100 mM NaCl, PhosSTOP, and Complete protease inhibitor). Then, cells were
sonicated for 10 s on ice. Protein estimation was determined using the BCA method.
450 μl cell lysate samples were added to 50 μl of 10% SDS, which was saved as total
protein, or to 10% TX-100 (final concentration of 1%) and incubated at 4°C for 30 min.
Lysates were then separated into cytosolic (supernatant, soluble) and membrane (pellet,
insoluble) fractions by centrifugation at 100,000 g for 1 h at 4°C. The pellets were
dissolved in 500 μl dissolving buffer (70 mM Tris-HCl [pH 6.8], 8 M urea, 2.5% SDS,
0.1 M DTT, 5 mM NaF, 5 mM Na3VO4, and Complete protease inhibitor). Equal
volume of total lysate, TX-100 soluble and insoluble portions, were loaded on a 10%
SDS-PAGE and immunoblotted with the Cx43 polyclonal antibody.

11.10 Surface Biotinylation Assay
Surface biotinylation assay followed the method described in (Johnson et al., 2013).
Briefly, cells were seeded in 60-mm dishes in replicate and grown to 70-80%
confluence. 24 hrs after transfection, cells were washed once with PBS and then 5 ml
of ice cold DMEM plus HEPES buffer (pH = 7.4, final concentration 30 mM) was
added for 10 min at 4°C. Cells were washed twice with cold PBS-plus (PBS with 1 mM
CaCl2 and 1 mM MgCl2). The biotinylation reaction was performed at 4°C using freshly
prepared EZ-LinkSulfo-NHS-SS Biotin reagent (Pierce) at 0.5 mg/ml in PBS-plus for
30 min. The reaction was terminated by adding PBS-plus containing 20 mM glycine.
Cells were lysed in lysis buffer (25 mM Tris-HCl pH 7.5, 0.05% SDS, 20 mM Glycine,

105

and Complete protease inhibitor) with homogenization by passing through a 25G
needle. 500 µg of total protein were incubated with 100 µl of streptavidin-agarose beads
(Pierce) on a rotator overnight at 4°C. Beads were then washed 6x and the streptavidinbound biotinylated proteins were eluted and resolved by SDS–PAGE followed by
Western blotting.

11.11 Biotin Peptide Pull Down Assay
Biotin-tagged phosphorylated (Y247) and non-phosphorylated Cx43CT234-255
peptides (LifeTein) were bound to streptavidin-agarose resin (GenScript) in PBS. NRK
cells were lysed in HEPES lysis buffer (50 mM HEPES, 150 mM NaCl, 0.25% TX-100,
2 mM PMSF, 10 mM EDTA, 50 mM NaF, 5 mM Na3VO4, and PhosSTOP and Complete
tablets, pH 7.4) and total protein concentration was assessed using the BCA protein
assay. A total of 2.5 mg of protein lysate was incubated with each of the resin-bound
peptide, overnight at 4°C. Beads were washed 3x with PBS before analyzing the pulldown products by SDS-PAGE and Western blot.

11.12 Semi-Quantitative Reverse Transcription (RT) PCR
Semiquantitative RT-PCR was modified from the method described in (Marone et
al., 2001). Briefly, NRK cells grown in 35-mm dishes were transfected with Tyk2V678F
and pretreated with the inhibitor Nifuroxazide (50 µM, Millipore) or SH-4-54 (5 µM,
Millipore). RNA extractions were carried out with the RNeasy mini kit (Quiagen),
according to the manufacturer's protocol. RT was performed with ProtoScript cDNA
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synthesis kit (New England Biolab). The following primers were used: Cx43 5’AGCCTCCAAGGAGTTCCA-3’ and 5’-AGAGCACTGACAGCCACA-3’, β-actin
5’-CACCCGCGAGTACAACCTTC-3’ and 5’-CCCATACCCACCATCACACC-3’.
Cx43 yielded an amplification product of 160 bp and β-actin of 207 bp. DreamTaq
green PCR master mix (Thermo Fisher Scientific) was used for PCR amplification. To
find out the exponential phase of amplification, different PCR cycles from 16 to 30
were tested. Each set of reaction included a no-sample negative control.

11.13 Statistical Analysis
All data were analyzed by GraphPad Prism 5.0 and presented as the standard error
of the mean (±S.E.M). Paired t-test was used to compare differences between the
experimental group and control or the two parallel experimental groups. P<0.05 was
considered to be statistically significant.
12. Results
12.1 Tyk2 Directly Interacts and Phosphorylates the Cx43CT Domain
Src (c-/v-Src) is the only known tyrosine kinase to both directly phosphorylate the
Cx43CT domain (pY247 and pY265) and affect gap junction intercellular
communication (Kieken et al., 2009; Sorgen et al., 2004). However, proteomic
discovery-mode mass spectrometry (MS) data identified other tyrosine residues (Y267,
Y286, Y301, and Y313) as potential phosphorylation targets (PhosphoSitePlus web
site). Unfortunately, the kinases involved were not identified nor was the functional
significance of phosphorylation at these sites. In this study, we focused on the JAK
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family of tyrosine kinases because of the potential direct link between Cx43 and RAS
in the pathogenesis of cardiovascular disease (Delmar and Makita, 2012; Lonn et al.,
1994; Pagliaro and Penna, 2005; Palatinus et al., 2012). An in vitro tyrosine
phosphorylation screen performed by Eurofins Scientific (KinaseProfiler) found that
Tyk2 phosphorylated purified Cx43CT (236-382; Figure 3.1A). JAK1 and JAK2, also
JAK family members, had significantly less ability to phosphorylate the Cx43CT
domain (JAK3 was not tested because it is not expressed in the heart). To confirm the
interaction between Cx43 and Tyk2, purified GST-tagged Cx43CT236-382 was
immobilized on glutathione-Sepharose beads and lysate from MDA-MB-231 cells that
express Tyk2 (but not Cx43) was used in a pull-down assay (Figure 3.1B). Tyk2 can be
pulled-down by GST-Cx43CT but not GST in MDA-MB-231 cells. v-Src was used as
a positive control.

12.2 Identifying the Cx43CT Tyrosine Residue(s) Phosphorylated by Tyk2
Purified Cx43CT236-382 was incubated in vitro with active Tyk2 (Life Technologies)
as described in (Cooper et al., 2000; Huang et al., 2012) and phosphorylation was
confirmed using an anti-phospho-tyrosine antibody (Figure 3.2B). After trypsin
digestion, Tandem MS/MS identified phosphorylation at Y247, Y265, Y267, and Y313
(Figure 3.2A and Table 3.1). To confirm tyrosine phosphorylation can occur at residues
other than Y247 and Y265, the in vitro kinase assay was performed using the
Cx43CT236-382(Y247,265F) (2YF) construct and phosphorylation detected with an antiphospho-tyrosine antibody (Figure 3.2B). The data indicate that while a majority of
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Figure 3.1 Phosphorylation of the Cx43CT domain by JAK tyrosine kinases. (A)
An in vitro kinase assay was performed using the catalytic domain of Jak1, Jak2, and
Tyk2 to phosphorylate purified Cx43CT. The amount of Cx43CT phosphorylation was
compared with a positive control peptide for each kinase (100% signal) (**P<0.01).
(B) Purified GST (26 kDa) or GST-Cx43CT (42 kDa) bound on glutathione-agarose
beads were incubated with or without MDA-MB-231 cell lysate (top) and the pulldowned product was analyzed by Western blot using an anti-Tyk2 antibody. GSTCx43CT pull down of v-Src from LA-25 cell lysate was used as positive control
(bottom).

Figure 3.1 Phosphorylation of the Cx43CT domain by JAK tyrosine kinases
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Figure 3.2 Identification of the Cx43CT tyrosine residues phosphorylated by Tyk2.
(A) Sequence of the Cx43CT domain. Highlighted (bold and underlined) are the
tyrosine residues identified from mass spectrometry to be phosphorylated from an in
vitro kinase assay using the Tyk2 catalytic domain to phosphorylate the Cx43CT. (B)
The same in vitro kinase assay in (A) was performed using wild type Cx43CT236-382 or
a Y247,265F (2YF) mutant as substrate and phosphorylation was detected by Western
blot using a general anti-phospho-tyrosine antibody. The control (Ctrl) group did not
contain Tyk2. The phospho-tyrosine level was quantified using ImageJ software (n=3,
Figure 3.2 Identification of the Cx43CT

**P<0.01)

tyrosine residues phosphorylated by Tyk2
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Table 3.1 Phospho-tyrosine containing peptides identified from mass spectrometry of the Cx43CT domain phosphorylated in vitro by Tyk2

Peptide sequence
GRSDPyHATTGPLSPSK

Start-end
242-258

Average
Mascot Delta
Ion Score
15.35

*Number of
phosphopeptides
4

Actual
peptide
mass
1849.84

Calculated
+1H peptide
mass
1850.84

Phosphorylation
site localization
Y247

SDPyHATTGPLSPSK

244-258

18.5

6

1636.72

1637.72

Y247

GRSDPyHATTGPLSPSKDc(Carbamidomethyl)GSPK

242-264

9.37

2

2667.04

2668.05

Y247

QASEQNWANySAEQNR

304-319

13.7

2

1974.79

1975.79

Y313

yAYFNGc(Carbamidomethyl)SSPTAPLSPm(Oxidation)SPPGYK

265-287

7.14

1

2588.07

2588.09

Y265

yAyFNGc(Carbamidomethyl)SSPTAPLSPm(Oxidation)SPPGYK

265-287

13.8

1

2667.05

2668.05

Y265, Y267

* Peptides with Mascot Delta Ion Score >7 were used to obtain the average Mascot Delta Ion Score according to (Savitski et al., 2011).
Table 3.1 Phospho-tyrosine containing peptides identified from mass spectrometry of the Cx43CT domain phosphorylated in vitro by Tyk2
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Tyk2 phosphorylation occurs on Y247 and Y265 (of note, Y247 and Y265 phosphospecific antibodies will be used in the next sections to further characterize these sites),
other tyrosine sites (i.e., Y267 and Y313) can be phosphorylated by Tyk2 in vitro.

12.3 Tyk2 Phosphorylates Cx43 Residues Y247 and Y265 Leading to Decreased
Stability of the Gap Junction Plaque in Normal Rat Kidney Epithelial (NRK) cells.
To determine if Tyk2 phosphorylation of Cx43 occurs in cells, we initially tested
in NRK cells if Cx43 (endogenously expressed) and Tyk2 (not expressed; transiently
transfected with a constitutively active construct, Tyk2V678F) colocalize (Figure 3.3).
The images suggest little-to-no colocalization in NRK cells that are over-expressing
active Tyk2. However, in those same NRK cells, Cx43 is significantly decreased at the
plasma membrane. The data suggests over-expressing active Tyk2 is leading to
internalization of Cx43 from the plasma membrane.
Next, tyrosine phosphorylation levels were evaluated in the NRK cells using the
only available Cx43 tyrosine phospho-specific antibodies pY247 and pY265 (Figure
3.4). Constitutively active Tyk2 increased both Y247 and Y265 phosphorylation levels
as compared to control (non-transfected cells). Importantly, the presence of active Tyk2
did not cause activation of c-Src. Since MAPK and PKC were reported to phosphorylate
Cx43 to down regulate Cx43 gap junction intercellular communication in response to
active Src in different cell lines (Mitra et al., 2012; Solan and Lampe, 2008), we
investigated if Tyk2 also indirectly affects serine phosphorylation. Cx43 serine
phosphorylation levels were evaluated using phospho-serine specific antibodies to
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pS279/282 (MAPK target) and pS368 (PKC target). pS279/282 and pS368 levels were
up-regulated in the presence of active Tyk2. Finally, while the amount of Cx43 at the
plasma membrane decreased (Figure 3.3A), active Tyk2 directly or indirectly caused
an overall increase in the total amount of Cx43. Numerous studies have shown that
differentially phosphorylated Cx43 results in multiple electrophoretic isoforms: a fast
migrating isoform (P0), and multiple slower migrating isoforms (P1 and P2) (Crow et
al., 1990; Matesic et al., 1994; Solan and Lampe, 2005). In particular, the P2 isoform
has been found at the stage of gap junctional plaques. Consistently, Western blots (here
and next sections) show an increase in the lower migrating P0 and P1 isoforms of Cx43
in the presence of active Tyk2.
Cx43 gap junction channels are localized in detergent-insoluble junctional plaques
(Musil and Goodenough, 1991; Sirnes et al., 2008). To confirm the increased amount
of Cx43 is not leading to an increase in the amount of Cx43 at junctional plaques, we
assessed the level of TX-100 detergent solubility. The detergent extraction Western blot
data show that active Tyk2 in NRK cells decreased the detergent-insoluble fraction of
Cx43 (Figure 3.5A). Quantification of the data revealed that the control insoluble to
insoluble + soluble ratio (I/(S+I)) was 67.1±6.0%. However, the number of assembled
gap junctions significantly decreased to 19.5±0.9% in the presence of active Tyk2. The
decreased amount of Cx43 in junctional plaques was corroborated by a biotinylation
assay which detected a significant decrease in the amount of Cx43 at the plasma
membrane (Figure 3.5B).
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Figure 3.3 Effect of Tyk2 on the cellular localization of Cx43. (A) Cellular
localization of endogenous Cx43 and constitutively active Tyk2 (Tyk2 V678F) in NRK
cells detected by immunofluorescence (green, Cx43; blue, DAPI-stained DNA; red,
active Tyk2). Scale bar is 20 μm. (B) Quantification of Cx43 expression level at the
plasma membrane. Cx43 pixel intensity of 204 cell pairs containing p-Tyk2 was
normalized to the Cx43 pixel intensity of 204 cell pairs without p-Tyk2 (Ctrl) by ImageJ
software. Cell pairs with p-Tyk2 or without p-Tyk2 were from the same images. The
data are representative of three independent experiments (***P<0.001).
Figure 3.3 Effect of Tyk2 on the cellular localization of Cx43.
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Figure 3.4 Phosphorylation of Cx43 by Tyk2 in NRK cells. Western blot of active
Tyk2 (p-Tyk2), total Tyk2, active c-Src (p-Src), total c-Src, Cx43 pY247, pY265,
pS279/282, pS368 and total Cx43 from NRK cells without (Ctrl) or with transfection
of Tyk2V678F. The Cx43 mobility shifts (P0, P1 and P2) are labeled. Relative protein
levels were quantified by analyzing scanned blots using ImageJ software, with
normalization of protein expression to the control lane (value set arbitrarily as 100%).
The data are representative of three independent experiments (*P<0.05, ***P<0.001).
Figure 3.4 Phosphorylation of Cx43 by Tyk2 in NRK cells
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Figure 3.5 Effect of Tyk2 on the plasma membrane localization of Cx43 in NRK
cells. (A) TX-100 solubility assay: Equal amounts of total protein fraction (T), TX-100
soluble fraction (S) and the insoluble fraction (I) were run on SDS-PAGE and blotted
with anti-Cx43 antibody. Protein levels were quantified to determine the insoluble to
insoluble + soluble ratio [I/(I+S)] (*P<0.05). (B) Biotinylation assay: NRK cells with
or without Tyk2V678F transfection were cell-surface biotinylated. Biotinylated proteins
were pulled down by immobilization on streptavidin agarose beads, and immunoblotted
for Cx43. Protein levels of biotinylated Cx43 were quantified (*P<0.05). Input shows
active Tyk2 and Cx43 protein in the cell lysate.
Figure 3.5 Effect of Tyk2 on the plasma membrane localization of Cx43 in NRK cells
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12.4 Interplay between Src and Tyk2 in the Regulation of Cx43
Murakami et al. (1998) observed that v-Src transfected cells indirectly caused
constitutive activation of Tyk2 and STAT3. Therefore, a modified NRK cell line
containing a temperature sensitive v-Src (called LA-25), commonly used in the gap
junction field to characterize Cx43 regulation by v-Src (Solan and Lampe, 2008; Zhou
et al., 1999), was used to study the effect of Tyk2 on Cx43 tyrosine phosphorylation
levels upon Src activation. v-Src is active in this cell line at the permissive temperature
(35°C) and not at the non-permissive temperature (40°C). Of note, temperature alone
does not affect gap junction communication in NRK or LA-25 cells (Atkinson et al.,
1981) and Tyk2 is endogenously expressed in LA-25 cells. To begin with, Western blot
data confirmed that active v-Src at 35°C resulted in activation of endogenous Tyk2
(Figure 3.6A). Immunostaining data then indicated that after 4 hrs of v-Src activation,
endogenous Tyk2 colocalizes with Cx43 at the plasma membrane (Figure3.6B). After
12 hrs, there was a decrease in the level of Cx43 and Tyk2 colocalization as well as the
amount of Cx43 at the plasma membrane. These results are similar to the
overexpression of active Tyk2 in the NRK cells (Figure 3.3). Next, Tyk2 siRNA was
transfected into the LA-25 cells (35°C) to differentiate the effect of v-Src and Tyk2 on
direct and indirect phosphorylation of Cx43 (Figure 3.7). Tyk2 siRNA significantly
reduced the level of active Tyk2 (>75%). As important, the Tyk2 siRNA does not affect
the level of active v-Src. Knock-down of Tyk2 in the presence of active v-Src
significantly decreases the level of Y247 and Y265 phosphorylation as compared to
control (scramble siRNA). Indirect serine phosphorylation was also affected by the
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knock-down of Tyk2. While pS279/282 phosphorylation was reduced by ~50%,
phosphorylation of pS368 was reduced by almost ~75% in the absence of Tyk2. Finally,
the knock down of Tyk2 led to a decrease in the total level of Cx43. Altogether, the data
indicate that similarities exist in the residues affected by Src or Tyk2, but differences
exist in the level of phosphorylation at each site and the overall amount of protein.

12.5 Tyk2 Increases Total Cx43 Protein Level through the STAT3 Pathway
In both the NRK and LA-25 cells, active Tyk2 caused an increase in the total protein
level of Cx43. To determine the mechanism for this effect, cycloheximide was used to
compare the turnover rate of Cx43 with or without Tyk2 (Figure 3.8). Western blot
analysis of Cx43 from NRK cells revealed that active Tyk2 increased the Cx43 turnover.
The data suggest the increased protein level of Cx43 is not a result of direct tyrosine or
indirect serine phosphorylation. Next, RT-PCR from cell lysate of NRK cells
transfected with active Tyk2 was used to determine if active Tyk2 indirectly affects the
level of Cx43 mRNA. Using different numbers of RT-PCR cycles, the data revealed
that active Tyk2 caused an increase in the level of Cx43 mRNA (Figure 3.9A). Actin
was used as a loading control. Because Tyk2 activates the STAT signaling pathway, we
tested if this is the mechanism leading to the increased mRNA and protein levels.
Experiments performed using NRK cells incubated with the STAT1/3/5 inhibitor
Nifuroxazide or the STAT3/5 inhibitor SH-4-54 eliminated the effect of active Tyk2
increasing Cx43 mRNA (Figure 3.9B) and protein levels (Figure 3.10A). Based upon
NRK cells expressing a very small amount of STAT1 and no STAT5 (Figure 3.10B),
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Figure 3.6 Colocalization of endogenous Tyk2 and Cx43 in LA-25 cells. (A) Western
blot of active v-Src (p-Src), total v-Src, active Tyk2 (p-Tyk2), total Tyk2, and Cx43 in
LA-25 cells at 40°C and 35°C. (B) Cellular localization of endogenous Cx43 and active
Tyk2 in LA-25 cells at 40°C or 35°C was visualized by using immunofluorescence
(green, Cx43; blue, DAPI-stained DNA; red, Tyk2). Scale bars is 20 µm. Colocalization
of Cx43 and p-Tyk2 was analyzed based on 12 images from three independent
experiments. Manders method was used to measure green signal (Cx43) coincident with
red signal (active Tyk2) over the total intensity of green signal (**P<0.01).
Figure 3.6 Colocalization of endogenous Tyk2 and Cx43 in LA-25 cells
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Figure 3.7 Effect of Tyk2 knockdown on the phosphorylation level of Cx43 in LA25 cells. Western blot of active Tyk2 (p-Tyk2), total Tyk2, active v-Src (p-Src), total vSrc, Cx43 pY247, pY265, pS279/282, pS368 and total Cx43 from LA-25 cells at 40°C
or 35°C treated with scrambled or Tyk2 siRNA for 12 h. Relative protein levels were
quantified using ImageJ software, and normalized to the expression level in the
scramble-RNA-treated sample at 35 ˚C (*P<0.05, **P<0.01).
Figure 3.7 Effect of Tyk2 knockdown on the phosphorylation level of Cx43 in LA-25 cells

120

Figure 3.8 Effect of Tyk2 on the turnover rate of Cx43 in NRK cells. Control (A) or transfected (B) NRK cells with the constitutively active
Tyk2 (Tyk2V678F) construct were treated with 100 μg/ml cycloheximide for different durations prior to lysis. Total Cx43 protein was immunoblotted.
(C) Protein level of three independent experiments quantified using ImageJ software and normalized to protein level at 0 hr.
Figure 3.8 Effect of Tyk2 on the turnover rate of Cx43 in NRK cells
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Figure 3.9 Effect of STAT3 activation by Tyk2 on Cx43 mRNA level. (A) RT-PCR
shows Cx43 mRNA level with or without transfection of active Tyk2 (Tyk2V678F). An
appropriate number of cycles was determined by testing different number of cycles (16,
21, 24, 27, 30) for Cx43 amplification (top panel). Cx43 intensity increased up to 24
cycles where a plateau was reached, thus 24 cycles was used to run semi-quantification
RT-PCR. Cx43 and β-actin were amplified for 24 cycles and ran on 2% agarose gel
(right panel). (B) NRK cells with or without active Tyk2 (Tyk2V678F) transfection for 8
hrs were treated with the STAT3/5 inhibitor SH-4-54 (5 µM) or STAT1/3/5 inhibitor
Nifuroxazide (50 µM) for another 16 hrs. Cx43 and β-actin were amplified for 24 cycles
and ran on 2% agarose gel. Cx43 and β-actin mRNA levels were quantified by
densitometry from three independent experiments (*P<0.05, **P<0.01).
Figure 3.9 Effect of STAT3 activation by Tyk2
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on Cx43 mRNA level.

Figure 3.10 Effect of STAT3 activation by Tyk2 on Cx43 protein level. (A) Western
blot of active Tyk2 (p-Tyk2), active STAT3 (p-STAT3), total STAT3, and Cx43 in NRK
cells transfected with or without active Tyk2 (Tyk2V678F) and treated with and without
SH-4-54 or Nifuroxazide. Cx43 protein level was quantified using ImageJ software
(*P<0.05, **P<0.01). (B) Western blot of STAT1, STAT3, and STAT5 from NRK cell
lysate. Cell extracts from HeLa cells treated with IFN-α (100ng/ml) for 5 min (9173,
Cell Signalling) were used as positive control for blotting STAT1 and STAT5. Jurkat
cell lysate was used as positive control for blotting STAT3.
Figure 3.10 Effect of STAT3 activation by Tyk2 on Cx43 protein level
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the data strongly indicates Tyk2 activation of STAT3 is responsible for the increased
Cx43 mRNA and subsequent protein levels.
12.6 Tyk2 Mediates Ang II Regulation of Cx43
Dysregulation of the RAS affects many aspects of the cardiovascular system
(Delmar and Makita, 2012; Lonn et al., 1994; Pagliaro and Penna, 2005; Palatinus et
al., 2012). RAS activation also decreases Cx43 gap junction intercellular
communication and changes cellular localization (Emdad et al., 2001; Hussain et al.,
2010). Based upon the involvement of Tyk2 in RAS signaling via the Angiotensin II
receptor 1 (AT1R), we tested if the changes observed for Cx43 are caused by Tyk2.
Western blot analysis was used to investigate wild type (WT) Tyk2 transfected NRK
cells treated with Ang II (Figure 3.11). The transfection of WT Tyk2 alone caused a
basal level of activation, however the presence of Ang II significantly increased the
amount of active Tyk2. The presence of Tyk2 or Ang II alone caused a significant
increase in the level of Y247, Y265, S279/282 and S368 phosphorylation. While the
phosphorylation level of Y247, S279/S282, and S368 was the greatest in the presence
of both Tyk2 and Ang II, only S279/282 phosphorylation was statistically significant
compared to Tyk2 alone. Interestingly, while the presence of Tyk2 or Ang II alone
caused an increase in the level of total Cx43 that was further increased in the company
of both, the presence of Tyk2 but not Ang II caused an increase in the lower migrating
P0 and P1 isoforms of Cx43.
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Figure 3.11 Effect of angiotensin II (Ang II) activation of Tyk2 on the
phosphorylation level of Cx43. Western blot of active Tyk2 (p-Tyk2), total Tyk2, Cx43
pY265, pY247, pS279/282, pS368, total Cx43 and the Angiotensin II type 1 receptor
(AT1R) from NRK cells with or without transfected wild-type (WT) Tyk2 and treated
with or without Ang II (10-7 M). Protein phosphorylation level were quantified using
ImageJ software (*P<0.05).
Figure 3.11 Effect of angiotensin II (Ang II) activation of Tyk2 on the phosphorylation level of Cx43
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Figure 3.12 Effect of Cx43 Y247 phosphorylation on the interaction with β-tubulin.
Western blot of β-tubulin from a biotin pull-down assay using a biotinylated-phosphopeptide Cx43CT234-255 (pY247) or non-phospho-peptide (Y247nop) bound to
streptavidin beads and incubated with NRK cell lysate. Biotin bound to streptavidin
agarose beads was used as negative control. Protein level were quantified using ImageJ
and normalized by input (1:20 loaded compared to pull-down groups) from three
independent experiments.
Figure 3.12 Effect of Cx43 Y247 phosphorylation on the interaction with β-tubulin.
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12.7 Phosphorylation of Cx43 residue Y247 Prevents the Binding of Tubulin
Previous studies have identified that Cx43 phosphorylation can inhibit the
interaction with the ZO-1 PDZ-2 domain (pS373; (Chen et al., 2008)) or enhance the
interaction with the Nedd4 WW2 domain (pS279/282; (Spagnol et al., 2016)).
Additionally, a Cx43 phospho-peptide (pY247) was not able to interact with purified
tubulin in vitro (Saidi Brikci-Nigassa et al., 2012). Since pY247 level was significantly
increased by Tyk2 in cells (Figures 3.4 and 3.11), a biotin-tagged Cx43 pY247
phosphorylated peptide or non-phosphorylated (K234-S255) version was used in a pull
down assay to assess the interaction with β-tubulin in NRK cell lysate (Figure 3.12).
The data indicate that Tyk2 phosphorylation of Y247 would inhibit the interaction with
β-tubulin.

13. Discussion
Up until now, Src has been the only non-receptor tyrosine kinase to directly
phosphorylate Cx43 leading to an inhibition of gap junctional intercellular
communication and subsequent gap junction disassembly (Lin et al., 2001; Swenson et
al., 1990). In this study, we identified another tyrosine kinase, Tyk2, which can directly
phosphorylate Cx43 on residues Y247 and Y265, and lead to indirect phosphorylation
on residues S368 and S279/282. While this phosphorylation pattern is similar to what
has been observed after Src activation (Solan and Lampe, 2008), importantly, the
response caused by Tyk2 (e.g. overexpression of the constitutively active version)
occurred when c-Src was inactive in NRK cells. This indicates that different signaling
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pathways can lead to the same cellular response to regulate Cx43 gap junctions.
Unexpectedly, when v-Src was activated in the LA-25 cells at the permissive
temperature, Tyk2 was activated as well. This observation is not unique to the LA-25
cells as constitutive activation of Tyk-2 was observed in a human gallbladder
adenocarcinoma cell line transfected with v-Src (Murakami et al., 1998). A significant
decrease in the phosphorylation of Cx43 residues Y247, Y265, S279/282, and
especially S368 (75% decrease) was observed in the LA-25 cells at the permissive
temperature when the expression of Tyk2 was knocked down. The data suggest that
although activation of Tyk2 and v-Src lead to phosphorylation of the same Cx43CT
residues they are not identical in level at each site. Additionally, the data would suggest
that activation of both Tyk2 and v-Src would work together to amplify the
phosphorylation response on Cx43. Differences in the level of phosphorylation between
Tyk2 and Src can be explained from the knowledge that the Tyk2 SH2 domain does not
need a phosphate to interact with its substrate, combined with the absence of the SH3
domain (Smyth et al., 2010).
A consistent observation from the immunofluorescence experiments was that
prolonged activation of Tyk2 led to a near complete removal of Cx43 from the plasma
membrane. Brikci-Nigassa et al. (Saidi Brikci-Nigassa et al., 2012) showed that a
Cx43CT phosphopeptide (pY247) does not interact with purified tubulin. We used a
biotinylated Cx43CT control (K234-S255) and phosphopeptide (pY247) in a pull down
assay using NRK cell lysate to show that phosphorylation inhibits the Cx43CT/βtubulin interaction. Increased levels of pY247 by Tyk2 (or Src) would block the Cx43
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interaction with tubulin (Saidi Brikci-Nigassa et al., 2012). At the gap junction plaque,
this may be a mechanism in the disassembly process; at the trans-Golgi network, this
may re-route trafficking to the plasma membrane (e.g., lateral membrane vs.
intercalated disc) or inhibit trafficking to the plasma membrane, leading to increased
intracellular proteasomal and/or lysosomal degradation (Alberts et al., 2002). Other
mechanisms that would contribute to the lack of Cx43 at the plasma membrane include
phosphorylation of residues S279/282 (MAPK) and S368 (PKC). Phosphorylation of
S279/282 increases the binding affinity by two-fold for the WW2 domain from the
ubiquitin ligase Nedd4 leading to Cx43 gap junction degradation (Girao et al., 2009;
Leykauf et al., 2006; Spagnol et al., 2016). Activation of PKC can halt the assembly of
new gap junctions and phosphorylation on S368 has been implicated in affecting gating
and/or disassembly (Lampe, 1994; Lampe et al., 2000; Saez et al., 1997). Of note,
although not investigated in this study, Src activation also leads to phosphorylation of
Cx43 on S373 by Akt (Park et al., 2007). The importance of phosphorylation on this
site is that the interaction with ZO-1 is inhibited, transitioning Cx43 from the nonjunctional plasma membrane into the gap junction plaque, and then through the
degradation pathway(s).
One difference observed in our (and others) studies performed in vitro as compared
to in vivo is the effect of Ang II on Cx43 protein level. We identified that activation of
Tyk2 by Ang II in vitro causes an increase in Cx43 protein level via the STAT3 pathway.
Other in vitro examples of an increase in Cx43 protein level include exposing freshly
isolated aortas of wild-type mice to Ang II for 4 hrs and the aorta smooth muscle cell
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line A7r5 to Ang II from 2 hrs to 48 hrs (maximum expression was observed at 4 hrs
and was maintained to the last time point of 48 hrs) (Alonso et al., 2010; Stein et al.,
2009). Conversely, chronic exposure of Ang II in animal models shows a decrease in
the protein level of Cx43. This was seen in the atria and ventricles of the transgenic
mouse model of cardiac-restricted overexpression of ACE (ACE8/8) described above
(Kasi et al., 2007) and in the double transgenic rat which harbors the human renin and
angiotensinogen genes (dTGR) (Fischer et al., 2007). While the length of Ang II
exposure (acute vs. chronic) and experimental conditions (in vitro and in vivo) are
important factors when interpreting the protein level of Cx43, the combined data can
be explained from the study of Kostin et al. (Kostin et al., 2004). Cx43 expression was
increased in the compensated hypertrophic stage from the left ventricles of pressureoverloaded human hearts with valvular aortic stenosis, but decreased and
heterogeneously distributed throughout the ventricles in the decompensated stage.
We identified that the effect Tyk2 elicited on the Cx43 protein level in NRK cells
was mediated through activation of STAT3. However, this increase did not correlate
with increased gap junction intercellular communication as Cx43 was not localized to
the plasma membrane. Evidence that STAT3 directly increases the transcriptional
activity of Cx43 was provided by Ozog et al. (Ozog et al., 2004). Three putative ciliary
neurotrophic factor-response elements (binding sites for STAT3 dimers that contain
base sequences TTCCN3-5AA) were identified in the promoter region of the mouse
Cx43 gene (located at regions -1510, -1179, and -893) as essential for enhanced Cx43
expression. Interestingly, STAT3 activation also leads to down-regulation of E-cadherin
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(Xiong et al., 2012). One mechanism for the decreased gap junction assembly may be
explained by the observation that expression of E-cadherin is necessary to enable the
assembly of Cx43 into gap junctions (Govindarajan et al., 2010).
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CHAPTER 4
Additional Studies
CHAPTER 4 Additional Studies
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In the following chapter, we will discuss additional studies that are still on going
in the lab at various stages as extension from my main projects. The first section
contains the identification of a kinase and a phosphatase that interact with Cx32.
Tyrosine phosphorylation has been found to modify Cx32 by different groups (Diez et
al., 1998; Locke et al., 2006; Stauch et al., 2012), Thus, understanding the regulatory
mechanism of tyrosine phosphorylation of Cx32 is crucial. Using in vitro kinase and
immunoprecipitation assays, we identified direct phosphorylation on Cx32 by EphB1.
We also showed evidence that TC-PTP directly dephosphorylates Cx32.
In the second section, we will discuss a novel phosphorylation site on Cx43CT,
Y313. Although phosphorylated Y313 was detected in multiple phosphoproteomic data,
for the first time, we identified that Y313 is phosphorylated by Src, Tyk2 and Pyk2 in
vitro.
When we identified that Tyk2 kinase phosphorylates Cx43 by the in vitro kinase
assay, we found that Pyk2 and Itk can also phosphorylate the Cx43CT. Cx43 gap
junction remodeling has been found in heart failure where Pyk2 is activated (Ai et al.,
2011; Glukhov et al., 2012); additionally, increase of Cx43 phosphorylation occurs at
the immunological synapse which is coincident with the activation of Itk (Andreotti et
al., 2010; Mendoza-Naranjo et al., 2011). These pieces of evidence implicate the
potential interplay between Cx43 and Pyk2 or Itk. In the third section, I will show data
regarding the phosphorylation of Cx43CT by Pyk2 and Itk. Future research will be
conducted to characterize the biological function of phosphorylated Cx43 in particular
situations.
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14. EhpB1 and TC-PTP Regulate Tyrosine Phosphorylation of Cx32
14.1

Introduction
Cx32 is the major gap junction protein in liver (Gingalewski et al., 1996). Cx32 is

also found in other tissues such as nervous tissue (myelinating cells), lung, placenta,
and kidney (Grazul-Bilska et al., 2011; King and Lampe, 2004; Wilgenbus et al., 1992).
Cx32 deficient mice have an increased chance of getting spontaneous liver tumors and
are more vulnerable to chemical-induced liver tumorigenesis (King and Lampe, 2004;
Temme et al., 1997). These mice exhibit other pathological phenotypes such as decrease
of nerve-dependent bile secretion, enhanced pancreatic amylase secretion, and
peripheral nerve demyelination (Chanson et al., 1998; Scherer et al., 1998; Temme et
al., 2001).
Cx32 is phosphorylated on its tyrosine residues in cytoplasm domains (Diez et al.,
1998; Locke et al., 2006; Stauch et al., 2012). So far, the only identified tyrosine kinase
that directly phosphorylates Cx32 is EGFR (Diez et al., 1998). Cx32 has three tyrosine
residues on its intracellular domains: one is on the NT domain (Y7) and two are on the
CT domain (Y211 and Y243). Since Y211 is at the juxtamembrane region, we speculate
that only Y7 and Y243 are accessible to tyrosine kinases. In Cx32 transfected HeLa
cells, phosphorylated Y7 has been observed by MS (Locke et al., 2006). However, to
date, no direct evidence of Y243 phosphorylation has been reported.
Using an in vitro kinase screening assay, we identified EphB1 as a novel tyrosine
kinase that phosphorylates Cx32. EphB1 is a erythropoietin-producing hepatocellular
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(Eph) receptor family member which has a wide expression in human organs including
liver, colon, brain, kidney, and in the cardiovascular system (Adams et al., 1999; Davy
et al., 2006; Ivanov et al., 2005; Kosinski et al., 2007; Zhou et al., 2014). Eph family is
the largest known subfamily of receptor tyrosine kinases (Lisabeth et al., 2013). This
family is divided into two groups, EphA and EphB, both of which need to interact with
their ligands, the Eph family receptor interacting proteins (Ephrins), for activation.
Ephrins are also divided into EphrinA and EphrinB groups due to structural and
functional differences. Membrane-bound or Fc-clustered Ephrins are capable of
activating Eph receptors. Eph-Ephrin complexes induce bidirectional signals that
influence cells that express both Eph receptor and Ephrin (Lisabeth et al., 2013). Ephephrins signaling is important for proper cell sorting during development, cell-cell
adhesion, migration, repair after nervous system injury, and maintenance of
intercellular junctions (Pasquale, 2008; Poliakov et al., 2004). A recently study showed
that the EphB4 receptor co-immunoprecipitated with Cx43 and its activation in primary
cultures of rodent cardiomyocytes inhibited gap junctional intercellular communication
(Ishii et al., 2011). Another study indicated that junctional Cx43 was decreased at
ectopic Eph/ephrin boundaries in mice (Davy et al., 2006). These studies suggest a
possibility of EphB interacting with gap junction proteins. However, whether Cx32 also
interacts with an EphB member is not known.
In this study, we used multiple approaches and identified that EphB1
phosphorylates the Cx32CT but not the NT in HeLa cells expressing Cx32 and EphB1.
We also tested TC-PTP, a tyrosine phosphatase that dephosphorylates Cx43, and
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discovered that TC-PTP directly dephosphorylates the Cx32CT in vitro and in HeLa
cells.

14.2 Results
14.2.1

EphB1 Directly Interacts and Phosphorylates the Cx32CT Domain

Softwares GPS 2.0, NetPhos 2.0 Server, and KinasePhos 2.0 were used to predict
novel kinases that phosphorylate Cx32. Five tyrosine kinases were selected for an in
vitro tyrosine phosphorylation screening assay performed by Eurofins Scientific
(KinaseProfiler) using the Cx32NT (1-21) or the Cx32CT (217-283) as substrates
(Figure 4.1A). Only the Cx32CT phosphorylated by EphB1 gave over 50% of control
signal. None of kinases efficiently phosphorylated the Cx32NT. Then, we repeated the
kinase assay using EphB1, Ron, and EGFR in our laboratory. Consistant with data from
Eurofins Scientific, EphB1 and Ron phosphorylated the Cx32CT but not EGFR (Figure
4.1B). Of note, EGFR was reported to phosphorylate immunoprecipitated Cx32 in vitro
(Diez et al., 1998). To confirm the Cx32 interaction with EphB1 and Ron kinases, the
purified GST, GST-tagged Cx32NT or CT were immobilized on glutathione-Sepharose
beads and lysates from HeLa cells that express EphB1 and Ron (but not Cx32) were
used in a pull-down assay (Figure 4.2A). EphB1 was pulled down by GST-Cx32CT but
not GST nor GST-Cx32NT in cells, whereas Ron could not be pulled down by any of
the

three

GST-tagged

purified

proteins.

The

crosslinker

DTSSP

(3,3 ́-

dithiobis[sulfosuccinimidylpropionate]) was used to capture weak and/or transient
interactions (Liu et al., 2011). Co-immunoprecipitate also showed EphB1 and Cx32
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were in the same complex in cells (Figure 4.2B). Ron could phosphorylate the Cx32CT
domain but was not pulled down by Cx32CT or NT, indicating the interaction between
Cx32 and Ron may be too weak to be detected in cells. Thus, Ron was excluded from
the following studies.

14.2.2

TC-PTP Interacts with and Dephosphorylates Cx32CT

Our previous study showed that TC-PTP directly interacts and dephosphorylates
Cx43CT (Li et al., 2014). Whether TC-PTP can dephosphorylate other connexin
isoforms is unknown. To identify if a direct interaction exists between TC-PTP and the
Cx32CT domain, NMR titration experiments were performed with purified TC-PTP
catalytic domain (TC-PTP1-314) and Cx32CT. Different concentrations of unlabeled TCPTP1-314 were titrated into

15

N-labeled Cx32CT (residues 217-283) and

15

N-HSQC

spectra were acquired (Figure 4.3A). Titration of TC-PTP1-314 caused a subset of
Cx32CT residues to broaden beyond detection. These are highlighted on the Cx32CT
sequence (Figure 4.3C). Strongly affected Cx32CT residues S240-G272 include Y243,
which is the only accessible tyrosine residue in CT domain. The decrease in signal
intensity caused by increasing TC-PTP1-314 concentrations was fit according to the
nonlinear least square method. The binding affinity (KD) was determined to be 19.9 ±
4.5μM (Figure 4.3B). A GST pull down experiment was performed to validate the NMR
results. Purified GST alone, GST-Cx32CT, or GST-Cx32NT bound to glutathione
agarose were incubated with purified TC-PTP1-314. Immunoblotting using an anti-TCPTP NT antibody identified that GST-Cx32CT, but not NT, directly interacted with the
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Figure 4.1 EphB1 and Ron phosphorylate the Cx32CT domain in vitro. (A)
Cx32NT and Cx32CT were used as substrates to be phosphorylated by EGFR, Blk,
EphB1, Met, and Ron kinases. The amount of Cx32CT phosphorylation was compared
with a positive control peptide for each kinase (% of control signal). Dash line
highlights the 50% of the control signal. (B) in vitro kinase assay was performed to
repeat the kinase screening assay done by Eurofin Scientific (EphB1, Ron, and EGFR).
A general anti-phospho-tyrosine antibody was used to detect the phosphorylation level
on Cx32CT by Western blot. Control group used buffer to substitute the kinases in the
reactions.
Figure 4.1 EphB1 and Ron phosphorylate the Cx32CT domain in vitro.
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Figure 4.2 Cx32 interacts with EphB1. (A) Purified GST alone, GST-Cx32CT (CT),
or GST-Cx32NT (NT) bound on glutathione-agarose beads were incubated with or
without HeLa cell lysate and the pull-downed product was analyzed by Western blot
using an anti-EphB1 or anti-Ron antibodies. The chemical crosslinker DTSSP was used
to capture the weak and/or transient interaction. (B) Co-IP experiment was performed
in HeLa cells stably expressing Cx32. Lysates were immunoprecipitated with anti-Cx32
or IgG and then blotted for Cx32 and EphB1.
Figure 4.2 Cx32 interacts with EphB1
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TC-PTP catalytic domain (Figure. 4.4A, B). GST-Cx32CT also pulled down wild-type
TC-PTP from HeLa cell lysate (Figure. 4.4C).
To identify if TC-PTP dephosphorylates the Cx32 on residue Y243, an in vitro
phosphatase assay was conducted using a peptide (H237-N249) containing pY243
incubated with TC-PTP1-314. Following the protocol for the Malachite green assay
(Millipore), we observed an increase in the amount of inorganic phosphate production
indicating TC-PTP dephosphorylated Cx43 on pY243 (Figure. 4.5). The rate of
dephosphorylation shows TC-PTP is efficient in dephosphorylating pY243 (table 4.1).

14.3 EphB1 Phosphorylates and TC-PTP De-phosphorylates Cx32 in HeLa Cells
We show that EphB1 phosphorylates Cx32 and TC-PTP dephosphorylates Cx32 in
vitro. To determine if EphB1 and TC-PTP affect pY243 level in cells, HeLa cells stably
expressing Cx32 wild-type were transfected with EphB1 or the TC-PTP catalytic
domain, and tyrosine phosphorylation level were detected on immunoprecipitated Cx32.
Results show that EphB1 increased Cx32 tyrosine phosphorylation and TC-PTP1-314
decreased tyrosine phosphorylation. Cx32 Y7 on the Cx32 NT has been reported to be
phosphorylated (Locke et al., 2006). To study if EphB1 phosphorylate Y7 as well, we
immunoprecipitated Cx32 from HeLa cells stably expressing Cx32 wild-type or Cx32
Y243F with or without EphB1 transfection, and Cx32 tyrosine phosphorylation level
was measured. EphB1 increased Cx32 wild-type phosphorylation, and using EphB2-Fc
to activate EphB1 further increased Cx32 phosphorylation. However, this effect was
not observed in the Cx32 Y243F mutant, suggesting EphB1 only phosphorylates
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Figure 4.3 Cx32CT residues affected by the direct interaction
with TC-PTP
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Figure 4.3 Cx32CT residues affected by the direct interaction with TC-PTP. A)
Overlaid

15

N-HSQC spectra of the

15

N-Cx32CT (residues 217-283; 30 μM) in the

presence of different concentrations of unlabeled TC-PTP1-314. The cross-peak color
changes according to the concentration ratio. The strongly affected peaks are labeled.
B) The KD for the Cx32CT/TC-PTP1-314 interaction was estimated by fitting the
decrease in signal intensity for the Cx32CT residues S229, S253, E247, K250, L263 as
a function of TC-PTP1-314 concentration. C) Amino acid sequence of Cx32CT. Residues
strongly affected by the addition of TC-PTP1-314 are highlighted in yellow (residues
broadened beyond detection at 1:0.1 molar ratio) and those less affected in green
(residues broadened beyond detection at 1:1 molar ratio). In red is the Cx32 residues
Y243.
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Figure 4.4 Cx32CT pulls down purified TC-PTP wild-type and catalytic domain.
(A) Purified GST or GST-Cx32CT or GST-Cx32NT on glutathione agarose beads were
incubated with (+) and without (-) purified TC-PTP217-283. After washes, samples were
ran on SDS-PAGE gel andFigure
stained
with pulls
Coomassie
Blue.
(B) GST pull-down samples
4.4 Cx32CT
down purified
TC-PTP
catalytic domain and wild-type

were blotted with the anti-TC-PTP NT antibody. The TC-PTP catalytic domain is 36
kDa. (C) Purified GST, GST-Cx32CT, or GST-Cx32NT bound on glutathione agarose
beads were incubated with HeLa cell lysate containing endogenous TC-PTP. Pulldowned products were analyzed by Western blot using an anti-TC-PTP NT or anti-GST
antibodies.
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Figure 4.5 TC-PTP dephosphorylates Cx32 residues pY243 in vitro. Plot of the
Malachite green assay shows the time course of Cx32 phospho-peptides (600 nM)
containing pY243 dephosphorylated by the TC-PTP catalytic domain (0.6 nM). Statistic
data were recorded based on readings at OD650. Each experiment was repeated three
times.
Figure 4.5 TC-PTP dephosphorylates Cx32 residues pY243 in vitro.
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Table 4.1. Kinetic constants for de-phosphorylation of Cx32 pY243 by TC-PTP 1-314
Km

kcat

kcat/Km•10-6

(mM)

(s-1)

(M-1s-1)

Positive control*#

0.022±0.001

52.820±10.622

2.418±0.473

pY243*

0.034±0.004

63.337±13.720

1.833±0.164

*All data were collected at pH 7.5, 25°C
#

Notably, the kinetic constants determined for the positive control (DADEpYL) by TC-

PTP1-314 are consistent with a previous report of the same peptide with the PTP1B
catalytic domain, whose sequence is very similar with TC-PTP1-314 (Peters et al., 2000).
Table 4.1

Kinetic constants for de-phosphorylation of Cx32 pY243 by TC-PTP 1-314
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Figure 4.6 EphB1 increases tyrosine phosphorylation level on Cx32 whereas TCPTP decreases tyrosine phosphorylation on Cx32. (A) HeLa cells stably expressing
Cx32 were transfected with EphB1 or TC-PTP catalytic domain. Cx32 was pulled down
and phospho-tyrosine antibody
was EphB1
used toincreases
detect tyrosine
tyrosine phosphorylation level.
Figure 4.6
phosphorylation level on Cx32 whereas TC-

Tyrosine phosphorylationPTP level
were
quantified
by ondensitometry from three
decreases
tyrosine
phosphorylation
Cx32

independent experiments (**P<0.01). (B) HeLa cells stably expressing Cx32 wild-type
and Cx32 Y-F mutant were transfected with EphB1. EphrinB1-Fc was used to activate
EphB1 receptor. Cx32 was pulled down and tyrosine phosphorylation level was
detected.
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Cx32CT on Y243 residue.

14.4 Discussion and Future Direction
In this study, we identified a tyrosine kinase EphB1, which phosphorylates Cx32
on the Y243 residue in the CT domain but not Y7 on NT domain. Addtionally, we
showed that TC-PTP, a tyrosine phosphatase, can dephosphorylate pY243. To the best
of our knowledge, our work is the first demonstration of the direct interaction between
a phosphatase and Cx32.
The first reported tyrosine kinase that phosphorylates immunoprecipitated Cx32 is
EGFR (Diez et al., 1998). However, in our in vitro kinase assay, EGFR did not directly
phosphorylate purified Cx32CT. A possible explanation is that a complex, but not pure
Cx32, could be pulled down in the immunoprecipitation assay. Thus, unknown Cx32
binding partner(s) in the complex may mediate the phosphorylation on Cx32 by EGFR.
We also found that Cx32 co-immunoprecipitated with EGFR which indicated that Cx32
and EGFR were in the same complex (data not shown). Thus, we suspect that EGFR
may indirectly increase tyrosine phosphorylation of Cx32.
Cx32 is considered as a tumor suppressor in many different cancers (Fujimoto et
al., 2005; King and Lampe, 2004; Temme et al., 1997). Cx32-deficient mice exhibit a
higher incidence compare with wild-type mice in lung tumor and liver cancer (King
and Lampe, 2004; Temme et al., 1997). Expression of Cx32 in renal cell carcinoma cell
line (Caki-1 cell) reduces invasion capacity (Fujimoto et al., 2005). Besides, Cx32 can
suppress human prostate cancer cell growth (Mehta et al., 1999). EphBs also play roles
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as cancer suppressors. During metastatic progression, EphB expression is lost which
leads to tight junction instability and allows cancer cells to become invasive (Park and
Lee, 2015). Evidence shows that loss of EphB1 is associated with invasion and
metastasis in gastric cancer and ovarian cancer (Wang et al., 2014; Wang et al., 2007);
decreased expression of EphB1 has also been found in renal cell carcinoma patients
(Zhou et al., 2014). Additionally, the tight junction protein E-cadherin interacts with
both EphB and Cx32 (Lee and Daar, 2009). Activation of EphB enhances E-cadherindependent adhesion in colorectal cancer cell lines (Lee and Daar, 2009). Also, positive
correlation between the expression of E-cadherin and Cx32 has been found in colorectal
cancers (Kanczuga-Koda et al., 2014), and colocalization of Cx32 and E-cadherin has
been found in Schwann cells (Balice-Gordon et al., 1998). These pieces of evidence
indicate a link between EphB and Cx32. Our data identify the direct interaction between
Cx32 and EphB1, which could help to understand the mechanism of Cx32 gap junction
decrease in cancer.
One question that has not been answered in this study is the biological effects of
phosphorylation on Cx32CT. The only well-defined phosphorylation site on Cx32 is
S233 which increases gap junctional communication when phosphorylated (Saez et al.,
1990). Based on the fact that both EphB1 and Cx32 decrease in cancer, we hypothesize
that phosphorylation on Y243 also increases gap junction intercellular communication.
To further study the function of Y243, Y243F mutant and wild-type Cx32 stably
expressed in HeLa cells will be transfected with or without EphB1. Dye transfer, TX100
solubility, and cycloheximide assays will be used to test the gap junction coupling,
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measure gap junction plaque, and study the gap junction turnover rate, respectively.

15. Identification and Functional Study of a Novel Phosphorylation Site on
Cx43CT
15.1 Introduction
We identified four tyrosine residues phosphorylated by Tyk2 (Y247, Y265, Y267,
Y313) by MS. Y313, which is located in one helix (K303-A322) in the Cx43CT
(predicted by our laboratory, (Grosely et al., 2013)), triggered our greatest interest. First,
tyrosine phosphorylation associates with decrease of helical propensity in the Cx43CT
(Grosely et al., 2013b). Therefore, Y313 phosphorylation may affect the secondary
structure of Cx43. Moreover, MS data obtained from the PhosphoSitePlus database
shows that Y313 is frequently detected as a phosphorylation site (Table 4.2). Of note,
Src phosphorylation sites Y247 and Y265 are also detected to be phosphorylated in high
frequency. Interestingly, when we studied Src in the in vitro kinase assay, we found that
Y313 was also phosphorylated by Src in addition to Y247 and Y265. Our hypothesis is
that Y313 phosphorylation induces a structure change in the Cx43CT and participates
in Cx43 degradation.

15.2 Results
Purified Cx43CT236-382 was incubated in vitro with active Src (Life Technologies)
as described in (Cooper et al., 2000; Huang et al., 2012) and phosphorylation was
confirmed using an anti-phospho-tyrosine antibody (Figure 4.7B). After trypsin
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digestion, Tandem MS/MS identified phosphorylation at Y247, Y265, Y267, and Y313
(Figure 4.7A and Table 4.3 ). To confirm tyrosine phosphorylation occurs at residues
other than Y247 and Y265, the in vitro kinase assay was performed using five
Cx43CT236-382 mutants and phosphorylation was detected with an anti-phospho-tyrosine
antibody (Figure 4.7B). The data indicate that Src phosphorylated Cx43 wild-type,
which showed a slower migration on SDS-PAGE gel (Figure 4.7B). Y267 and Y313
can be phosphorylated by Src in vitro. The Cx43CT mutant with all tyrosine residues
except Y313 mutated to F also showed a slower migration on the SDS-PAGE gel
suggesting a possible alteration of structure.

15.3 Discussion and Future Direction
Y247 and Y265 are well established as phosphorylation sites for Src (for review
see (Lampe and Lau, 2004; Solan and Lampe, 2007)). Interestingly, for the first time,
we found that Src can also phosphorylate the Y313 site in vitro. Since Y313 is contained
within one of the CT α-helical domains, the negatively charged phosphate could induce
a conformational change of the Cx43CT and further affect the function of Cx43 gap
junctions. In fact, phosphorylated Y313 has been observed in proteomics data multiple
times which strongly suggests its existent in cells. However, no study has identified a
kinase that directly phosphorylates Y313.
We hypothesize that Y313 phosphorylation by Src induces gap junction closure and
Cx43 degradation. We recently acquired a custom phospho-specific antibody to pY313.
This antibody will be used to test if Y313 is phosphorylated in cells after v -Src
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Table 4.2 Tyrosine phosphorylation sites on the Cx43CT domain summarized by
PhosphoSitePlus.

Modification site

SS

MS

Species

Y247-p

9

253

H, M, R

Y265-p

14

12

H, M, R

Y267-p

1

10

H, M, R

Y286-p

1

12

H, M

Y301-p

0

8

H

Y313-p

1

312

H, M, R

SS: the number of record in which this modification site was determined using sitespecific methods, including amino acid sequencing, site direct mutagenesis,
modification site specific antibodies, etc. MS: The number of record in which this
modification site was assigned using ONLY proteomic discovery mode. Species: H:
human, M: mouse, R: rat
Table 4.2 Tyrosine phosphorylation sites on the Cx43CT domain summarized by PhosphoSitePlus.
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Figure 4.7 In vitro kinase assay using active Src to phosphorylate Cx43CT wildtype and mutants. Purified Cx43CT wild-type and mutants were incubated with or
without

(Control)

Src

for

16

hrs

at

30°C.

2YF=Y247/265F,

267Y=Y247/265/286/301/313F,
Figure 4.7 In vitro kinase assay using286Y=Y247/265/267/301/313F,
active
Src to phosphorylate Cx43CT wild-type and

301Y=Y247/265/267/286/313F,
mutants 313Y=Y247/265/267/286/301F (A) Sequence of the
Cx43CT domain. Highlighted in red are phospho-tyrosine residues identified by MS in
an in vitro kinase assay using Src to phosphorylate the Cx43CT. show The two tyrosines
which are not phosphorylated by Src are highlighted in blue. (B) Products from kinase
assay were ran on SDS-PAGE gel, stained with Coomassie blue and Western blotted
with anti-tyrosine antibody.
152

Table 4.3 Phospho-tyrosine containing peptides identified from mass spectrometry of the Cx43CT domain
phosphorylated in vitro by Src.

Peptide sequence

SDPyHATTGPLSPSK
GRSDPyHATTGPLSPSK

Start-end
244-258

Average
Mascot Delta
Ion Score
17.1

*Number of
phosphopeptides
9

Actual
peptide
mass

242-258

16.9

5

1636.72
1849.84

Calculated
+1H peptide
mass
1637.72
1,637.72

Phosphorylation
site localization
Y247

1850.84

Y247

GRSDPyHATTGPLSPSKDc(Carbamidomethyl)GSPK

242-264

17

1

2667.04

2668.05

Y247

QASEQNWANySAEQNR

304-319

14.1

11

1974.79

1975.79

Y313

yAYFNGc(Carbamidomethyl)SSPTAPLSPm(Oxidation)SPPGYK

265-287

9.8

13

2588.07

2588.09

Y265

yAyFNGc(Carbamidomethyl)SSPTAPLSPm(Oxidation)SPPGYK

265-287

26.9

10

2667.05

2668.05

Y265, Y267

*Peptides with Mascot Delta Ion Score >7 were used to obtain the average Mascot Delta Ion according to (Savitski et al., 2011).
Table 4.3 Phospho-tyrosine containing peptides identified from mass spectrometry of the Cx43CT domain phosphorylated in vitro by Src.
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activation. Seven Cx43 mutants (Y247F, Y265F, Y313F, Y247/313F, Y256/313F,
Y247/265F, Y247/265/313F) have been successfully cloned in pcDNA3.1 and pEGFP
vectors. With these constructs, we will test the cellular localization of Cx43 wild-type and
mutants after Src activation in HeLa cells (gap junction negative cell line) and Cx43 knockout NRK cells. Also, the localization of Cx43 phosphorylated at Y313 will be observed by
immunofluorescence assay using the pY313 phospho-antibody. Gap junction closure and
Cx43 degradation will be studied by dye transfer assay and surface biotinylation assay,
respectively.
Additionally, we briefly studied the Y267 phosphorylation site, however, our results
are inconsistent with previous study. Giepmans et al. (2001) used COS-7 cells cotransfected with Myc-tagged Cx43 (wild-type, Y265F, and Y267F) and c-Src, and they
showed that wild-type Cx43 and Y267F mutants were phosphorylated on tyrosine but not
Y265F mutant (Giepmans et al., 2001). They concluded that Y267 is not a phosphorylation
site for Src (Giepmans et al., 2001). However, our MS study shows that Y267 was
phosphorylated by Src in vitro. To test if Y267 is phosphorylated in cyto, a phosphospecific antibody will be necessary.

16. Characterize the Mechanism and Biological Function of the other Tyrosine
Kinases that Phosphorylate Cx43.
16.1 Introduction
One goal of my dissertation is to identify novel tyrosine kinases that phosphorylate
154

Cx43. By using the in vitro phosphorylation screen (Merck Millipore), we identified eight
tyrosine kinases which have high likelihood of phosphorylating Cx43. Among these
tyrosine kinases, Pyk2 and Itk showed the best affinity for the Cx43CT domain in a GST
pull down assay, and will be the focus of this study.
Pyk2 is a Ca2+-dependent non-receptor tyrosine kinase of the FAK family (Figure 4.8).
Many factors can induce Pyk2 activation, including activation of Src and PKC, as well as
an increase in intracellular Ca2+ level (Avraham et al., 2000). In normal adult heart, Pyk2
is expressed in ventricular tissue and cardiomyocytes, but much less than in neonatal
(Bayer et al., 2001). In animal models of heart failure (pressure-overload-induced or
overexpression of tropomodulin), an increase in Pyk2 expression, activation, and
phosphorylation has been reported (Bayer et al., 2002; Melendez et al., 2002). Since
changes in the level and pattern of Cx43 phosphorylation are commonly observed in both
ischemic and nonischemic forms of human heart failure (Ai et al., 2011; Glukhov et al.,
2012), our hypothesis is that in the failing heart, phosphorylation of Cx43 by Pyk2 leads to
gap junction channel closure and relocation of Cx43 from the intercalated disc.
Itk is a Tec kinase family member which is predominantly expressed in T-cell. The
most important function that Itk is involved in is the antigen-dependent T cell activation.
Interaction of the T-cell receptor with peptide-MHC complexes on antigen presenting cells
promotes Itk recruitment to the membrane and its activation, leading to the phosphorylation
of its downstream targets (Andreotti et al., 2010). Similar with Src, Itk also contains an
SH3-SH2-kinase cassette (Figure 4.8). This structure similarity supports the possibility for
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Itk to phosphorylate Cx43.
Antigen-dependent T cell activation relies on cell-cell contact, therefore intercellular
communication is necessary. Indeed, the increase of Cx43 expression and phosphorylation
are observed to be associated with T cell activation (Oviedo-Orta et al., 2010). During T
cell priming, Cx43 is recruited at the immunological synapse (Mendoza-Naranjo et al.,
2011). This accumulation is antigen-specific and time-dependent (Mendoza-Naranjo et al.,
2011). As both Itk activation and Cx43 relocation occur during the antigen-dependent T
cell activation, we hypothesize that Itk phosphorylates Cx43 resulting in Cx43
redistribution at the immunological synapse.

16.2 Results
To identify novel kinases that can phosphorylate Cx43CT, an in vitro phosphorylation
screening assay was conducted using purified Cx43CT as substrate (by Eurofins Scientific,
KinaseProfiler). 27 tyrosine kinases were selected for the kinase assay as they were
predicted to phosphorylate the Cx43CT by GPS 2.0 software, and NetPhos 2.0 and
KinasePhos 2.0 servers. Eight tyrosine kinases which gave over 50% of positive control
signal were considered to be capable to phosphorylate Cx43CT (Figure 4.9).
Then, we tested if these kinases that phosphorylated Cx43 can bind with Cx43 in cells
by performing a GST pull down assay. Purified GST and GST-Cx43CT were immobilized
on glutathione-sepharose beads, and cell lysates from cell lines that express each of kinase
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Figure 4.8 Pyk2 and Itk Schematic. Pyk2 is composed of a N-terminal FERM (protein
4.1, ezrin, radixin and moesin homology) domain, a CT focal adhesion targeting (FAT)
domain, a kinase domain, and several proline rich regions (PRR). Phosphorylation of Pyk2
at Y402 creates a SH2 binding site for Src. Association of Pyk2 with c-Src leads to further
phosphorylation of Pyk2 at Y579 and 580 in the kinase domain. Itk contains an NT region
that includes a pleckstrin homology (PH) domain, followed by a Zn++ binding region
termed the Btk homology (BH) motif, a PRR that conforms to the consensus sequence of
an SH3 ligand, SH3 and SH2 domains, and kinase domain at the C-terminus.
Figure 4.8 Pyk2 and Itk Schematic.
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of interest were added. Out of the eight candidates, six kinases were in the same complex
with the Cx43CT. In particular, Pyk2 and Itk were pulled down by Cx43CT without
crosslinker (Figure 4.10). Of note, the crosslinker DTSSP captures weak and transient
interactions (Liu et al., 2011). These data suggest that Pyk2 and Itk have a greater binding
affinity for the Cx43CT than the other tested kinases.
To study which tyrosine residues are phosphorylated by Pyk2, we conducted an in vitro
kinase assay followed by MS (Figure 4.11). In the in vitro kinase assay, Cx43CT wild type
and Cx43 mutants were incubated with Pyk2 and products were ran on SDS-PAGE gel.
Similar to Src phosphorylation on Cx43, MS data show that Pyk2 induced phosphorylation
on Y247, Y265, Y267, and Y313. Western blot using a general phospho-tyrosine antibody
conformed that Y313 is one of the sites phosphorylated by Pyk2. However, the Y267
mutant did not show any signal suggesting little to no phosphorylation at Y267 by Pyk2.

16.3 Discussion and Future Directions
We showed that Pyk2 directly phosphorylates Cx43CT on Y247, Y265, Y267, and
Y313, while Itk also phosphorylates Cx43CT in vitro. These residues have not been
identified in a cell system yet. From our studies and others, we know that at least 3 tyrosine
kinases target Cx43CT on Y247/265/313, suggesting a possible competition between these
kinases. They may also coordinate with each other (for example, one kinase creating
docking site to amplify the binding affinity for another kinase) to increase Cx4 3
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Figure 4.9 Identification of tyrosine kinases phosphorylating Cx43. In vitro kinase
assays were conducted using E. coli expressed Cx43CT as substrate. Peptides which can
be phosphorylated by each kinase were used as positive control. The phosphorylated
substrates were detected by radiometric assay. Quantification of phosphorylated Cx43CT
was normalized to the control phospho-peptide for each kinase (% of control signal). Dash
line highlights 50% of the control signal.
Figure 4.9 Identification of tyrosine kinases phosphorylating Cx43
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Figure 4.10 Itk and Pyk2 interact with Cx43CT. GST pull down assays using GST
(negative control) and GST-Cx43CT immobilized on glutathione beads as baits were
conducted in different cell lines. Eight kinases (giving >50% of control signal in the in vitro
kinase assay) were blotted.Figure
Pyk24.10
andItkItk
pulledwith
down
by GST-Cx43CT but not GST
andwere
Pyk2 interact
Cx43CT.
without crosslinker DTSSP. BTK, TrkA, EphB2 and PDGFRβ were pulled down by GSTCx43CT only in present of the crosslinker DTSSP. V-Src which is known to bind with
Cx43CT was pulled down by GST-Cx43CT both with and without crosslinker DTSSP.
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Figure

4.11

Identification

of

the

phosphorylation sites on Cx43CT by Pyk2
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Figure 4.11 Identification of the phosphorylation sites on Cx43CT by Pyk2. Active
Pyk2 was used to phosphorylate Cx43CT wild-type and mutants in an in vitro kinase assay.
Purified

Cx43CT

wild-type

and

267Y=Y247/265/286/301/313F,

mutants

(2YF=Y247/265F,

286Y=Y247/265/267/301/313F,

301Y=Y247/265/267/286/313F, 313Y=Y247/265/267/286/301F) were incubated with or
without (Control) Pyk2 for 16 hrs at 30°C. (A) Sequence of the Cx43CT domain.
Highlighted in red are the phospho-tyrosine residues identified by MS in an in vitro kinase
assay using Pyk2 to phosphorylate Cx43CT. Highlighted in blue show two tyrosines which
are not phosphorylated by Pyk2. (B) Products from the kinase assays were ran on SDSPAGE gel followed with Coomassie staining, and western blotted with an anti-tyrosine
antibody were performed.
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phosphorylation level. Moreover, although these kinases phosphorylate on the same
tyrosine residues, the phosphorylation levels could be different, suggesting that these
kinases may regulate Cx43 gap junction in slightly different ways. To sum up, different
kinases may permit a fine-tuning of Cx43 function to meet the specific needs of a certain
tissue or developmental stage.
Future direction will focus on the functional study in cells and particular disease model.
To characterize the phosphorylation events caused by Pyk2 in cyto, the LA-25 cell line
stably expressing Pyk2 will be used to study Cx43 phosphorylation levels (Western blot)
and cellular localization (immunostaining) with or without v-Src activation. Structured
illumination microscopy could be used to determine the relationship between Pyk2 and
Cx43 at the gap junction plaque. Heart failure rat model could be used to study the effect
of Pyk2 on Cx43 regulation in pathological situations. To find out the biological relevance
between Pyk2 and Cx43 in heart failure, we will quantify mRNA and phospho-protein
levels of Cx43 and Pyk2, and define the cellular distribution of Cx43 and Pyk2.
The biological function of Cx43 phosphorylation by Itk in T cells activation will be
characterized in co-cultured spleen dendritic and T cells with or without antigen
presentation. We will test the relevance between phosphorylation of Cx43 and activation
of Itk, observe the cellular localization of Itk and Cx43, and study the gap junctional
communication. Itk inhibitors (BMS 509744 and CTA 056) will be used to test if the effects
are caused by Itk specifically. These innovative studies will help to demonstrate how
phosphorylation affects Cx43 channel gating and degradation, and provide a foundation
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for understanding cardiac pathophysiology and T-cell activation.
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CHAPTER 5
Summary and Future Directions
CHAPTER 5 Summary and Future Directions
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17. Summary
Gap junctions mediate vitally important processes such as electrical impulse
propagation and cell-to-cell metabolic coupling. A better understanding of the functional
and structural basis of connexin regulation will lead to improved strategies to modulate
and/or reestablish junctional communication that has been altered in different pathological
situation such as heart failure and cancer. Our laboratory’s major focus has been to
comprehensively address the regulatory mechanism of gap junction channel gating and a
connexin’s life cycle. As one important post-translational modification, phosphorylation
has been involved in all these regulatory mechansims. Falk et al. (2016) provide a model
of continuous phosphorylation event to regulate Cx43 life cycle, in which Akt, PKA, PKC,
MARK phosphorylation occur sequentially (Falk et al., 2016). In some particular situations
including wounding and EGF stimulation, Src is responsible for chronic gap junction
degradation (Solan and Lampe, 2016; Spagnol et al., 2016). The regulatory mechanism of
phosphorylation on gap junctions is complicated. The negative charge of the phosphate
could affect the permeability of ions to the pore, alter the structure of the transmembrane
α-helices to influence pore size, or modify the binding affinities of protein binding partners
involved in regulating gap junction (Grosely et al., 2013b). Notably, if phosphorylation
modifies protein interactions to affect the kinetics of channel assembly/disassembly or
degradation, cell-to-cell communication will also be altered. Evidence have been emerged
that a phosphate can directly block the Cx43CT interaction with ZO-1 (Chen et al., 2008),
tubulin (Saidi Brikci-Nigassa et al., 2012) and drebrin (Ambrosi et al., 2016) or enhance
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the interaction with Nedd4 (Leykauf et al., 2006; Spagnol et al., 2016). This information is
critical because a particular cellular condition can be correlated with a specific Cx43
phosphorylation status to understand which proteins will and will not interact to affect
regulation of Cx43.
Numerous serine phosphorylation sites have been identified on the Cx43CT. Compare
with serine phosphorylation, studies on tyrosine phosphorylation are relatively lacking.
The objective of this project was to use a multidisciplinary approach to investigate the role
of tyrosine phosphorylation in altering the structure and function of Cx43 gap junctions.
By using a kinase screening assay, we identified eight tyrosine kinases that phosphorylate
Cx43CT in vitro. One of them is a JAK family member, Tyk2. We focused on Tyk2 because
of its role in Ang II induced cardiovascular diseases. Tyk2 can be activated by a high level
of Ang II (Kodama et al., 1998; Marrero et al., 1995; Pan et al., 1997; Pan et al., 1999;
Yoon et al., 2013). Over-activation of RAS signaling is associated with increased risk of
ventricular arrhythmia, hypertrophy, and sudden death (Luft, 2011; Sadoshima and Izumo,
1993). Besides, we found that among three JAK family members expressed in heart (JAK1,
JAK2 and Tyk2), only Tyk2 phosphorylates Cx43CT. Our data described in Chapter 3
identified that Tyk2 phosphorylates Cx43 on Y247 and Y265 both in vitro and in cyto.
Similar to Src, Tyk2 leads to an indirect phosphorylation on residues S279/282 (MAPK)
and S368 (PKC), and, this response occurred when Src was inactive in NRK cells. Y313
phosphorylation was also detected by MS in the in vitro kinase assay and functional study
will be conducted with phospho-specific antibody. Different kinases phosphorylating the
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same sites is commonly occurring on Cx43, suggesting a fine-tuning mechanism on gap
junction function.
Tyrosine phosphorylation is regulated by the coordination of protein tyrosine kinases
and protein tyrosine phosphatases. To date, only two potential Cx43 tyrosine phosphatases
have been reported, however, the directly interaction was not demonstrated. We identified
a

ubiquitously expressed

phosphatase TC-PTP which

directly

interacts

and

dephosphorylates Cx43 on Y247 and Y265 by NMR and in vitro phosphatase assay,
respectively. By co-immunoprecipitation and immunofluorescence assay, we were able to
observe that Cx43 and TC-PTP were in the same complex in NRK cells. In LA-25 cells
which express a temperature sensitive v-Src, TC-PTP indirectly led to dephosphorylation
of Cx43 S368 by inactivating PKCα and PKCδ, suggesting a cross-talk between tyrosine
phosphatase and PKC pathways. However, TC-PTP does not affect S279 and S282
phosphorylation levels.
Since Cx43 is a highly phosphorylated protein, understanding the effect of
phosphorylation would be fundamental for deciphering the regulatory mechanism of gap
junction function. We know that Y247 phosphorylation disrupts tubulin binding; Y265
phosphorylation is involved in the chronical decrease of gap junctional communication;
while S368 and S279/282 phosphorylation lead to acute gap junction closure. By using dye
transfer and TX100 assay, we observed that the activation of v-Src significantly decreased
gap junctional communication, while dephosphorylation by TC-PTP partially reversed
channel closure caused by v-Src as well as stabilized gap junctions at the plaque. Similar
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as Src, Tyk2 phosphorylation decreases gap junction plaque stability and increase turnover
rate. These observations are in agreement with reported effects of phosphorylation on these
involved individual residues. Since TC-PTP does not decrease S279/282 phosphorylation
level, we tried to identify if any serine phosphatase could dephosphorylate these sites. An
in vitro phosphatase screening assay was conducted using phospho-peptides with
pS279/282 or pS368 as substrate. Unfortunately, only PP2A present a moderate efficiency
on dephosphorylating pS279/282, although PP2A targeted pS368 with a high efficiency.
These results from in vitro experiment need to be validated in cell system.
Our data implicate that Tyk2 not only regulates Cx43 translationally, but also increases
Cx43 expression transcriptionally. Evidence show that the Cx43 protein level increased
acutely (in cell lines) but decreased chronically (in animal model) with high level of Ang
II stimulation (Iravanian et al., 2011; Jia et al., 2008; Sovari et al., 2011). Ang II increased
Src while decreasing TC-PTP expression in vascular smooth muscle cells (Touyz et al.,
2002; Tsiropoulou S, 2014). Therefore, we propose a hypothetic model of Ang II induced
pathogenesis in cardiovascular system: over-activation of Ang II increases Src and Tyk2
activation and decreases TC-PTP expression, thus Cx43 phosphorylation level is increased
resulting in Cx43 internalization. To compensate, Tyk2 may increase Cx43 level through
STAT3 in the early stage; however, the Cx43 level eventually drops due to the increased
degradation. Since our studies are based on Cx43 model cell lines (NRK and LA-25), not
cardiovascular cells, further studies in a mouse model or cardiomyocytes may be needed
to test our hypothetic model. Our findings provide a molecular mechanism of Cx43
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remodeling in cardiac pathological situation. Understanding phosphorylation/dephosphorylation of Cx43 will help build a better foundation to modulate the regulation of
gap junction channels and benefit human health.

18. Future Directions
18.1 The Potential Role of PTP1B in the Regulation of Cx43 ERAD
PTP1B and TC-PTP exhibit high identity in their catalytic domain (Iversen et al., 2002).
PTP1B mainly locates in the ER while TC-PTP mainly locates in the nucleus and can
translocate to the cytoplasmic membrane (Bourdeau et al., 2005). PTP1B and TC-PTP
share some membrane protein substrates such as EGFR and PDGFR (Dube and Tremblay,
2005). Inspired by our discovery of the interaction between TC-PTP and Cx43, we
hypothesize that PTP1B interacts with Cx43 in ER and regulates Cx43 ERAD. The other
rationale include the facts that 1) Cx43 is phosphorylated as early as in the ER or Golgi
apparatus (Laird et al., 1995); 2) PTP1B is a mediator of ERAD (Nezvitsky et al., 2014);
3) PTP1B dephosphorylates Tyk2 (Myers et al., 2001). These studies will provide a new
perspective of the regulatory role of phosphorylation on Cx43 gap junction.

18.2 The Mechanism for a Decreased Level of Cx43 in Cardiovascular Diseases
Our Tyk2 study shows that Cx43 level increases in response to high level of Ang II
stimulation in cells. However, in the ACS8/8 mouse model, Cx43 gap junctions decrease
significantly compare with normal mice. We hypothesize that Ang II stimulation induces
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the increase of Cx43 synthesis as a compensation mechanism of reduced gap junction
channel at the plaque caused by increased internalization. In the long term, Cx43 level
decreases due to degradation. Further studies are necessary to prove this hypothesis. Also,
the mechanism of transition from the increase to the decrease of the Cx43 protein level
could be essential to the progression of cardiovascular pathology. Moreover, we are
interested in the cellular destiny of these redundant Cx43. Do they work as signaling
molecules in the cytoplasm and trigger the feedback mechanism to decrease Cx43
expression? And what degradation pathway do they undergo?
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